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Glossary of terms
Blood-borne viruses (BBVs): viruses that some 
people carry in their blood and that can be spread 
from one person to another. Those infected with 
a BBV may show little or no symptoms of serious 
disease, but other infected people may be severely 
ill. An infected person can transmit a BBV to another 
person by various routes and over a prolonged 
time period. These viruses can be found in, and 
transmitted through, other body fluids besides blood. 
The most prevalent BBVs in people who use drugs 
are:
» human immunodeficiency virus (HIV) – a virus 
which causes acquired immunodeficiency 
syndrome (AIDS), a disease affecting the body’s 
immune system, and
» hepatitis B virus (HBV) and hepatitis C virus (HCV) 
– BBVs causing hepatitis, a disease affecting  
the liver.
Co-occurring serious mental health problems and 
alcohol/drug use (COSMHAD): having co-occurring 
severe mental health problems and problem 
substance use. This term replaces the terms ‘dual 
diagnosis’ and ‘co-occurring disorders’, which have 
historically been used in practice and in the literature 
around substance use and mental health. 
Health Service Executive (HSE): the Government 
agency that provides all of Ireland’s public health 
services in hospitals and communities across the 
country.
Homelessness: the state of being without stable, 
suitable, permanent housing; this includes rough 
sleeping, as well as residing in hostels, the homes of 
others, or any other insecure/unsuitable housing.
Housing First: an approach to ending homelessness 
that focuses on providing immediate, permanent, low-
barrier, non-abstinence-based supportive housing for 
individuals with lived experience of homelessness.
Illicit drugs: drugs that are controlled/prohibited 
under national (e.g. Misuse of Drugs Act, 1977) or 
international (e.g. United Nations Conventions) 
legislation; such drugs include non-medical cannabis 
products, amphetamine-type stimulants, illicit opioids 
(such as heroin), and formerly new psychoactive 
substances (e.g. synthetic cannabinoids).
Inclusion health initiatives: the concept of inclusion 
health is founded on the premise that not all citizens 
have access to the highest standards of healthcare, 
and that there are challenges to meeting the 
healthcare needs of socially excluded individuals 
and their communities. This population has poorer 
predicted health outcomes and a shorter life 
expectancy than the majority of the population. The 
aim of inclusion health initiatives is to increase the 
understanding and visibility of the healthcare needs 
and health outcomes of socially excluded groups 
(Davis & Lovegrove, 2016).
Low-threshold services: services (often outreach) 
for anyone who takes substances, and because of 
this finds themselves getting into difficulties either 
with their substance use or with other areas of their 
life. ‘Low threshold’ just means that anyone can get 
help, even if they do not want to drink less or stop 
taking drugs. Help can include, for example, debt, 
accommodation, or harm reduction services, including 
overdose prevention (Public Health Agency, 2018).
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Opioid substitution therapy: a type of harm 
reduction initiative that offers people who are 
dependent on opioids (such as heroin) an alternative, 
prescribed medicine – typically methadone or 
buprenorphine – which is swallowed rather than 
injected. This approach is also sometimes called 
opioid agonist therapy.
Polysubstance use: the use of multiple substances 
within a specified period of time. Substances may 
be used at the same time, or within the same use 
episode. This includes the use of substances and 
medicines to ameliorate adverse drug effects.
Problem drug use: high-risk drug use, which refers to 
the long-term use of drugs and to behaviours, such 
as injecting drugs, which place a person at a higher 
risk of health, psychological, or social problems. The 
European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) defines problem drug use as 
“injecting drug use or long duration/regular use of 
opioids, cocaine and/or amphetamines” (EMCDDA, 
2020a), but this definition specifically excludes the 
use of other drugs – such as prescription medicines, 
ecstasy, or cannabis – which may also be associated 
with poor health and social outcomes.
Problem substance use: a pattern of harmful use 
of any substance, such as alcohol and other drugs 
(whether illegal or not), as well as some substances 
that are not drugs at all.
Psychologically informed environments: an 
approach within the field of homelessness research 
to understanding people’s behaviours as a result of 
their emotional and psychological needs, which often 
stem from trauma.
Seroconversion rate: the time period during which a 
specific antibody develops and becomes detectable 
in the blood.
Successful completion of treatment: there is no 
normalised definition of ‘successful treatment’ in the 
literature, thus the research team was guided by the 
outcomes used by authors in the included reviews, 
rather than using an existing definition of successful 
treatment. For example, ‘successfully improved 
housing stability’ was defined as spending more days 
housed and being more likely to be housed at 18–24 
months after intervention (Baxter et al., 2019).
Supportive housing: a service model which provides 
independent housing with additional community 
supports for people experiencing homelessness 
and other complex needs (Henwood et al., 2013). 
The terms ‘supportive’ and ‘supported’ are used 
interchangeably in the literature, but for the purpose 
of this review, we will use the term ‘supportive’.
Systematic review: a review that typically involves 
a detailed and comprehensive plan and search 
strategy developed prior to the review, with the 
goal of reducing bias by identifying, appraising, 
and synthesising all relevant studies on a particular 
topic. This report is a review of reviews, which is a 
type of systematic review, but focuses on analysing 
other reviews, including, but not limited to, other 
systematic reviews.
Trauma-informed care: an approach to working 
with people which takes into account people’s 
experiences of trauma and aims to ensure that the 
services provide effective support and do not re-
traumatise people.
Treatment entry/engagement and retention: refers 
to engaging the population of interest to enter 
treatment/engage with a service, and to those who 
complete treatment activities as planned. ‘Treatment’ 
was deemed to be any treatment or service provision 
for people who are homeless and use substances, 
which reports on substance use outcomes (and 
potentially other outcomes).
Treatment outcomes: the results of a treatment, 
which may include measures such as use of the 
primary drug of concern, use of illicit substances 
alongside prescribed opioid substitution therapy,  
or drug injecting, as well as criminal justice  
system outcomes.
Vocational services: services that offer support to 
people who wish to overcome personal and social 
barriers which they feel are holding them back from 
education, training, or employment. Vocational 
services can also support people in their recovery 
through a wide range of rehabilitation resources.
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Introduction
People who are homeless have complex and 
challenging lives. They tend to have worse physical 
and mental health, and are more likely to report 
problem substance use, than the general population. 
Substance use is more prevalent among people who 
are homeless than in the general population, and 
providing support services and drug treatment in a 
holistic way for this population should be a priority 
(St Mungo’s, 2020). Increasing the provision of 
evidence-based support may lead to improvements 
in health, well-being, and quality of life (QoL), and to 
a reduction in costs to healthcare and wider public 
services. The Irish National Drugs Strategy aims to 
improve access to treatment services for people 
who are homeless who use drugs and have complex 
needs.  
On behalf of the Department of Health, the Health 
Research Board commissioned this report to 
systematically review and synthesise the international 
evidence on the efficacy of interventions designed 
to serve this population. This synthesis will inform 
the development of policies regarding the provision 
of services to people who are homeless. This 
report comprises two parts: the first part 
presents a description of the current trends relating 
to drug use and of the current services in Ireland 
in primary care, mental health, and drug treatment 
settings for people who are homeless who use 
drugs; the second part is an integrative review 
of the international research evidence regarding 
interventions aiming to address the needs of  
this population.
Trend analysis
Recent data show that illicit drug use in the general 
population in Ireland increased between 2010 and 
2020. Substance use is more commonly reported 
among people who experience homelessness than 
it is in the general population. Polysubstance use 
is also high within this population, particularly the 
concurrent use of illicit drugs and alcohol. There 
are currently gaps in the data available for this group 
which makes it difficult to establish service and 
treatment need. For example, there are no data on 
drug-related deaths for people who are homeless. 
The number of people who are homeless and have 
accessed drug treatment services has increased 
since the mid-2010s, which could indicate either 
improvements in service provision and greater reach, 
or an increase in the number of people who are 
homeless who use drugs in Ireland.
Overview of services in Ireland for 
people who are homeless who use 
drugs 
There appears to be a wide range of services in 
Ireland for people who are homeless and use drugs. 
These include health and social care services 
specific to substance use, such as counselling; drop-
in centres; assessment and intervention advice; 
information and education; ongoing support; follow-
up care; and a drug screening facility. Outreach 
clinics are also available across Ireland. Specific 
programmes relevant for people who are homeless 
include the Health Service Executive Social Inclusion 
programme, which is designed specifically for 
marginalised groups to help enable and improve 
Executive summary
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their access to mainstream services (HSE, 2020). For 
example, the Inclusion Health Service at St James’s 
Hospital attends to the complex needs of marginalised 
groups, such as people who are homeless and people 
who use drugs (HSE, 2017). Other existing services 
include abstinence-based drug treatment services, 
such as residential rehabilitation, as well as harm 
reduction drug services, such as prescribing services 
(including opioid substitution therapy (OST)); and 
static, pharmacy, and outreach needle and syringe 
programmes (NSPs). There are also housing support 
services across Ireland, such as transitional housing 
and emergency accommodation provision. It is 
important to note that many services across Ireland 
take a holistic approach to treatment and support 
and it is therefore not possible to categorise them 
neatly by service type. In particular, many third 
sector organisations offer a range of services in order 
to best meet people’s needs. These can include drug 
treatment services, other harm reduction services, 
housing support services, and more general health 
and social care services, among others.
Evidence review on effective 
interventions for people who are 
homeless and use drugs
This systematic review of reviews aimed to synthesise 
international evidence on effective interventions 
for this population. Twenty-two publications (18 
published papers and 4 grey literature reports) 
published between 2004 and 2020 were included. 
Thirteen out of the 18 included academic reviews 
were deemed to be systematic (with 2 of these also 
including a meta-analysis), and 5 were deemed to 
be non-systematic. Twelve of the reviews included 
quantitative studies only, eight included different 
study types/mixed designs (including one realist 
synthesis), one presented a meta-ethnography and 
included qualitative studies only, and one was a 
review of reviews. Ten of the reviews were undertaken 
in the United Kingdom (UK), four in the United States of 
America (USA), four in Canada, three in Europe (Spain, 
Ireland, and a Dutch/Belgian collaboration), and one 
was an international collaboration by researchers 
from Switzerland, the UK, and Canada. Despite this, 
nearly all the reviews (n=19) were international in 
focus, although two reviews focused on the USA only 
and one focused on the UK only. Even though the 
focus of most of the reviews was international, the 
majority of the authors were based in the UK, and 
the majority of primary studies were undertaken in 
the USA. This may affect the generalisability of the 
findings to non-USA contexts. 
The focus of the included reviews varied, and a 
large number of interventions were investigated. 
The largest number of reviews (n=6) focused on 
housing interventions, including Housing First (HF) 
initiatives. Of the remaining reviews, four focused 
on interventions for people with co-occurring 
serious mental health problems and alcohol/drug 
use (COSMHAD); three focused on substance use 
treatment specifically; two investigated healthcare 
treatments and interventions in general; two focused 
specifically on case management interventions; one 
focused solely on Assertive Community Treatment 
(ACT); one focused on sexual health promotion 
interventions; one investigated the impact of harm 
reduction interventions on the incidence of hepatitis 
C virus (HCV); one examined the effectiveness of 
intentional peer support (IPS) for people who are 
homeless; and one examined emergency department 
(ED) based interventions. The primary outcomes of 
interest were treatment engagement and retention, 
and successful treatment completion. We also 
synthesised information relating to substance use 
outcomes, housing outcomes, and ‘other’ outcomes 
(primarily health and well-being outcomes).
Treatment engagement and retention
Treatment engagement and retention for the 
homeless population can be problematic regardless 
of intervention type. ACT can lead to increased 
engagement rates for people who experience 
homelessness and use drugs. In contrast, treatment 
engagement with intensive case management (ICM) 
can be low, with more than two-thirds of participants 
experiencing both substance use problems and 
homelessness who enrol in shelter-based ICM 
services dropping out of these programmes. There 
is some evidence to suggest that Motivational 
Interviewing and Motivational Enhancement Therapy 
can increase treatment engagement during the 
short term for those experiencing homelessness and 
COSMHAD. Adherence to highly active antiretroviral 
therapy (HAART) among people who use drugs is 
comparable to that among people who do not use 
drugs, but the addition of OST to HAART treatment 
for those who use drugs increases treatment 
adherence and leads to better treatment outcomes. 
Data from studies of HF interventions suggest that 
engagement can be difficult, and this was suggested 
to be due to the fact that, while supported and 
encouraged through a harm reduction approach, 
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treatment engagement within HF is ultimately self-
determined. Finally, there is evidence suggesting that 
the way that interventions are delivered can play a 
crucial role in treatment engagement and retention, 
with compassion, warmth, and a lack of judgement 
and stigma from the staff supporting individuals 
being paramount. 
Successful treatment completion
There is a lack of studies reporting on successful 
treatment completion, and (limited) data were only 
presented in two of the included reviews. One 
low-quality review presented evidence from four 
randomised controlled trials (RCTs) and one meta-
analysis of a linear, rigorous abstinence-contingent 
housing approach (called the Birmingham model), 
which suggests that treatment completion rates 
in such an approach (65% in the most recent trial) 
can be higher than the approximate 50% for social 
interventions (such as case management, congregate 
living, and vocational training), and comparable to 
those of modified therapeutic communities. There is 
some evidence that integrated approaches in short-
term residential programmes (lasting 6 months or 
less) for people with COSMHAD were associated with 
higher rates of programme completion. Moreover, 
there was evidence that monetary and non-
monetary incentives can increase completion rates 
of directly observed preventive therapy in young 
people with latent tuberculosis who are homeless; 
however, it was not specified whether they were also 
experiencing problem substance use. Lastly, there 
was some evidence that for people experiencing 
homelessness who also inject drugs, an accelerated 
hepatitis B virus (HBV) immunisation schedule (with 
doses administered at 0, 7, and 21 days, and a booster 
at 12 months) can result in superior completion rates, 
compared with traditional schedules that have similar 
seroconversion rates. 
Treatment outcomes: substance use
All the included reviews reported on some element 
of substance use outcomes and, overall, the results 
were mixed. Firstly, there is a large number of 
intervention types available for people experiencing 
homelessness with concurrent substance use 
problems. In general, the greater the level of 
integration and partnership working there is between 
programmes and agencies dealing with people who 
are homeless and have co-occurring substance 
use problems, the better the outcomes. Evidence 
suggests that harm reduction interventions can lead 
to decreases in drug-related risk behaviour (e.g. 
needle sharing) in this population in the same way as 
they do for other groups. Co-locating a number of 
harm reduction approaches together (termed ‘full 
harm reduction’) creates additional opportunities for 
clients that can lead to better outcomes than single 
(partial) harm reduction interventions. The reviews 
suggested that HF does not seem to impact either 
positively or negatively on substance use outcomes.
Treatment outcomes: housing
Reviews which reported on housing outcomes largely 
support the HF approach in terms of its effectiveness 
in increasing housing stability and retention, and 
indicate the HF approach as a preferred option due 
to the flexibility and harm reduction ethos associated 
with it. However, the reviews identified some issues 
relating to programme fidelity and type of HF housing 
(scattered versus single site). There is also some 
evidence that supportive housing can have a positive 
effect on housing stability. Other non-housing-
specific interventions can also have a positive effect 
on housing outcomes. Most notably, peer support 
interventions, with IPS specifically being assessed, 
can lead to a decrease in the number of homeless 
days and a reduction in relapse to homelessness. 
Evidence regarding case management interventions 
and their impact on housing outcomes is mixed and 
varies between intervention types.
Treatment outcomes: other
Some treatment outcomes that were not related 
to housing or substance use were reported. These 
related primarily to mental health and well-being 
outcomes, with mixed evidence regarding the 
effectiveness of the different interventions studied. 
There is some evidence from interventions delivered 
in the USA that permanent supportive housing for 
people experiencing homelessness and who have 
additional mental health problems can lead to a 
reduction in mental health symptoms, compared 
with a control condition. There is strong evidence 
that HF can improve measures of physical health in 
the short term for ‘housing-vulnerable’ adults. This 
included moderate-strength evidence for positive 
effects on personal well-being, mental health, and 
locality-related well-being (i.e. well-being related 
directly to one’s living situation and conditions), 
with no effects on personal finance or community 
well-being being reported. There is some evidence 
that the HF congregate model (where all residents 
live in one apartment block) can lead to greater 
improvements in mental health and QoL than the 
scattered HF model (where residents live in various 
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individual locations). Lastly, there is evidence that 
integration of services and holistic treatment for 
people with comorbidities and COSMHAD leads to 
better psychosocial and substance use outcomes.
Policy and research recommendations
People who experience homelessness and problem 
substance use are a population with complex needs. 
However, it is important to note that they are not a 
homogenous group. Individuals will be dealing with 
severe challenges imposed by being homeless, but 
may also be facing concurrent issues relating to 
substance use. There are gaps in monitoring and 
other routinely reported data that would provide 
better insights into the needs of this population, 
and the harms associated with substance use. This 
includes regular prevalence surveys; data on drug-
related deaths in people who are homeless; and 
infectious disease and blood-borne virus prevalence 
monitoring in people who inject drugs (PWID), 
including data on housing needs. A substantial 
evidence base exists regarding effective interventions 
for people who experience homelessness, and for 
people with problem substance use, but not enough 
research has been conducted that focuses on the 
unique needs of people who experience both, 
despite these issues commonly co-occurring. In 
order to ensure that the needs of this population are 
well met, targeted provision can be helpful. There are 
also specific subgroups within this wider population 
whose needs can be even more complex – for 
example, people who experience homelessness and 
COSMHAD. Other identity characteristics, such as 
gender, age, ethnic background, and experiences of 
physical disability/physical health problems, will also 
have an impact on a person’s needs, preferences, and 
overall treatment experience. Unfortunately, there 
are few studies that focus on making sure that people 
with these very complex and challenging experiences 
are well heard. It is also important to note that 
people who experience homelessness and problem 
substance use experience different circumstances 
and have different needs, wants, and preferences, 
and these are also likely to change over time, making 
listening to individuals and providing choice critically 
important. A balance is therefore needed between 
providing an approach that is tailored specifically 
to each individual, and delivering key components 
of evidence-based services and interventions. 
Currently, there is a lack of standardisation of 
measures and outcomes, which can make meaningful 
comparisons between different types of service 
models, and, subsequently, any distillation of key 
elements of success, challenging. 
Regarding specific intervention types, the evidence 
suggests that the HF model supports a flexible harm 
reduction approach that enables referral to other 
services needed by the residents. The evidence 
base strongly suggests consistent positive housing 
outcomes and the absence of negative effects on 
substance use, alongside some evidence for positive 
effects regarding physical health and well-being. We 
found that case management-type interventions can 
be effective, both when applied on their own and 
when combined with other interventions such as 
contingency management, positive reinforcement 
or incentives, art therapy, and health prevention 
and promotion programmes. ACT has consistently 
produced positive effects on housing stability and 
has been found to be cost-effective, but this model 
seems to be suitable mainly for those experiencing 
homelessness and COSMHAD. Finally, the evidence 
suggests that formal IPS can lead to positive housing, 
substance use, and well-being outcomes, and 
that it has the potential to have a positive impact 
on the peers who provide the support. For this 
reason, we recommend the development of peer 
support interventions for people who experience 
both homelessness and problem substance use. 
However, due care must be given to planning for the 
embedding of peers in services in order to ensure 
that they are respected, valued, and offer meaningful 




1.1 Chapter overview 
This chapter starts with the scope and aims of the 
review and then outlines the main types or models 
of treatment provided to people who use drugs, and 
those that might be most appropriate for people who 
are also experiencing homelessness. These service 
models are then discussed throughout the report. 
It then discusses a range of issues that should be 
kept in mind when thinking about meeting the needs 
of people with complex and very difficult lives. The 
chapter ends with a section exploring the relevance 
of COVID-19 for this group and for those providing 
services for them. 
1.2 Scope and aims of the review 
People who are homeless can be described as 
being without stable, suitable, permanent housing 
(Fountain et al., 2003). This includes those who are 
rough sleeping, as well as those who are residing 
in hostels, the homes of others, or any other 
insecure/unsuitable housing. This is the definition 
used for both parts of this report. The route into 
homelessness is complex and is generally a result 
of many contributing factors. Poverty is a key factor 
in the likelihood of someone becoming homeless 
(Bramley & Fitzpatrick, 2017), but many other factors 
- for example, childhood trauma, mental health 
problems, substance use, previous imprisonment, and 
a myriad of other issues - can increase the likelihood 
of someone becoming homeless (Fitzpatrick, Bramley, 
& Johnsen, 2013). Homelessness is a growing issue 
worldwide and, in Ireland, the Department of Housing, 
Planning and Local Government reported that there 
were approximately 6,262 adults who were homeless 
at the end of April 2020, or 9,335 people who were 
homeless when young people aged under 18 years 
were included (Department of Housing, Planning and 
Local Government, 2020). This has increased from 
approximately 3,800 adults who were homeless in 
Ireland in 2011 (Keogh et al., 2015).
The Irish National Drugs Strategy aims to improve 
access to treatment services for people who are 
homeless who use drugs and have complex needs. 
On behalf of the Department of Health, the Health 
Research Board commissioned this report to 
systematically review and synthesise the international 
evidence on the efficacy of interventions designed 
to serve this population. This synthesis will inform 
policies that are currently under review regarding the 
provision of services to people who are homeless. 
This report comprises two parts: the first part 
presents a description of the current trends relating 
to drug use and of the services in Ireland in primary 
care, mental health, and drug treatment settings 
for people who experience homelessness who use 
drugs; the second part is an integrative review of 
the international research literature providing a 
systematic evaluation of the evidence regarding 
interventions aiming to address the needs of this 
population. 
1.3 Models of drug treatment for 
people who are homeless 
If the needs of people who are homeless and use 
drugs are to be met, it is essential that a range of 
treatments, services, and supports are available. 
Research shows that a range of support services 
exist for this group, and that treatment ranges from 
high-threshold, abstinence-based approaches 
to lower-threshold, harm reduction approaches. 
Internationally, examples of existing support services 
for people who are experiencing homelessness 
and use substances include, but are not limited to: 
joint working and case management services; fixed-
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site detoxification services; transitional housing 
services; HF services; permanent supportive housing; 
preventive services; peer-mentoring interventions; 
and medical services (Bates et al., 2017; Pleace, 
2008). One of the main challenges of abstinence-
based approaches for people who are homeless 
and use drugs is that it can be hard for individuals 
to adhere to what is expected of them, particularly 
when their lives are chaotic. They are exposed to 
more harm but are less able to protect themselves 
from that harm (Advisory Council on the Misuse of 
Drugs (ACMD), 2019; Pleace & Quilgars, 2013). Harm 
reduction approaches place fewer expectations on 
service users and aim to minimise harms related to 
substance use without the requirement of abstinence 
(International Harm Reduction Association, 2009; 
Pleace & Quilgars, 2013). Harm reduction may include 
services supporting safer drug use, such as needle 
and syringe programmes (NSPs); take-home naloxone 
to counter the effects of an opioid overdose; 
medically supervised safer injection facilities to 
reduce risky injection behaviours; outreach services; 
education; psychological interventions; and health 
promotion (ACMD, 2019; Groundswell, 2012). 
In Chapter 3 we cover the wide range of services 
that are currently available in Ireland. A brief, high-
level summary is provided here to indicate how 
these broad treatment categories relate to service 
provision on the ground. In Ireland, the Health 
Service Executive (HSE) provides public health and 
social care services. Health and social care services 
specific to substance use include counselling; a 
drop-in centre; assessment and intervention advice; 
information and education; ongoing support; follow-
up care; and a drug screening facility. Outreach 
clinics are also available across Ireland. Specific 
programmes relevant for people who are homeless 
include the HSE Social Inclusion programme, which 
is designed specifically for marginalised groups to 
help enable and improve their access to mainstream 
services (HSE, 2020). For example, the Inclusion 
Health Service at St James’s Hospital attends to 
the complex needs of marginalised groups, such 
as people who are homeless and people who use 
drugs (HSE, 2017). Other existing services include 
abstinence-based drug treatment services, such 
as residential rehabilitation, as well as harm 
reduction drug services, such as prescribing services 
(including opioid substitution therapy (OST)); and 
static, pharmacy, and outreach NSP services. The 
passing of the Misuse of Drugs (Supervised Injecting 
Facilities) Act 2017 enabled the establishment of a 
medically supervised injecting facility in Merchants 
Quay Ireland in Dublin, which would provide services 
for people who are homeless, although at the time 
of writing this it has yet to be opened (Merchants 
Quay Ireland, 2020). There are also housing support 
services across Ireland, such as transitional housing 
and emergency accommodation provision. 
In summary, it is important to highlight that many 
services across Ireland take a holistic approach 
to treatment and support and it is therefore not 
possible to categorise them neatly by service type. 
In particular, many third sector organisations offer 
a range of services incorporating those already 
mentioned in order to best meet people’s needs. 
These can include drug treatment services, other 
harm reduction services, housing support services, 
and more general health and social care services, 
among others. We will return to the service mapping 
in Chapter 3. 
1.4 People with complex and 
challenging lives 
This report focuses specifically on treatment 
services for people who use drugs and experience 
homelessness. It is crucial, however, to pay attention 
to the complexity of wider intersecting health and 
social challenges that often co-occur in the lives of 
individuals. This section aims to cover some of the 
most important of such considerations: physical 
health problems, criminal justice contact, and 
inclusion health approaches; co-occurring severe 
mental health problems and alcohol/drug use 
(COSMHAD); trauma-informed and psychologically 
informed environments (PIEs), and the importance of 
taking a life course approach to supporting people. 
1.4.1 Physical health, criminal justice 
involvement, and inclusion health 
approaches
People experiencing homelessness are vulnerable to 
‘tri-morbidity’, with poor mental and physical health 
and problem substance use (Hewett & Halligan, 
2010). The use of alcohol and drugs is often a factor 
contributing to someone becoming homeless, and 
can increase as a way of coping with homelessness 
(Crisis, 2011). People who are homeless often report 
significantly worse physical and mental health than 
the general population (Hwang et al., 2005; Wright & 
Tompkins, 2006; Ijaz et al., 2017; Aldridge et al., 2018). 
They are four times more likely to die prematurely, 
and seven times more likely to die as a result of drug 
use, than the general population (Morrison, 2009), 
and the longer a person is homeless, the higher 
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their risk of ill health and premature death (Hewett 
& Halligan, 2010). Health problems can include a 
range of issues, many of which can be co-occurring. 
For example, diabetes, skin conditions, and 
respiratory diseases such as asthma, bronchitis, and 
pneumonia, among others, are often seen in people 
who are homeless (Edidin et al., 2012). The majority 
of physical health problems experienced by the 
homeless population are also seen within the general 
population, but people who are homeless usually 
experience them at a higher frequency or severity 
(Baggett et al., 2010; Fazel, Geddes & Kushel, 2014; 
Herndon et al., 2003). People who are homeless also 
have a higher risk of developing diseases that are 
rare within the general population, such as blood-
borne viruses (BBVs) including hepatitis and human 
immunodeficiency virus (HIV) (Hwang et al., 2009; 
O’Reilly et al., 2015). 
Many people who are homeless do not typically 
access healthcare services until reaching a crisis 
point, utilising accident and emergency services 
rather than primary care (Hewett & Halligan, 2010; 
Anderson & Ytrehus, 2012; Wise & Phillips, 2013; 
Queen et al., 2017), which is costly to healthcare 
funders (Hewett & Halligan, 2010; Zaretzky et al., 
2017). Furthermore, when they do access mainstream 
healthcare or substance use services, their needs are 
not generally well met. They often experience stigma 
and negative attitudes from staff, and encounter 
inflexible services that do not meet their needs 
(Anderson & Ytrehus, 2012; Wise & Phillips, 2013; Mills, 
Burton & Matheson, 2015; Pauly et al., 2015). 
However, despite higher rates of physical and mental 
ill health, people who are homeless attend primary 
care and preventive services less often than the 
general population (Keogh et al., 2015), and access 
to treatment and services can be particularly 
challenging (Drake, Osher & Wallach, 1991; The 
Shaw Mind Foundation, 2020). Barriers to accessing 
appropriate care can include perceived prejudice, 
negative previous experiences, lack of coordination 
between healthcare services, cost of medication, lack 
of continuity of care, other priorities such as shelter 
and food, challenges with strict appointment times, 
and complex administrative forms (ACMD, 2019; Keogh 
et al., 2015). These barriers can lead to delayed or 
no treatment, which in turn can increase the risks 
of more serious health problems. Indeed, globally, 
the rate of hospital admissions for people who are 
homeless has been shown to be between two and 
five times higher than for the general population 
(Chambers et al., 2013). In Ireland, it is estimated 
that up to 45% of people who are homeless are not 
registered with a general practitioner (GP) (O’Reilly et 
al., 2015). As documented in international research, 
emergency hospital admissions are higher for people 
who are homeless than for those in the general 
population, but people who are homeless are also 
more likely to leave hospital early without having 
accessed appropriate treatment (Ní Cheallaigh et al., 
2017).
There are also strong links between involvement in 
the criminal justice system and homelessness. The 
relationship is complex and often cyclical in nature 
(Hickey, 2002). The report Hard Edges: Mapping 
Severe and Multiple Disadvantage in England found 
that in a population of more than 580,000 people 
experiencing severe and multiple disadvantage in 
England, approximately 112,000 had a history of 
offending, and around 31,000 had experienced 
homelessness and offending (Bramley et al., 
2015). A range of structural inequalities influence 
homelessness following release from prison, including 
a lack of adequate and affordable housing, a lack 
of substance use treatment, and a lack of family 
support services (Hickey, 2002). Recommendations 
for service providers to reduce the rates of 
homelessness for those in the criminal justice system 
include: changes to custodial sentences for minor 
offences; providing access to training, education, and 
support in prison; needs assessment immediately 
prior to release from prison; family-friendly facilities 
in prison; family mediation and support services; 
greater partnership working; substance use 
treatment and support in prison and on release; and 
provision of suitable accommodation upon release 
from prison (Hickey, 2002; Homeless Link, 2011). 
Inclusion health aims to prevent and reduce social 
and health inequalities for marginalised populations, 
including those experiencing homelessness and drug 
use, criminalisation, among other issues (Luchenski 
et al., 2018). In their systematic review, Luchenski 
and colleagues identified a range of inclusion health 
interventions. These included pharmacological 
interventions for people with problem substance 
use and mental health problems, including BBV 
treatments; psychosocial interventions, including  
integrated mental health and drug treatments; case 
management; harm reduction schemes, including 
BBV screening; and provision of housing (Luchenski 
et al., 2018). Several systematic reviews have 
indicated that tailoring primary care services to those 
experiencing homelessness (Hwang & Burns, 2014), 
providing case management (Hwang et al., 2005; 
Fitzpatrick-Lewis et al., 2011; de Vet et al., 2013), and 
providing housing (Fitzpatrick-Lewis et al., 2011) can 
be effective in improving mental and physical health, 
and in assisting with addressing problem substance 
use, among people who are homeless. 
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1.4.2  Co-occurring serious mental health 
problems and alcohol/drug use 
(COSMHAD) 
As with physical health, people who are homeless are 
also much more likely than the general population 
to experience mental health problems (Arnold 
et al., 2020; Duke & Searby, 2019; O’Reilly et al., 
2015), with COSMHAD affecting around 10-20% of 
those experiencing homelessness (Rees, 2009). 
People experiencing homelessness and COSMHAD 
are more likely to report more severe symptoms 
and more ill health than those without COSMHAD 
(Rees, 2009; Megnin-Viggars et al., 2015; Schutz 
et al., 2019). Systematic reviews have found that a 
range of psychosocial treatments can be effective 
for those experiencing COSMHAD, including 
Motivational Interviewing, cognitive behavioural 
therapy, case management, and skills training 
(Horsfall et al., 2009). Additionally, there are a range 
of factors which should be included in all treatment 
approaches. These include having multidisciplinary 
team approaches, long-term follow-up, being well 
coordinated, having highly trained specialist staff, and 
involving a range of programme types (Horsfall et al., 
2009). There is also evidence that those accessing 
these treatments are highly satisfied (Schulte, Meier 
& Stirling, 2011). The most consistent finding is that 
treatment should be integrated and delivered by 
multidisciplinary teams (Drake et al., 2004; Horsfall 
et al., 2009). However, in practice, such services 
continue to be provided separately (Bjørkquist & 
Hansen, 2018; Foley, 2018). In Ireland, there has been 
increasing awareness of COSMHAD in recent years, 
but this does not appear to have resulted in service 
or policy changes (MacGabhann, Moore & Moore, 
2010). National guidelines, national policy responses, 
estimates of its prevalence, and the involvement 
of those with lived experience of COSMHAD in 
education and practice developments have been 
recommended (MacGabhann et al., 2010). 
1.4.3 Trauma-informed and psychologically 
informed approaches 
Pathways into homelessness are often explained as 
being a result of childhood trauma. Fitzpatrick and 
colleagues (2013) conducted a multistage quantitative 
survey with 452 people in seven cities in the United 
Kingdom (UK). Childhood trauma and deprivation 
were significant predictors of future homelessness. 
Other studies have identified being care experienced 
and childhood poverty as predictors (Piat et al., 
2015; Bramley & Fitzpatrick, 2017). Trauma-informed 
and psychologically informed care have grown in 
recognition in the homelessness and problem drug 
use fields in recent years for this reason. They come 
from an understanding that people who are homeless 
are likely to have experienced trauma in their early 
years, adolescence, and adulthood, and that this may 
be a contributing factor to their becoming homeless 
(Johnson & Haigh, 2010; Breedvelt, 2016). Drug use 
can also be a way of coping with trauma (Homeless 
Link, 2017). 
Trauma-informed care (TIC) is an approach that can 
be adopted by services working with people who 
are homeless who use drugs in order to ensure that 
the services provide effective support and do not 
re-traumatise people (Homeless Link, 2017). Such 
approaches involve trauma awareness (helping 
service providers understand trauma and change 
organisational practices accordingly); an emphasis 
on safety (building physical and emotional safety 
for people by being aware of power dynamics, 
boundaries, privacy, and mutual respect, as well 
as cultural differences); opportunities to rebuild 
control (by providing choice to people and having 
predictable environments to enable self-efficacy and 
control); and a strengths-based approach (focusing 
on strengths to develop coping skills and resilience) 
(Hopper, Bassuk, & Olivet, 2010; Homeless Link, 
2017). There is evidence that TIC approaches support 
better outcomes than non-TIC approaches, in terms 
of functioning, trauma symptoms, drug/alcohol use, 
mental health symptoms, housing stability, and less 
use of crisis-based services (Hopper et al., 2010). 
There is also evidence that service users report 
greater self-efficacy, increased sense of safety, and 
better collaboration with staff (Hopper et al., 2010). 
Staff also report greater collaboration with service 
users, improved staff morale, greater empathy for 
colleagues, awareness of their own traumatic stress, 
and more effective services (Hopper et al., 2010; 
Damian et al., 2017). In their systematic review of 
trauma-informed organisational interventions, Purtle 
(2020) found that, despite some positive outcomes for 
clients, the strength of the evidence is limited due to 
the research design of the studies. Many published 
studies regarding TIC conclude that further research 
is required to assess the effectiveness of such 
approaches.
PIEs are a related approach to TIC and are informed 
by the emotional and psychological needs of the 
client group. PIEs have low-threshold engagement 
(informal engagement sessions in an open 
environment; Keats et al., 2012); place an emphasis 
on the physical environment and social spaces 
(having a welcoming, well-decorated, and well-lit 
service; Keats et al., 2012; Breedvelt, 2016); develop 
an  organisational culture of reflexivity, learning, 
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and discussion centred around the psychological 
needs of the clients (Johnson & Haigh, 2010); value 
relationships with clients (Johnson & Haigh, 2010); 
and foster a sense of shared ownership in the service 
(Westaway, Nolte & Brown, 2017). PIEs have been 
shown to improve client outcomes in terms of mental 
health and well-being; housing; behavioural issues; 
involvement with criminal justice and emergency 
services; and engagement with health and other 
care services (Williamson & Taylor, 2015; Cockersell, 
2016; Phipps, 2016). Despite these positive outcomes, 
the evidence base regarding PIEs is somewhat 
limited, with data from only small-scale studies. 
More rigorous research is required to examine the 
effectiveness of PIEs. 
1.4.4 Life course approaches
There are also links between the life course and 
substance use, with most substance use beginning 
during adolescence (Bonomo & Proimos, 2005; 
Mirza & Mirza, 2008). The earlier a young person 
uses substances, the more likely they are to use 
them more frequently and develop substance 
use problems (Bonomo & Proimos, 2005; Mirza & 
Mirza, 2008; Bremner et al., 2011; Feinstein, Richter 
& Foster, 2012). Those at higher risk of drug use 
typically experience a range of negative experiences 
during childhood, including parental substance use, 
life stress, environmental factors and low social 
attachment (Hser, Longshore & Anglin, 2007). This 
also links with the evidence regarding adverse 
childhood events (ACEs), whereby those who have 
experienced negative events in childhood (such 
as abuse, neglect, or parental substance use or 
imprisonment) are more likely to experience a range 
of physical and mental health problems, including 
problem drug use. In a study by Dube et al. (2003), 
there were strong links between ACEs and early 
initiation of drug use. Compared with people who 
had not experienced any ACEs, people with five or 
more ACEs were 7–10 times more likely to report 
illicit drug use and problem drug use (Dube et al., 
2003). Thus, the factors that increase the likelihood 
of someone using drugs are also those that affect 
whether or not they may become homeless. 
Adulthood experiences are also a key factor in the 
pathways into homelessness. Housing and labour 
markets; social security policies; income inequality 
and poverty; education; relationships; long-term 
illness/disability; and involvement in the criminal 
justice system influence the likelihood of someone 
experiencing homelessness (Fitzpatrick, Johnsen 
& White, 2011; Fitzpatrick et al., 2013; Bramley & 
Fitzpatrick, 2017). In their quantitative study in 
seven UK cities, Fitzpatrick and colleagues (2013) 
examined the temporal sequencing of homelessness 
experiences. Certain adverse events tended to occur 
at different times in the lives of people experiencing 
homelessness, with leaving home or care and 
substance use occurring in the mid to late teens; 
prison, anxiety, and depression and injecting drug use 
in the early 20s; being hospitalised for a mental health 
problem, redundancy, and bankruptcy in the late 20s; 
and divorce or death of a partner occurring in the 
30s or 40s (Fitzpatrick et al., 2013). Thus, there are a 
range of factors across the life course that influence 
the likelihood of someone becoming homeless. 
1.5 Implications of COVID-19 
While this study began before the COVID-19 
pandemic, it is important to pay brief attention to 
how this has impacted the study topic. In March 
2020, the World Health Organization declared a 
worldwide pandemic relating to the novel coronavirus 
disease 2019 (COVID-19). COVID-19 is a disease of 
the respiratory system (World Health Organization, 
2020) which has spread to over 150 countries 
worldwide (Wei & Shah, 2020). While everybody is 
at risk of infection, some individuals are more at 
risk of ill health from COVID-19 compared with the 
general population, either due to underlying health 
conditions or to public health measures introduced 
to try to contain the virus, which have a detrimental 
effect on already challenging life situations (European 
Centre for Disease Prevention and Control, 2020). 
While some underlying health conditions increase 
the risks associated with COVID-19, the social 
determinants of health (SDOH) also make people 
from marginalised communities more vulnerable  
even when they have no underlying conditions, with 
people who are homeless being one such group 
(Bambra et al., 2020). 
Services have responded in several ways to support 
people who are homeless who use substances 
during the pandemic, including ensuring that people 
who use drugs have access to COVID-19 screening 
and testing (Dunlop et al., 2020); increasing the use 
of telehealth for consultations and prescriptions 
(Barney et al., 2020; Conway, Truong & Wuerth, 2020; 
Jemberie et al., 2020); changing to daily pick-up 
of methadone and buprenorphine prescriptions to 
weekly or monthly, where appropriate (European 
Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA), (2020b); decreasing the use of medication 
supervision regimes (Dunlop et al., 2020); improving 
access to naloxone (Dunlop et al., 2020; O’Carroll, 
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Duffin and Collins, 2020); delivering medication to 
family members (American Society of Addiction 
Medicine, 2020); home delivery of medications such 
as methadone and buprenorphine (EMCDDA, 2020b; 
NHS Substance Misuse Alliance, 2020; O’Carroll, 
Duffin & Collins, 2020); increasing the availability of 
benzodiazepine maintenance therapy (O’Carroll et 
al., 2020); increasing the supply of clean injecting 
equipment (Dunlop et al., 2020); and releasing 
general guidance about reducing COVID-19 spread 
in recovery and treatment services (Cooksey et 
al., 2020; Dong et al., 2020) and reducing harm for 
people who use drugs in shelter settings (Hyshka et 
al., 2020). In Ireland specifically, a range of services 
were introduced in response to the COVID-19 
pandemic, particularly in relation to homelessness, 
harm reduction, and drug use (O’Carroll et al., 2020). 
These included improved access to methadone 
treatment; improved access to naloxone; shifting 
the management of high-dose benzodiazepine 
dependency towards maintenance therapy; home 
delivery of prescription medication; rapid rehousing 
of people who were homeless who were at increased 
risk of illness; redeployment of staff; and offering new 
services (O’Carroll et al., 2020). 
1.6 Chapter summary 
In this chapter we have presented the scope and 
aims of the review and outlined the main types or 
models of treatment provided to people who use 
drugs, and those that might be most appropriate for 
people who are also experiencing homelessness. 
It is essential that a range of treatments, services, 
and supports are available to ensure that the 
needs of people who are homeless and use drugs 
are met. A range of support services exist for this 
group, with treatment ranging from high-threshold, 
abstinence-based approaches to lower-threshold, 
harm reduction approaches. We discussed a range 
of issues that should be kept in mind when thinking 
about meeting the needs of people with complex and 
very difficult lives, such as: physical health problems 
and inclusion health approaches; co-occurring 
severe mental health problems; trauma-informed 
and psychologically informed environments; and 
the importance of taking a life course approach to 
supporting people. The chapter ended with a section 
exploring the relevance of COVID-19 for people 
experiencing homelessness and for those providing 
services for them. 
Chapter 2 provides a project overview, the study 
research questions, and the outcomes of interest, 
and states how the methods for conducting the 
two parts of the review were chosen and executed. 
Chapter 3 presents the contextual background to 
the project and should be viewed as a standalone 
piece, presenting the trend analysis of the current 
drug situation in Ireland and the mapping of existing 
drug services for people who are homeless and use 
drugs in Ireland. Chapter 4 concerns the systematic 
review of reviews of the international evidence 
regarding treatment and intervention for people 
who are homeless and use drugs. Finally, Chapter 5 
presents a discussion of the report's main themes 
and conclusions, particularly relating to the review 
of reviews presented in Chapter 4. It includes 
strengths and limitations of the study, identifies 
research and evidence gaps, and ends with a set of 
recommendations for policy and practice. 
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2.1 Chapter overview 
This chapter provides information about both 
sections of the study (trends and service mapping, 
and the review of reviews), and is supported by 
appendices with further detail. A systematic review 
of reviews approach is appropriate where a large 
body of evidence already exists (sufficient numbers 
of primary studies and, subsequently, a body of 
existing reviews) on the topic under consideration, 
and is considered a “logical and appropriate next 
step…allowing the findings of separate reviews to 
be compared and contrasted, thereby providing 
decision-makers with the evidence they need” (Smith 
et al., 2011, p. 2). The primary research question 
for this review of reviews developed by the team 
in collaboration with the Health Research Board 
(HRB) and its stakeholders, is: What interventions 
are effective in engaging homeless people who use 
drugs in drug treatment services and in facilitating 
retention in treatment? The PICOS framework 
(population, interventions, comparators, outcomes, 
and study design) (Methley et al., 2014) was used to 
identify appropriate literature search terms (see 
Appendix 1). The research team extracted information 
regarding population parameters included in the 
search results but did not search separately for 
specific subpopulations (e.g. women, families). 
Although the search focused on controlled drugs, 
the team also extracted data about alcohol and 
prescription drugs if the selected reviews included 
such details. 
The main outcomes of interest in this review were: 
i) treatment entry/engagement and retention; and 
ii) treatment outcome and successful completion 
of treatment. Treatment entry/engagement refers 
to engaging the population of interest to enter 
treatment/engage with a service, and treatment 
retention refers to attrition rates throughout the 
treatment duration. ‘Treatment outcomes’ have 
been defined by primary study researchers as 
including, for example, use of the primary drug 
of concern, use of illicit substances alongside 
prescribed OST, or drug injecting, or connected to 
criminal justice involvement/offending behaviour. 
‘Successful treatment’ was more difficult to define, 
as this was also defined by primary study authors 
based on different follow-up times, and so the 
research team was guided by these definitions 
rather than using an existing definition of ‘success’. 
For example, Penzenstadler et al. (2019) measured 
success in terms of treatment engagement levels 
and reductions in substance use, and Turner et al. 
(2011) looked at success from the point of view of the 
incidence of new hepatitis C virus (HCV) infections. 
Looking at other interventions, Baxter et al. (2019) 
concluded that HF approaches successfully improved 
housing stability, which was defined as intervention 
participants spending more days housed and being 
more likely to be housed at 18–24 months after 
intervention. Similarly, Kertesz et al. (2009) identified 
HF success as better housing stability and housing 
retention after 5 years. Differences with regard 
to outcome measures and a lack of homogeneity 
across various psychosocial intervention studies are 
common and make pooling and generalisation of 
results difficult (Hunt et al., 2019). 
2.2 Trend analysis and mapping of 
service provision in Ireland 
Chapter 3 of this report contains a trend analysis 
using key epidemiological indicators included in the 
Irish national report for the EMCDDA, which includes 
data on prevalence, treatment demand, drug-related 
deaths, and health consequences, as well as social 
indicators used to monitor the situation and report 
information to the EMCDDA. For the review of the 
existing drugs situation in Ireland, the focus was on 
synthesising evidence from between 2010 and 2020 
(as per the systematic review), primarily through data 
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submitted to the EMCDDA (EMCDDA, 2019b), but 
also drawing upon secondary analysis of the sources 
listed in Appendix 2. Sources included reports, 
journal articles, and other relevant data. We also 
approached the HRB National Drugs Library to help 
identify further data from relevant primary studies 
undertaken in Ireland. It is important to note that the 
data provided to the EMCDDA on drug prevalence 
does not specifically include data on people who are 
homeless. However, prevalence estimates for the 
homeless population can be made using other data, 
such as reports from homelessness services, surveys 
of people who use drugs, and other secondary 
sources. The National Drug Treatment Reporting 
System (NDTRS) and the National Drug-Related 
Deaths Index include information on the housing 
status of each case recorded in these databases. 
An estimate of the proportion of people who use 
drugs presenting with communicable diseases or 
who are using NSP services was also available from 
the providers of these services, from the Health 
Protection Surveillance Centre, or from individual 
research studies.
Chapter 3 also includes a description of existing 
services that are provided to meet the needs of 
people who are homeless who use drugs, including 
low-threshold services, inclusion health initiatives, 
mobile health services, and public health services 
provided by the HSE. Methods focused on retrieving 
relevant information from the HRB’s monitoring 
work, and from the data sources listed in Appendix 
3. The review team worked closely with the HRB to 
define this search. We identified evidence/service 
information published since 2010 in order to capture 
the most up-to-date and relevant information 
through Google/Google Scholar searches. Additional 
searching to supplement these data was discussed 
with the HRB and drew upon additional resources 
and expertise, such as that provided through the HRB 
National Drugs Library. Information about services was 
also identified through contacting several key contacts 
working in third sector homelessness services in 
Ireland, who provided details about those services 
that were not identified through other searching. 
2.3 Review of reviews 
The second part of the evidence review provides 
a synthesis of international evidence regarding 
interventions in primary care, mental health, and 
drug treatment settings for people who are homeless 
and who use drugs. As there was a large body of 
existing evidence available on the topic, a systematic 
review of reviews was agreed to be an appropriate 
approach to the work. A review of reviews approach 
was also previously adopted by team members in The 
effectiveness of interventions related to the use of 
illicit drugs: prevention, harm reduction, treatment 
and recovery. A ‘review of reviews’, commissioned 
by the HRB (Bates et al., 2017). It should be noted 
that, while the body of evidence is large, it is also 
quite disparate and relates most specifically to 
homeless services, with different outcomes to our 
own study’s primary outcomes of interest. The 
review methodology proceeded in accordance with 
guidelines from the Joanna Briggs Institute (JBI, 2014).
2.3.1  Search strategy
An information specialist (MM) led the development 
and application of the search strategies, supported 
by the review team, all of whom have extensive 
experience in conducting systematic searches of the 
literature. The search strategy (see Appendix 4) was 
designed for the main research question based on 
team discussion and consultation with the HRB, and 
was finalised in December 2019. All searches were run 
on 30 December 2019. 
The searches were conducted across 10 electronic 
databases (Table 1): MEDLINE (Ovid), CINAHL 
(EBSCOhost), Embase (Ovid), PsycINFO (Ovid), 
PROSPERO, Epistemonikos, Cochrane Database of 
Systematic Reviews, JBI Database of Systematic 
Reviews, Health Technology Assessment (HTA) 
(National Institute for Health Research (NIHR) 
Journals), and Campbell Collaboration. Articles 
unavailable from the research team’s university 
libraries were acquired through the interlibrary 
loan system. Reference details identified through 
the literature search were collated and managed 
using the bibliographic software EndNote. In order 
to optimise data retrieval, the team screened the 
reference lists of included articles for additional 
relevant publications (reviews rather than primary 
studies) which may otherwise have been missed in 
the original search strategy. 
One reviewer (JM) screened all titles and abstracts 
of the 511 reviews (stage one) as well as the full-text 
articles of any titles/abstracts that were considered 
relevant. A second reviewer (WM) independently 
assessed 20% of all titles and abstracts to ensure 
inter-rater reliability, as deemed to be good practice 
in rapid systematic review methodology (Taylor-
Phillips, Geppert, & Stinton, 2017). Following the 
completion of title/abstract/full-text screening by 
reviewer one, a new EndNote library was created 
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containing the top 20% of the original, unfiled 
EndNote library. As the original EndNote library 
contained records that were unfiled and unsorted 
(i.e. were not sorted alphabetically or by year but 
were instead added as they were imported from the 
various databases), this ensured that the selected 
20% were chosen at random. The new EndNote 
library was shared with reviewer two. The relevance 
of each article was assessed according to the criteria 
set out in Appendix 5. Any discrepancies were 
resolved by consensus or, if necessary, by consulting 
a third reviewer (HC). Subsequently, four papers were 
reviewed by the third reviewer. Upon completion 
of the screening process by both reviewers, a team 
meeting was scheduled to discuss the included 
papers for a second reliability check. 
Several members of the team (TP, HC, WM, and JM) 
discussed 28 papers in which not all of the primary 
studies included in the review met this review’s 
inclusion criteria (for example, a review may have 
only included one study focusing on homelessness 
among other studies focusing on substance use), as 
detailed in Appendix 5. By consensus it was agreed 
to only include those reviews where at least 40% of 
their included papers were relevant to substance 
use and homelessness. Adopting a cut-off point 
or minimum percentage in this context has also 
been used in other systematic reviews (Barker & 
Maguire, 2017). These criteria were selected in order 
to ensure that the included reviews maintained a 
focus on both homelessness and substance use, as 
some reviews explored other issues within other 
contexts and did not specifically include participants 
experiencing homelessness or problem drug use 
in their sample. Papers which reported pooled 
data or meta-analyses without an accompanying 
systematic review were also rejected. Subsequently, 
adopting these extra steps resulted in the decision 
to include 16 out of these 28 reviews in our final 
synthesis. Appendix 6 illustrates the final decisions 
made regarding inclusion and exclusion. The team 
also discussed potentially excluding papers based on 
quality appraisal scores; however, it was decided that 
it was important to keep all the available evidence 
but comment on the evidence quality, in accordance 
with the recommendations proposed by the Centre 
for Reviews and Dissemination (CRD, 2008). This 
commentary is reported in our quality appraisal in 
Section 4.2 and in Chapter 5. 
Table 1 presents the databases searched and the 
number of potentially relevant reviews identified 
in each (pre-deduplication). As the Campbell 
Collaboration database and HTA are web-based and 
do not allow for complicated search strings (and 
truncation), the searches of these two sources were 
performed on the homelessness terms only. These 
terms can be found in Appendix 4. The systematic 
search identified 665 results; 205 duplicates were 
removed, leaving a total of 460 reviews to screen 
against the inclusion criteria.








Cochrane Database of Systematic Reviews 11
JBI Database of Systematic Reviews 16
HTA (via NIHR Journals) 32
Campbell Collaboration 5
During stage one (title and abstract screening), we 
identified 15 potentially relevant reviews via the 
PROSPERO database, and a search was conducted 
to identify if these papers had yet been published. 
Due to their potential relevance to the review, it was 
decided that prior to data extraction of the final 
included papers, the search for these 15 papers 
would be re-run to identify whether any had been 
subsequently published. This search was conducted 
on 26 February 2020 and resulted in 2 of the 15 
studies being identified for inclusion in the final 
synthesis, thus bringing the final total number of 
included reviews to 18. Of the remaining 13 potentially 
relevant studies identified via the PROSPERO 
database, 8 have not yet been published, 3 have been 
published but did not meet our inclusion criteria, and 
2 were identified in the main search as full texts (1 was 
included and 1 was excluded at stage one). 
During the quality appraisal stage, it transpired that 
one of the systematic reviews previously identified 
for inclusion (Formosa et al., 2019) only presented 
an abstract from a conference, but the full review 
was not available/had not been published. Full data 
extraction was therefore not available for this paper. 
The literature searching and screening process are 
shown using a PRISMA flow diagram (Figure 1). 
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The search strategy did not include any language 
restrictions in order to minimise bias and ensure 
that all relevant reviews could be captured. Two of 
the included papers were written in languages other 
than English (Canadian French and Spanish). They 
were translated via Google Translate and deemed 
of acceptable quality by the research team for the 
purposes of data extraction. 
In order to ensure that we identified good-quality 
evidence reviews in the grey literature, we searched 
a range of relevant websites between December 2019 
and January 2020 for any reviews published since 
2010 (Appendix 7). 
PRISMA 2009 flow diagram
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Figure 1: PRISMA diagram
* Not eligible (n=413); PROSPERO only (n=15)
From: Moher et al., 2009. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The 
PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097
www.hrb.ie22
2.3.2 Inclusion criteria
A full set of inclusion and exclusion criteria 
(Appendix 5) were developed by the research team 
in consultation with the HRB. Criteria included study 
type, types of participants, types of interventions, 
and outcomes. Due to the time available to 
undertake the work, the review primarily sought to 
identify systematic reviews of studies reporting on 
interventions in the areas identified in the tender; 
specifically, interventions that:
1. Were designed to engage and retain people 
who are homeless in problem substance use 
(drug)1 treatment, and/or
2. Improved problem substance use treatment 
and harm reduction outcomes for people who 
are homeless.
Inclusion criteria relating to population, comparators, 
and outcomes were developed in consultation with 
the HRB. Non-systematic reviews were also included; 
however, these reviews received lower quality appraisal 
scores. Reviews of both quantitative and qualitative 
studies were included in this systematic review.
2.3.3 Data extraction/quality assessment and 
synthesis 
Data relating to study design and key characteristics, 
including populations, interventions, outcomes, 
and implications for policy, were extracted by one 
reviewer (JM) into an Excel spreadsheet. Data from 
the reports identified through the grey literature 
search were extracted into the same spreadsheet by 
a second reviewer (WM). The data extraction table 
was shared with other team members (HC, TP, HS) 
for comment in order to ensure accuracy of data 
extraction. Two reviewers (JM and HC) independently 
assessed the quality of the included reviews using 
the JBI Critical Appraisal Checklist for Systematic 
Reviews and Research Syntheses (Appendix 8), which 
considers the validity of evidence reviews and the 
applicability of findings to local populations (JBI, 2014). 
Each review received a score based on this quality 
assessment, and scores were tabulated into a Word 
document independently by both reviewers. The 
scores and tabulation are presented in Appendix 9. 
Any disagreement in scores was resolved through 
consensus and, if necessary, a third reviewer (WM) 
was consulted (Appendix 10). 
1  Alcohol was also included if it was addressed 
alongside controlled drugs, but not if it was addressed 
independently.  
Data extracted from the included reviews have been 
reported in Appendix 11, including study descriptions 
and information about the populations, methods, 
and results reported in included reviews. Scores 
relating to study quality are presented in Appendix 9. 
Findings relating to the review research questions are 
summarised and discussed in a narrative synthesis 
in Sections 4.3-4.5 to supplement tabulated data in 
Appendix 11.
2.4 Chapter summary 
This chapter has provided detail on all elements of 
this study: the trends and mapping components and 
the review of reviews. We now move on to presenting 
the trends and mapping components in a standalone 
section, Chapter 3.
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3
Contextual background
3.1 Chapter overview 
This chapter provides the contextual background 
for the review of reviews. Firstly, a trend analysis 
of the drug situation in Ireland from 2010 to 2020 
is presented, primarily using data submitted to the 
EMCDDA, but also drawing upon secondary analysis 
of sources listed in Appendix 2. Secondly, a mapping 
of existing drug services in Ireland for people who are 
homeless is provided.
3.2 Trend analysis 
The current drug situation in Ireland is analysed using 
the most recently available data on the EMCDDA’s 
five key epidemiological indicators: prevalence and 
patterns of drug use; problem drug use (this includes 
high-risk drug use, which refers to long-term use 
of drugs and to behaviours, such as injecting drugs, 
which place a person at a higher risk of health, 
psychological, or social problems); drug-related 
deaths and mortality; drug-related infectious 
diseases; and treatment demand (EMCDDA, 2020a). 
Data gathered from the general population, as well 
as from specific groups such as people who are 
homeless, are presented to provide an overview of 
drug use in Ireland since 2010. 
3.2.1 Prevalence and patterns of drug use
This indicator refers to the patterns of use, risk 
perceptions, social and health correlates, and 
consequences of drug use. These are measured 
through general and school population drug surveys, 
targeted surveys, and through new technology, such 
as wastewater-based drug epidemiology (EMCDDA, 
2019c). Bates (2017) reports data from the National 
Advisory Committee on Drugs and Alcohol (NACDA, 
2016), which uses a representative sample to estimate 
lifetime use, use in the past year, and use in the past 
month in people aged 15 years and over in Ireland. 
Data show that the number of people using any 
drug increased to 8.9% in 2014/2015 from 7.0% in 
2010/2011. Drug use continues to be more common 
among men (38.8%) than among women (22.6%) 
(NACDA, 2016). Illicit drug use is also reported to be 
more common in younger people aged 15–34 years 
compared with older age groups (NACDA, 2016). 
Cannabis continues to be the most commonly used 
illicit drug, and use has increased since the 2010/2011 
survey. In 2010/2011, the cannabis dependence rate 
in the general population was estimated to be 0.6%, 
and by 2014/2015, it was estimated to have increased 
to 1.5% (Bates, 2017). Estimates in the EMCDDA 
Ireland Country Drug Report 2019 (EMCDDA, 2019b) 
show that 13.8% of young adults (aged 15–34 years) 
used cannabis in 2015. 
MDMA (3,4-Methylenedioxymethamphetamine) 
use among young adults increased sharply from 
approximately 1.0% in 2010/2011 to 4.4% in 
2014/2015. Cocaine use has remained stable since 
2010/2011, with approximately 2.9% of young people 
reporting using it in 2014/2015. Amphetamine use 
decreased slightly by around 0.2% since 2010/2011, 
with approximately 0.6% reporting use in 2014/2015. 
Although exact figures are unknown, experts taking 
part in a recent study on the non-medical use 
of pharmaceuticals (otherwise known as street 
tablet use) in Ireland reported that there has been 
a noticeable increase in the use of street tablets 
since the mid-2010s (Duffin, Keane & Miller, 2020). 
According to this report, the increase in pregabalin 
use is an emerging issue. A 2014 survey of more 
than 13,000 people aged 15–24 years (TNS Political 
& Social, 2014) indicated that around 22% of the 
participants from Ireland had ever used novel 
psychoactive substances (NPS), newly synthesised 
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substances which are designed to mimic existing 
established recreational drugs; however, only 9% had 
done so in the year prior to the survey. In the Ireland 
Country Drug Report 2019, prevalence of NPS use in 
young adults (aged 15–34 years) was reported to have 
decreased to 1.6% from 6.7% in 2010/2011 (EMCDDA, 
2019b). Bates (2017) highlights that differences in such 
figures around drug use could reflect the changing 
legal status of NPS, as well as differences in survey 
design and recruitment of participants. 
In some specific populations, the prevalence of 
drug use appears to be higher than in the general 
population. For example, in a recent systematic 
review and meta-analysis, Gulati and colleagues 
(2019) reported that the pooled percentage 
across studies of people in prison who reported 
problem substance use was 50.9%. Data on the 
prevalence and patterns of drug use specifically 
among subgroups of people who are homeless are 
presented in Bates (2017). These include a health 
needs assessment in Cork with 115 women who were 
living in temporary or emergency accommodation 
(Good Shepherd Services & Simon Community, 2011); 
an interview study with 60 Irish women who were 
living in temporary or emergency accommodation, 
although almost half had slept rough at some point 
in their lives (Mayock & Sheridan, 2012); a survey 
with 601 people who were living in emergency 
accommodation or rough sleeping in Dublin and 
Limerick in 2013 (O’Reilly et al., 2015); and a study of 
the health needs of 105 people who were accessing 
Safetynet primary health clinics and who had no fixed 
abode or who were at high risk of homelessness in 
Dublin (Keogh et al., 2015). 
Data from the Good Shepherd Services and Simon 
Community health needs assessment of women 
in Cork (2011) showed that 40% of respondents 
indicated problem alcohol use and 20% of 
respondents reported current drug use, with heroin 
(10%) and cannabis (9%) being the most commonly 
used drugs reported. Heroin use was more common 
in people aged 26 years and over, whereas cannabis 
use was more common in people under the age 
of 26 years. These data show a lower prevalence 
rate of drug use compared with that reported in 
other studies, which Bates (2017) suggests may be 
due to respondents already accessing drug support 
services. For example, in Mayock and Sheridan’s study 
(2012), 53% of women reported problem substance 
use, with the most common drug being heroin. In 
Keogh et al.’s study (2015), 60% of participants had 
ever used illicit drugs, and 33% had used drugs in 
the past 3 months. O’Reilly et al. (2015) reported 
that 78% of survey participants had ever used illicit 
drugs, and 55% had used drugs in the past 3 months. 
In relation to the previous 3 months, 45% of people 
reported having used cannabis, 34% had used 
benzodiazepines, 29% had used heroin, 13% had 
used cocaine, 11% had used crack cocaine, and 7% 
had used MDMA. Opioids were reported to be 41% 
of respondents’ primary drug. The same percentage 
of respondents reported that alcohol was their main 
problem substance. It is worth highlighting that, from 
the data in this study, prevalence of past and current 
drug use in Dublin was higher than in Limerick (80% 
and 60%, respectively), and problem opioid use was 
also higher in Dublin than in Limerick (44% and 16%, 
respectively). 
In summary, the number of people using illicit drugs 
in Ireland has increased since 2010. Since NACDA 
only commissions a survey on the prevalence of drug 
use every 4 years, the statistics for the prevalence 
of current drug use in Ireland will not be known until 
after 2020. However, existing data suggest that men 
continue to use illicit drugs more than women do, 
and that people aged 15–34 years are more likely to 
use drugs than any other age group (NACDA, 2016). 
This profile is similar to all European comparator 
countries (EMCDDA, 2019b). Cannabis continues 
to be the most commonly used illicit drug, and use 
has increased. In terms of prevalence of drug use 
among people who are homeless, data indicate that 
substance use is more commonly reported in this 
population than in the general population, and that 
alcohol, cannabis, heroin, and benzodiazepines are 
the most commonly reported substances (Good 
Shepherd Services & Simon Community, 2011; Keogh 
et al., 2015; Mayock & Sheridan, 2012; O’Reilly et 
al., 2015). However, differences in substance use 
prevalence were reported in each study, possibly 
due to differing study methodologies, cities, 
demographics (e.g. two studies only included data 
from women), and study years. 
3.2.2 Problem drug use
The purpose of this indicator is to provide data 
on the prevalence and patterns of more harmful 
forms of drug use, which includes high-risk drug 
use. This includes long-term use of drugs, as well 
as behaviours, such as injecting drugs, which 
place a person at a higher risk of harm, as well as 
other health, psychological, or social problems 
(Bates, 2017). The Ireland Country Drug Report 
2019 (EMCDDA, 2019b) estimates that there were 
approximately 19,000 people who used opioids in 
Ireland in 2014, with more than one-half being over 
the age of 35 years. This equates to 6.18 per 1,000 
of the population aged 15–64 years. In comparison, 
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statistics reported from other European Union 
member states range from 0.48 per 1,000 population 
to 8.42 per 1,000 population aged 15–64 years. The 
prevalence rate for Dublin in 2017 was higher than 
any other area in Ireland at 15.15 per 1,000 population 
(Hay et al., 2017). The prevalence rate in 2017 for Cork 
was 5.67 per 1,000 population; for Galway it was 1.93 
per 1,000 population; for Limerick it was 8.82 per 
1,000 population; and for Waterford it was 6.72 per 
1,000 population (Hay et al., 2017). Estimates suggest 
that two-thirds of people who use opioids in Ireland 
live in Dublin (EMCDDA, 2019b). Data from the NDTRS 
show that the percentage of people injecting drugs 
as their route of administration was 29.9% in 2019 
(HRB, 2020). This has gradually decreased from 35.6% 
in 2012 (HRB, 2019b). 
Opioids, and predominantly heroin, remain the 
most common primary drug overall for all clients 
accessing drug services in Ireland, and the mean 
age at first treatment entry is 32 years. However, in 
2011, cannabis became the most frequently reported 
primary drug for first-time service users, and the 
mean age at first treatment entry that year was 
23 years. Data indicate that cannabis was still the 
most frequently reported primary drug for first-
time service users in 2019 (HRB, 2020). The number 
of first-time service users who report any form of 
cocaine as their primary problem drug has been 
increasing since 2012, with 30 being the mean age 
for treatment entry among this group (HRB, 2020). 
In 2019, crack cocaine was reported as the main 
drug for 14.3% of cases where cocaine was the main 
problem drug (HRB, 2020). MDMA and amphetamines 
continue to be infrequently reported as primary 
problem drugs, and this has remained stable since 
2010 (EMCDDA, 2019b). Data from the NDTRS show 
that the number of cases entering treatment in 
Ireland for benzodiazepines as their main problem 
drug remained relatively stable between 2014 and 
2019, with 1,082 people entering treatment in 2019 
compared with 953 in 2014 (HRB, 2020). However, 
as reported in the EMCDDA Ireland Country Drug 
Report 2019 (EMCDDA, 2019b), treatment entry for 
hypnotics and sedatives, mainly benzodiazepines, 
appears to be increasing. 
Concerns about rising trends of non-medical use of 
benzodiazepines and other prescription drugs have 
been flagged by harm reduction services in Ireland, 
which are reporting increasing levels of street tablet 
use (Duffin et al., 2020). In 2017, benzodiazepines 
were the second most common primary drug 
reported for treatment entrants in prison (Duffin 
et al., 2020). Drug-related death statistics show an 
overall increase in the number of deaths involving 
alprazolam, zopiclone, and pregabalin. In particular, 
pregabalin-related deaths increased by 221% 
between 2013 and 2017, from 14 deaths in 2013 to 45 
deaths in 2017 (HRB, 2019a). 
Rates of simultaneous illicit drug use and alcohol use 
are very high (NACDA, 2016). Data from 2014/2015 
show that 87.4% of people who had used cannabis 
had also used alcohol; 97.1% of those who had 
used amphetamine-type stimulants such as MDMA 
and amphetamines had also used alcohol; 100% of 
those who had used cocaine had also used alcohol; 
and 54.8% of those who had used sedatives or 
tranquillisers had also used alcohol (NACDA, 2016). 
According to the NDTRS report, the proportion of 
people reporting polysubstance use has decreased 
from 62.9% in 2012 to 55.0% in 2018 (HRB, 2020). 
Just over one-quarter of people entering treatment 
for problem drug use in 2019 were female (26.2%) 
(HRB, 2020), which is an increase from 18% in 2012 
(HRB, 2019b). However, demographics vary according 
to primary drug and treatment programme (EMCDDA, 
2019b). For cannabis use, 79% of people entering 
treatment services were male, compared with 21% 
who were female. For cocaine use, 81% of people 
entering treatment services were male, compared 
with 19% who were female. For heroin use, 70% 
of people entering treatment services were male, 
compared with 30% who were female. And for 
amphetamine use, 63% of people entering treatment 
services were male, compared with 37% who were 
female (EMCDDA, 2019b). 
Data on problem drug use among people who are 
homeless have been reported by O’Reilly et al. (2015) 
and Keogh et al. (2015). O’Reilly et al. (2015) report 
that 24% of their 601 survey respondents who were 
in emergency or temporary accommodation, or 
who were rough sleeping at the time of the study, 
had injected drugs in the previous year. Nearly every 
person who reported intravenous drug use used 
heroin, and one-third reported injecting cocaine. 
Keogh et al. (2015) reported that 22% of the 105 
participants in their study had injected drugs in the 
previous 3 months. In this study, 56% of participants 
reported having either reused their own injecting 
equipment or having shared injecting equipment 
with others. Regarding polysubstance use, 71% of 323 
respondents in O’Reilly et al.’s (2015) survey reported 
that they had used a number of different drugs over 
the previous 3 months, with 28% having used four 
or more different drugs. Of those who had reported 
use of illicit drugs, simultaneous alcohol use was 
very high. Furthermore, 46% reported simultaneous 
use of prescribed methadone, 40% reported use 
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of prescribed sedatives, and 19% reported use 
of prescribed antipsychotics. Almost one-half of 
those using illicit benzodiazepines were also using 
prescribed benzodiazepines. 
In summary, the data suggest that there were 
approximately 19,000 people who used opioids in 
Ireland in 2014 (EMCDDA, 2019b). Heroin remains 
the most common primary drug overall for those 
accessing drug services, although cannabis is the 
most common primary drug for first-time service 
users (HRB, 2020). The number of people reporting 
cocaine as their primary problem drug is also 
increasing (EMCDDA, 2019b; HRB, 2020). Although 
the rates of polysubstance use have decreased, they 
remain very high (HRB, 2020). The number of men 
in drug treatment services is almost three times 
higher than the number of women (HRB, 2020). In 
terms of problem drug use among people who are 
homeless, around one-quarter of people who reside 
in emergency accommodation or who are rough 
sleeping have injected drugs within the past year 
(O’Reilly et al., 2015). Polysubstance use is high among 
this population, particularly with illicit drug use and 
alcohol. Variations in data could be due to different 
demographics, study methodologies, cities, and study 
years.
3.2.3 Drug-related deaths and mortality
This indicator comprises two components. The first 
is drug-induced deaths, which are deaths directly 
caused by drugs by way of poisoning (this includes 
overdoses as well as other poisonings). The second 
component is non-poisoning deaths, which include 
deaths among people with a history of problem drug 
use or dependency, regardless of whether the drug 
was implicated in the cause of death. Non-poisoning 
deaths are reported as either traumatic deaths or 
medical deaths. Traumatic deaths refer to deaths due 
to trauma such as suicide, whereas medical deaths 
refer to death by a medical cause, such as a cardiac 
event (HRB, 2019a). The HRB reported that the 
combined number of poisoning and non-poisoning 
deaths has been rising each year since 2010, from 
607 deaths in 2010 to 786 deaths in 2017 (HRB, 2019a). 
The total number of poisoning deaths rose from 339 
in 2010 to 376 in 2017, and non-poisoning deaths 
rose from 268 to 410 over the same time period 
(HRB, 2019a). The annual number of poisoning deaths 
increased by 2% between 2016 and 2017, from 368 to 
376. 
In 2017, 67% of poisoning deaths involved drugs that 
can be prescribed, with methadone implicated in  
95 deaths, diazepam implicated in 90 deaths, and 
alprazolam implicated in 63 deaths (HRB, 2019a). 
Injecting-related incidents represented 4% of 
all drug deaths in 2017, a 1% decrease since 2016 
(HRB, 2019a). Of these deaths, 79% were male, 41% 
occurred in Dublin City, and 94% (32 out of 33) 
involved opioids. Of those who had been injecting 
opioids, 16% were injecting in a public space, and 
41% were not alone at the time of the incident 
(HRB, 2019a). The HRB reported that, in 2017, more 
than one-half of poisoning deaths were linked to 
polysubstance use. The number of deaths due to 
polysubstance poisonings rose from 192 in 2008 to 
218 in 2017 (HRB, 2019a). Benzodiazepines were the 
most commonly implicated drug in polysubstance 
deaths. In deaths where methadone was implicated, 
89% involved other drugs, mainly benzodiazepines. 
In deaths where heroin was implicated, 86% involved 
other drugs, again mainly benzodiazepines. All deaths 
where diazepam was implicated involved other drugs. 
The median age for a person dying from poisoning 
was 43 years in 2017; this has stayed relatively 
consistent since 2010 (HRB, 2019a). Men continue to 
be more likely to die from illicit drug use compared 
with women, with 263 men dying from poisonings in 
2017 compared with 113 women. In terms of non-
poisoning deaths, 312 men and 98 women died in 
2017 (HRB, 2019a). 
Medical causes of death, such as cardiac problems, 
were more common than traumatic deaths in older 
people (median age of 49 years), with 214 medical-
attributable deaths in 2017 (HRB, 2019a). Cardiac 
events were the most common cause of medical 
death, with 56 overall, accounting for 14% of non-
poisoning deaths in 2017 (HRB, 2019a). The number 
of liver disease deaths rose from 12 in 2008 to 33 in 
2017 (HRB, 2019a). Traumatic deaths, as described 
earlier, are more commonly reported in younger 
people (median age of 35 years). Drug-related 
hanging deaths were the most common traumatic 
drug-related deaths in 2017, accounting for 114 of 196 
traumatic non-poisoning deaths in 2017 and making 
up 28% of non-poisoning drug-related deaths overall 
(HRB, 2019a). In these incidents, 78% of people 
were male and 63% had a history of mental health 
problems. Cannabis was the drug most commonly 
implicated in hanging deaths, followed by cocaine.
In summary, drug-related deaths have been rising 
each year since 2010, reaching 786 deaths in 2017 
(HRB, 2019a). These deaths consist of poisoning 
deaths and non-poisoning deaths, both of which 
Evidence review of drug treatment services for people who are homeless and use drugs 27
have increased in number. The number of poisoning 
deaths increased to 376 in 2017, and 67% of these 
deaths involved drugs that can be prescribed. Men 
continue to be more likely than women to die from 
both poisoning and non-poisoning drug deaths (HRB, 
2019a). There are no data for drug-related death 
rates specifically among people who are homeless. 
However, given that high-risk behaviours (such as 
injecting) are more prevalent among this population, 
the risk of drug-related death is likely to be higher 
than in the general population. 
3.2.4 Drug-related infectious diseases
This indicator refers to rates of infectious diseases 
among people who inject drugs (PWID). The data 
collected are primarily for the BBVs HIV, HCV, and 
hepatitis B virus (HBV), and are obtained through 
serological testing, monitoring of routine diagnostic 
tests, and data reported through the National Drug-
Related Deaths Index (EMCDDA, 2019a). There are 
no research programmes specifically designed to 
routinely assess BBVs in PWID (e.g. the Unlinked 
Anonymous Monitoring survey in England; Needle 
Exchange Surveillance Initiative in Scotland). 
Fourteen PWID were diagnosed with HIV in 2017, a 
decrease from 50 people in 2015 (EMCDDA, 2019b). 
The increased number of HIV diagnoses in 2015 was 
linked to the increased injecting of psychostimulatory 
synthetic cathinones among people who were 
homeless, with the most common of these drugs 
being mephedrone and methylone (EMCDDA, 
2019b). Between 2010 and 2014, males accounted 
for a greater proportion of PWID with HIV, but this 
percentage declined from 81% in 2011 to 52% in 2015 
(Bates, 2017). Data for HCV prevalence attributable 
to drug use in 2016 are difficult to determine, since 
the route of transmission was not gathered for more 
than 50% of reported HCV cases (EMCDDA, 2019b). 
However, estimates from 2016 suggest that around 
33% of cases are attributable to injecting drug use 
(EMCDDA, 2019b). The number of people being 
diagnosed with HBV has stabilised since 2014, with 
less than 5% of cases in 2017 being attributable to 
injecting drug use (EMCDDA, 2019b). 
There are limited data available on the homeless 
population. O’Reilly et al.’s survey study (2015) 
provides some limited data on the prevalence of 
drug-related infectious diseases among people who 
are homeless, with approximately 27% of survey 
respondents reporting that they had a BBV diagnosis. 
The most common of these was HCV (29%), followed 
by HBV (5%) and HIV (4%). Further data collected in 
this study show that BBV prevalence was reported to 
be most common among people who were currently 
using drugs, or who had used drugs throughout their 
lives. All of the people diagnosed with HIV were in 
treatment, and approximately 50% of those with HBV 
or HCV were in treatment (O’Reilly et al., 2015). 
In summary, the data suggest that the number 
of people who use drugs and who have been 
diagnosed with HIV is decreasing, and that the 
number of males and females being diagnosed is 
now roughly equal. The transmission route of HCV 
is not consistently gathered, but estimates suggest 
that 33% of diagnoses are attributable to injecting 
drug use, whereas less than 5% of HBV cases are 
attributable to injecting drug use (EMCDDA, 2019b). 
HCV is reported to be the most common BBV among 
people who are homeless, followed by HBV and then 
HIV (O’Reilly et al., 2015). However, as noted, data are 
very limited for this population.
3.2.5 Treatment demand
This indicator refers to the number of people 
accessing treatment services for problem drug use 
in a particular area. This allows an insight into trends 
in problem drug use as well as into the availability of 
relevant organisations and their treatment facilities. 
Ireland’s current drug strategy, Reducing Harm, 
Supporting Recovery: A health-led response to drug 
and alcohol use in Ireland 2017-2025 (Department 
of Health, 2017, aims to minimise harm caused by 
drugs, and to promote rehabilitation and recovery. 
The HSE provides many drug treatment services and 
also funds a number of non-statutory services. The 
majority of treatment is provided through publicly 
funded outpatient services, and there are several 
types of treatment and services offered depending on 
need, as discussed at the beginning of this chapter. 
The report National Drug Treatment Reporting 
System 2013-2019 Drug Data (HRB, 2020) recorded 
67,875 treatment cases in total from 2013 to 2019, 
with the total number of annual cases increasing 
from 9,006 in 2013 to 10,664 in 2019. The proportion 
of new treatment cases has decreased slightly from 
38.6% in 2013 to 37.3% in 2019. Of all the treatment 
cases in 2019, 65.1% were in outpatient services. The 
percentage of cases treated in inpatient settings 
was 14.7%, which is a slight increase from 13.7% in 
2013, but a decrease from 19.7% in 2017 (HRB, 2020). 
The NDTRS report indicates that in 2019, 351 people 
accessed services provided by a GP; 948 people 
accessed low-threshold services; 6,946 people 
accessed outpatient services; 1,571 people accessed 
inpatient services such as residential detox settings, 
therapeutic communities, or respite; and 848 people 
accessed services in prisons (HRB, 2020). 
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In 2019, opioids remained the most common primary 
drug overall for those accessing drug services, 
although, as a proportion of all cases treated, 
opioids decreased year on year from 51.4% in 
2013 to 38.8% in 2019. However, the percentage of 
service users aged 45 years or over presenting with 
problem opioid use is reported to be steadily rising 
compared to other age groups (EMCDDA, 2019b). 
Cannabis continues to be the most common problem 
drug in new cases (37.8%) (HRB, 2020), but cocaine 
became the second most common main problem 
drug across all cases in 2019, overtaking cannabis for 
the first time (24.0% compared with 23.5%) (HRB, 
2020). The number of people with problem cocaine 
use entering services is continuing to rise, and, in 
2019, crack cocaine was reported as the main drug 
for 14.3% of cases where cocaine was the main 
problem drug, compared with 11.3% in 2018 (HRB, 
2020). The number of people entering treatment 
for problem use of other classified drugs, such as 
benzodiazepines, is also slowly rising (EMCDDA, 
2019b). Harm reduction services in Ireland have 
also expressed concern about the rising number 
of people reporting use of prescribed medication 
for non-medical use (Duffin et al., 2020). In 2017, 
benzodiazepines were the second most common 
drug reported for treatment entrants in prison (Duffin 
et al., 2020).
Available data on treatment demand for people who 
are homeless are limited; however, the NDTRS report 
(HRB, 2020) indicates that the number of people 
who were homeless and accessed drug treatment 
services rose from 581 in 2013 to 1,173 in 2019. Of the 
1,173 cases, 263 were new cases, 810 had received 
previous treatment, and there were no treatment 
status data for the remaining cases. O’Reilly et al.’s 
study (2015) also provides a very brief overview of 
the situation, although it must be noted that many 
of the respondents in this study were in emergency 
or temporary accommodation, meaning that they 
may be more likely to be in touch with services. The 
majority (89%) of respondents in their survey who 
had reported problem opioid use said that they had 
used a drug treatment service in the 6 months prior 
to the survey. Three-quarters of participants who 
had reported injecting drugs in the 6 months prior 
to the survey had used a needle exchange service, 
and around 68% of those who either had previously 
used or currently used heroin had methadone 
prescriptions. Around 11% of respondents who 
previously had methadone prescriptions reported 
that they no longer did. 
3.3 Mapping of existing drug 
services provided to meet the 
needs of people experiencing 
homelessness and who use 
drugs 
The trend analysis above has highlighted that data 
on treatment demand for people who are homeless 
and use drugs in Ireland are limited. There are limited 
data about what treatment types are available across 
Ireland and about referral pathways. There are 10 
regional and 14 local drugs task forces that operate 
in Ireland (Drugs.ie, n.d.). These task forces receive 
funding from the Department of Health each year 
to fund delivery of substance use services, and their 
aim is to provide effective, targeted responses to 
problem drug use through a partnership approach 
between statutory, voluntary, and community 
sectors. Local and regional drug and alcohol task 
forces are required to work together to develop 
cross-task force initiatives, and to share information 
about best practice. Existing services in Ireland 
for people who are homeless and use drugs are 
summarised below. Services have been categorised 
based on their primary focus. However, it is must 
be noted that many services across Ireland provide 
a holistic approach to treatment and support and 
it is therefore not possible to categorise them 
neatly by service type. In particular, many third 
sector organisations offer a range of services which 
can include drug treatment services, other harm 
reduction services, housing support services, and 
other more general health and social care services, 
among others. 
3.3.1 Wider health and social care services
The HSE provides public health and social care 
services to everyone living in Ireland, and specific 
services are listed on the HSE website. Most of the 
services specific to substance use are not specifically 
for people who are homeless but can be accessed by 
anyone. These include counselling; a drop-in centre 
in Monaghan (open Monday to Friday, 9.30 am to 5.00 
pm); assessment and intervention advice; information 
and education; ongoing support; follow-up care; 
and a drug screening facility. Outreach clinics are 
also available in Monaghan Town, Castleblayney, 
Carrickmacross, Ballybay, Cavan Town, Kingscourt, 
Cootehill, and Virginia. The HSE also has a freephone 
confidential drug and alcohol hotline which is open 
Monday to Friday from 9.30 am to 5.00 pm. For 
people who are homeless, and other marginalised 
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groups, the HSE Social Inclusion programme is 
designed specifically to help enable and improve 
access to mainstream services. For example, the 
Inclusion Health Service at St James’s Hospital 
attends to the complex needs of marginalised groups, 
such as people who are homeless and people who 
use drugs (HSE, 2017). Specialised staff work with 
people who have complex needs in order to ensure 
the best level of aftercare once they leave hospital.
3.3.2 Drug treatment services
3.3.2.1 HSE addiction services 
The HSE’s Dublin North Addiction Service covers 
Dublin North City and County (HSE, 2018). The 
primary role of this service is to assess opioid 
dependence and to provide a recovery-oriented 
care plan for service users. Methadone is dispensed 
at the Drug Treatment Centres where this service is 
run (HSE, 2018), and other services are also provided 
here, such as nursing interventions and counselling. 
The HSE Addiction Service’s multidisciplinary team 
includes psychiatrists, doctors, nurses, counsellors, 
rehabilitation workers, outreach workers, and general 
staff. Mid-West Addiction Services (four locations 
listed) (HSE, 2018) and Midlands Community Alcohol 
and Drug Service (five locations listed) (HSE, 2018) 
cover other areas of Ireland outside of Dublin.
The HSE’s Addiction Rehabilitation Service, Soilse, 
is based in Dublin City Centre (HSE, 2018). Soilse 
runs two programmes: Henrietta Place, which helps 
prepare service users for detox and treatment, 
and Green Street, which supports service users 
through the early stages of their recovery. The HSE’s 
Adolescent Addiction Service and the Substance 
Abuse Service Specific to Youth (SASSY) provide 
advice, support, assessment, counselling, family 
therapy, professional consultation, and medication 
for young people aged under 18 years in Ballyfermot, 
Clondalkin, Palmerstown, Lucan, Inchicore, and 
Dublin North City and County (HSE, 2018). The Youth 
Drug and Alcohol Service (YoDA), based in Tallaght, 
provides support, assistance, and treatment to 
people aged under 18 years who are from Dublin 
South West and Dublin South City (HSE, 2018). YoDA 
provides assistance, support, and treatment for those 
with problem alcohol and/or drug use.
Additional HSE addiction services that we were 
made aware of through relevant stakeholders in 
Ireland include the Cuan Dara Inpatient Therapeutic 
Detoxification Centre and the Keltoi Residential 
Treatment Centre. The Cuan Dara Inpatient 
Therapeutic Detoxification Centre provides 6-week 
detoxification and 3-week stabilisation programmes, 
and the Keltoi Residential Treatment Centre provides 
an 8-week treatment programme (HSE, 2018). 
3.3.2.2 Abstinence-focused third sector services 
A number of services were identified that require a 
service user to be abstinent or commit to abstinence 
in order to access services. An example of this is 
Daisyhouse (n.d.), a charity that supports women 
who are homeless. Service users are referred to 
Daisyhouse through the HSE and are required to be in 
recovery and drug- and alcohol-free for 6 months. 
It does not specify if this also includes medications 
such as methadone. Another example is a Depaul 
service called Suaimhneas (Depaul, 2018), a residential 
service for women who have previously completed 
a residential drug treatment programme and have 
been abstinent for a minimum of 8–10 weeks. Another 
abstinence-based programme available across 
Ireland is Narcotics Anonymous (NA), a non-profit, 
community-based organisation which follows a 12-
step programme. Currently, there are approximately 97 
groups in the eastern counties of Ireland, 20 groups in 
the western counties, 27 in the northern counties, and 
68 in the southern counties (Narcotics Anonymous, 
n.d.). Although service users commit to working 
towards complete abstinence, there is no requirement 
of abstinence when joining. NA is not specifically 
for people who are homeless, so it is unclear how 
accessible these services are for this population. 
Cuan Mhuire, Ireland’s largest voluntary sector 
provider of substance use services and residential 
rehabilitation, follows an abstinence-based 12- or 
20-week programme (Cuan Mhuire, 2017). Like NA, 
it has no requirement of abstinence when joining, 
but requires a desire to work towards abstinence. 
While not specifically for people who are homeless, 
according to the Cuan Mhuire website, around 
40% of all people who have accessed treatment in 
Cuan Mhuire centres were homeless at the time of 
admission. Support is given to people completing 
programmes, and transition houses are available 
until the person feels ready for independent living 
and has secured accommodation. The Rutland 
Centre (2020) is the largest private drug rehabilitation 
facility in Ireland. Services include residential care, 
an outpatient programme, continuing care, family 
support, and workshops. While there are no explicit 
exclusions for people accessing these programmes, 
the centre charges clients for treatment. The 
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treatment costs are high; for example, a 5-week 
residential programme costs €11,500, and so it is 
unlikely that this is a feasible treatment option for 
people who are homeless (The Rutland Centre, 2020).
3.3.2.3 Lower-threshold third sector services
Other services for people who are homeless are 
lower threshold, which means there are fewer 
constraints or contingencies placed on service users 
with regard to existing substance use. For example, 
The Society of St. Vincent de Paul (n.d.) is the largest 
voluntary charitable organisation in Ireland, providing 
services each night to more than 300 people who are 
homeless. Service users are assigned a designated 
key worker who will aid the person in accessing 
services (such as substance use services) and provide 
ongoing support.
The Ana Liffey Drug Project (2007) is a national 
problem substance use service with a low-threshold 
and harm reduction ethos. The Ana Liffey Drug 
Project’s services include open access hours, where 
people can attend without an appointment, as 
well as an assertive outreach programme in Dublin 
that provides advice and support on the street, in 
cafes, in community centres, or anywhere else that 
suits the service user. Outreach services include 
the provision of NSPs, advocacy, referrals, medical 
services (such as BBV testing and wound care), and 
brief interventions. The Ana Liffey Drug Project also 
provides the National Community Detox Initiative, 
which could be chosen as an alternative to residential 
treatment or as a step towards necessary entry 
requirements for residential treatment. Funding for 
the Ana Liffey Drug Project is provided by a number 
of sources, including the HSE (Addiction Services and 
National Office of Social Inclusion), the Department 
of Health, local and regional drug and alcohol task 
forces, Dublin City Council, Dublin Regional Homeless 
Executive, and the Department of Justice and 
Equality. 
Merchants Quay Ireland (2020) is a national voluntary 
organisation that helps people who are homeless 
and those who use drugs. Its main building in Dublin 
provides a drop-in breakfast and lunch service; an 
extended day service which offers evening meals, 
support, advice, and assistance; and a night café 
providing showers, clean clothes, information, brief 
counselling, drug treatment options, assistance 
with accommodation, and a place to sleep if there 
are no other suitable options. Merchants Quay 
Ireland offers advice and information about the risks 
associated with drug use and how to minimise these 
risks, and also offers pathways into treatment for 
substance use. An example of this is the stabilisation 
programme which is run as part of the Community 
Employment Scheme. This service not only supports 
people who use drugs on their recovery journey, 
but also incorporates an education and employment 
programme which enables service users to learn new 
life skills (Merchants Quay Ireland, 2020). 
The Peter McVerry Trust (2019) is a charity that works 
predominantly with younger people and adults with 
complex needs, including housing and substance use, 
and in 2018 it worked with more than 5,800 people 
across 14 local authorities in Ireland. It provides 
housing services and substance use services, including 
a low-threshold entry drug stabilisation and recovery 
service, a Residential Community Detox service, and 
a residential aftercare service for those exiting the 
programmes. All services are based in Dublin; however, 
the Residential Community Detox is a national centre 
and works with people from across Ireland. This 
service operates with full clinical governance from 
the HSE (Peter McVerry Trust, 2019). While the Peter  
McVerry Trust provides services for people who are 
homeless and for people who use drugs, it is not 
clear how integrated these services are. 
Safetynet (n.d.) is a medical charity that delivers 
care to marginalised groups who face challenges in 
accessing typical healthcare services. Safetynet’s 
services for people who are homeless include 
GP and nurse services situated in emergency 
accommodation across Dublin, and a mobile health 
and screening unit that operates across Dublin 3 
nights a week in conjunction with the Dublin Simon 
Community. Both of these services are provided in 
partnership with the HSE’s National Social Inclusion 
Office. The Simon Communities (n.d.) support 
more than 13,000 people each year across Ireland. 
A large number of different services are provided 
by the Simon Communities, including emergency 
accommodation, pathways out of homelessness, 
outreach services such as needle exchange, and 
substance use treatment and recovery services. The 
Simon Communities services cover Cork, Dublin, 
Dundalk, Galway, Midlands, the Mid West, the North 
West, and the South East (Simon Communities, n.d.). 
Clondalkin Tus Nua (2014) is a community-based 
support service for problem substance use, providing 
holistic and therapeutic services. It provides a 
number of services specifically for people who 
are homeless, such as a drop-in service with food, 
shower, and laundry facilities. An outreach service 
is also provided for people who are homeless in 
Clondalkin. The main aim of this service is to build 
non-judgemental relationships with people who 
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are homeless and use drugs. Support is provided 
by the outreach service, including help accessing 
shelters/accommodation; hygiene packs; harm 
reduction supplies and information; education 
materials; general health promotion; and referrals. 
Clondalkin Tus Nua also provides confidential 
support sessions consisting of relapse prevention, 
crisis intervention, harm reduction, Motivational 
Interviewing, care plan development, referrals, 
pre-assessments, and community reintegration. As 
part of the holistic approach, service users are also 
offered complementary therapies, such as massage, 
reflexology, acupuncture, and meditation (Clondalkin 
Tus Nua, 2014).
3.3.2.4 Needle and syringe programmes 
There are three models of NSP in Ireland: static, 
outreach, and pharmacy-based. According to the 
Review of Needle Exchange Provision in Ireland 
(HSE, 2015), Dublin Mid-Leinster has 14 static needle 
exchange services, the highest number in the 
country. Pharmacy-based NSP services are based 
outside Dublin, Kildare, and Wicklow. There are a 
small number of outreach/mobile NSP services, 
with the Dublin Mid-Leinster area having the most, 
with six. There are no static or outreach NSP 
services in Co Cork or Co Kerry, with very limited 
static and outreach NSP services in Co Louth, Co 
Meath, Co Cavan, and Co Monaghan (HSE, 2015). The 
majority of static services are open for between 1 
and 6 hours a week, with some services only being 
open once a week. No static or outreach services 
operate at weekends, according to the Review of 
Needle Exchange Provision in Ireland (HSE, 2015). 
Pharmacies are reportedly open for around 8 hours 
a day, Monday to Saturday, and some pharmacies 
also open on Sundays for limited hours. The review 
indicates that this provides a potential total of 3,408 
hours a week of pharmacy-based NSP delivered by 
63 pharmacies. However, according to pharmacy 
records, only 33 out of the 63 pharmacy NSPs 
reported any transactions in 2012 (HSE, 2015). A 
2-year take-home naloxone programme was also 
initiated in 2015 and, by 2017, 800 people had 
received naloxone training and 1,200 naloxone kits 
had been distributed (EMCDDA, 2019b).
3.3.2.5 Supervised injecting facility 
A medically supervised injecting facility was due to 
open in 2019 at Merchants Quay Ireland in Dublin in 
response to the rising number of drug-related deaths 
in this area, ambulance call-out rates for overdose, 
and people injecting drugs in public areas. Plans 
were delayed by Dublin City Council, as there was a 
concern from some business groups that the location 
of the proposed service, in the main retail area of 
the city, could negatively impact tourism and future 
regeneration of the area. However, An Bord Pleanála 
(the Irish Planning Appeals Board) approved the 
plans on 24 December 2019, concluding that negative 
effects have not been seen in other countries where 
supervised injecting facilities exist, and that refusal to 
approve the plans would lead to preventable deaths, 
as well as antisocial behaviour associated with drug 
use in the area. A Judicial Review was lodged in 
relation to the planning approval in February 2020, 
so progress with this facility has halted until the 
outcome of this Judicial Review.
3.3.3 Housing
Third sector housing services that we were made 
aware of through relevant stakeholders in Ireland 
include Sophia Housing (2020), HAIL (Housing 
Association for Integrated Living) (n.d.), and 
Novas (n.d.). Sophia Housing is an organisation 
that provides housing and other support for 
marginalised populations across Ireland. It also 
works in partnership with the HSE and acts as a 
referral agency and intermediator for people who 
are homeless, linking them to HSE services such 
as Addiction Services (Sophia Housing, 2020). HAIL 
provides housing and support for those on local 
authority housing waiting lists, primarily those with 
mental health problems. Although it does not specify 
on HAIL’s website whether it provides services 
for problem substance use, it does state that it 
provides a range of support, including help accessing 
necessary community and statutory services (HAIL, 
n.d.). Novas provides temporary and long-term 
housing for people who are homeless in Ireland, as 
well as other support such as drug services. This 
includes the Mid-West Community Detox Programme 
and a respite house for the families of people who 
use drugs (Novas, n.d.). While not specifically a 
housing organisation, Tus Nua is a Depaul service 
for women leaving prison and provides effective 
transitional support (Depaul, 2018). This is particularly 
important for women who are homeless or at risk 
of homelessness upon release. Tus Nua provides 
accommodation for up to 6 months and provides 
a support plan covering harm reduction, access 
to detoxification services, and physical and mental 
health support (Depaul, 2018).
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3.3.4 Other services
A number of services exist across Ireland that provide 
support for people who are homeless, but some 
explicitly do not support people who use drugs, 
and others do not specify whether they support 
people who use drugs (HSE, 2018). O’Connell Court 
(n.d.) supports people aged over 50 years who are 
homeless, as well as people aged over 50 years with 
poor mental health. However, it does not support 
people who use drugs or with problem alcohol use at 
its hostels. YMCA Ireland (2019), Threshold (2019), The 
Iveagh Trust (2020), and Crosscare (2019) all provide 
support for people who are homeless, but do not 
mention substance use support on their websites. 
Depaul provides a number of managed alcohol 
programmes based around harm reduction and 
alcohol use; however, it is unclear if it also provides 
support with illicit drug use. These services include 
Sundial House, Rendu apartments, Orchid House, 
and Back Lane Hostel (Depaul, 2018). Focus Ireland 
is a charity that helps families, young people, and 
children at risk of homelessness (Focus Ireland, 2019). 
It does state that it provides support for people who 
are homeless and use drugs but does not explicitly 
list the services it provides. The Salvation Army 
(2019) is a Christian church and charity that offers 
support and services worldwide. In Dublin, there 
are four Lifehouses (residential hostels) that provide 
accommodation for people who are homeless. 
Substance use support, as well as outreach and 
community services, are available within each 
Lifehouse. However, further information on services 
specifically for people who are homeless and have 
problem substance use in Ireland is not listed on 
the Salvation Army website. Finally, RADE (Recovery 
through Arts, Drama and Education) (2020) does 
not provide services specifically for people who are 
homeless, but its vision is that creativity is open to 
everyone. Its mission is to work with people who 
use drugs and introduce them to the arts and other 
therapeutic supports, and to provide a platform for 
artistic expression (RADE, 2020).
3.4 Chapter summary 
In summary, the most recent data show that illicit 
drug use in the general population has increased 
in Ireland since 2010. The number of drug-related 
deaths in Ireland rose each year between 2010 and 
2017, from 607 to 786, respectively. Data for the 
prevalence and patterns of drug use indicate that 
substance use is more commonly reported among 
people who are homeless than among the general 
population. A key message from this chapter is 
that the lack of data for people who are homeless 
makes treatment and service needs for this group 
difficult to ascertain. For example, there are no data 
for drug-related death rates specifically for people 
who are homeless; however, given that high-risk 
behaviours, such as injecting, are greater among 
this population, the risk of drug death is likely to be 
higher than in other groups. Future research must 
address this gap, for example through a retrospective 
review of coroner records, or through establishing a 
confidential enquiry system, or through a prospective 
cohort study.
The total number of drug treatment cases in Ireland 
increased to 10,664 in 2019. This is the highest 
number of recorded cases in the 10-year period 
between 2010 and 2020. The number of people who 
are homeless and have accessed drug treatment 
services rose from 581 in 2012 to 1,173 in 2019. This 
chapter has synthesised the wide range of services 
that exist in order to meet the needs of people who 
are homeless and use drugs in Ireland. However, it 
is currently unclear by what pathways people who 
are homeless and use drugs are referred to services, 
and information on partnership working is limited. 
This possibly makes service provision appear more 
fragmented than it is. There is also limited information 
about specific outcomes relating to services,  
and limited evidence of what works best for this 
population. To address this gap in knowledge, the next 
part of the review aims to explore the international 
evidence on effective interventions in the areas of 
engagement, retention, and treatment outcomes for 
people who are homeless and use drugs. 
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4.1 Chapter overview 
The aim of this chapter is to present the findings 
from the systematic review of reviews that examined 
which interventions are effective in engaging people 
who are homeless and who use drugs in drug 
treatment services and in facilitating their retention 
in treatment. This section begins with a presentation 
of the quality appraisal outcomes, followed by an 
overview of the included reviews and a discussion of 
findings on treatment outcomes, engagement, and 
completion.
4.2 Quality appraisal of included 
reviews
Two reviewers (JM and HC) independently assessed 
the quality of the included reviews (n=18)2 using 
the JBI Critical Appraisal Checklist for Systematic 
Reviews and Research Syntheses. Each review 
received a score based on this quality assessment, 
and any disagreement in scores was resolved through 
a third reviewer (WM) and further discussions. The 
third reviewer was involved in resolving differences 
in appraisal for 6 of the 18 papers (Beaudoin, 2016; 
Brunette, Mueser, & Drake, 2004; Carver et al., 2020; 
Chambers et al., 2017; Penzenstadler et al., 2019; 
Wright & Tompkins, 2006). Four of the disagreements 
were resolved outright by the third reviewer 
(Beaudoin, 2016; Brunette et al., 2004; Chambers 
2 Only academic reviews identified via the systematic database 
search were quality appraised. Grey literature reports 
underwent data extraction and are presented in the final 
synthesis.
et al., 2017; Penzenstadler et al., 2019), and the 
other two papers were discussed until a consensus 
was reached. The differences in scores and their 
resolution are presented in Appendix 10. 
Overall, the quality of the included reviews was 
moderate. Two of the included papers achieved 
the highest possible score of 11, whereas 6 of the 
appraised papers received a score of 6 or lower. The 
inclusion of individual reviews in this document was 
not based on quality appraisal thresholds; however, 
we have noted each review’s quality when presenting 
evidence and making recommendations. The most 
common questions/concerns identified were 
whether the reviews included appropriate criteria 
for appraisal; whether the appraisal was conducted 
independently by two or more reviewers; whether 
there were methods used to minimise data extraction 
errors; and whether publication bias was assessed. 
Only four papers explicitly assessed publication bias. 
Similarly, only four papers reported having the quality 
appraisal performed independently by at least two 
reviewers. The final quality appraisal scores and 
tabulation are presented in Appendix 9. 
4.3 An overview of the included 
reviews
Data relating to study design and key characteristics 
were extracted into an Excel spreadsheet. The 
final data extraction is presented in Appendix 11. 
Included papers were published between 2004 
and 2020. The 22 included studies consisted of 4 
grey literature reports (Bates et al., 2017; Minyard et 
al., 2019; Pleace, 2008; Pleace & Quilgars, 2013); 13 
systematic reviews (Barker & Maguire, 2017; Baxter 
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et al., 2019; Beaudoin, 2016; Benston, 2015; Carver et 
al., 2020; Chambers et al., 2017; de Vet et al., 2013; 
Formosa et al., 2019; Hwang et al., 2005; O’Campo 
et al., 2009; Torres Del Estal & Álvarez, 2018; Turner 
et al., 2011; Wright & Walker, 2006), 2 of which also 
included a meta-analysis (Baxter et al., 2019; Turner 
et al., 2011); and 5 reviews which were deemed to be 
non-systematic3 (Brunette et al., 2004; Kertesz et al., 
2009; Penzenstadler et al., 2019; Sun, 2012; Wright & 
Tompkins, 2006). The majority of the papers included 
only quantitative studies (12/22); eight included 
any study type/mixed designs, including one realist 
synthesis (O’Campo et al., 2009); one review of only 
qualitative studies presented a meta-ethnography 
(Carver et al., 2020); and one grey literature report 
was a review of reviews (Bates et al., 2017). The 
number of included studies per review ranged from 
4 (Baxter et al., 2019) to 151 (Minyard et al., 2019), 
and 5 papers did not report how many studies were 
included in the final synthesis (Kertesz et al., 2009; 
Pleace, 2008; Pleace & Quilgars, 2013; Sun, 2012; 
Wright & Tompkins, 2006).
Most of the reviews (10/22) were undertaken in the 
UK, four in the United States of America (USA), four in 
Canada, three in Europe (Spain, Ireland, and a Dutch/
Belgian collaboration), and one was an international 
collaboration by researchers from Switzerland, the 
UK, and Canada. Despite this, nearly all the reviews 
(n=19) were international in focus, with two reviews 
focusing on the USA only and one focusing on the 
UK only. Even though the focus of the reviews was 
international, the majority of the authors were 
based in the UK, and the majority of primary studies 
were undertaken in the USA. This may affect the 
generalisability of the findings to non-USA contexts. 
For example, Barker and Maguire (2017) included 11 
studies, of which 9 were undertaken in the USA, 1 was 
undertaken in Canada, and 1 was undertaken in the 
Netherlands. Similarly, de Vet et al. (2013) included 21 
studies, of which 20 were undertaken in the USA and 
1 was undertaken in the UK.
3 The classification of reviews as being either systematic or 
non-systematic was performed using the JBI Critical Appraisal 
Checklist for Systematic Reviews and Research Syntheses, with 
the criteria of the first three items of the tool needing to be 
met for the review to be classified as ‘systematic’. 
The papers included in the review were diverse in 
terms of their primary focus (Table 2), ranging from 
interventions targeting specific populations – for 
example, those with COSMHAD (Brunette et al., 
2004; Minyard et al., 2019; O’Campo et al., 2009; 
Sun, 2012) – to focusing on specific harm reduction 
interventions or practices, such as OST or NSPs 
specifically in terms of HCV prevention (Turner et al., 
2011).
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Table 2: Focus of the included papers







HF focuses on providing immediate, permanent, low-barrier, non-
abstinence-based supportive housing for individuals with lived 
experience of homelessness.
6 Baxter et al. (2019); 
Beaudoin (2016); Benston 
(2015); Chambers et al. 
(2017); Kertesz et al. (2009); 
Pleace and Quilgars (2013)
COSMHAD Residential programmes and community-based treatment. 
Residential programmes can integrate mental health treatment, 
substance use interventions, housing, and other types of support. 
Community-based treatment can also include integrated 
treatment (integrated mental health and substance use treatment) 
with counselling and housing support; or integrated assertive 
community treatment (IACT).
4 Brunette et al. (2004); 
Minyard et al. (2019); 





Treatment approaches for problem substance use are wide-
ranging and can be placed on a continuum, ranging from harm 
reduction to abstinence-based approaches.
3 Bates et al. (2017); Carver 
et al. (2020); Pleace (2008)




These included: adequate oral opioid maintenance therapy; 
tetanus and hepatitis A, B, and C immunisations; safer injecting 
advice and access to needle exchange programmes; supervised 
injecting rooms; peer distribution of take-home naloxone; 
assertive outreach programmes; supportive programmes 
for substance dependence; and sexual health promotion 
programmes.
2 Hwang et al. (2005); Wright 
and Tompkins (2006)
Case management Case management is a strategy to support rapid rehousing, 
especially for those with complex needs. It provides outreach, 
assessment, planning, linkage, monitoring, and advocacy services. 
This strategy typically provides support in developing independent 
living skills, acute care in crisis situations, support with medical 
and psychiatric treatment, and assistance with contacts between 
clients and people in their social and professional support systems 
(de Vet et al., 2013). 
2 de Vet et al. (2013); Torres 
Del Estal and Álvarez (2018)
Assertive community 
treatment (ACT)
A subtype of case management, ACT is typically targeted at 
individuals with the greatest service needs and prescribes more 
intensive services, more frequent client contact, and smaller 
individual caseloads than standard case management, and the 
responsibility for providing services to clients is shared by a 
multidisciplinary team that is accessible 24 hours a day, 7 days a 
week (de Vet et al., 2013).




These are interventions provided/initiated at the ED, aiming 
to improve health and/or access to the social determinants of 
health (SDOH). These include case management, HF, substance 
use interventions, and ED-based resource desks and ED 
compassionate care.
1 Formosa et al. (2019)
Sexual health 
promotion
This includes programmes combining HIV education; alcohol 
and drug counselling; benefits and housing assistance; acquired 
immunodeficiency syndrome (AIDS) videotapes and group sessions 
on AIDS education; HIV testing; condom use; use of bleach to 
sterilise injecting equipment; signposting to community resources; 
and more tailored individual sessions with extra support for coping 
skills and self-esteem improvement.
1 Wright and Walker (2006)
Peer support Peers with experience of homelessness offer support to those 
currently experiencing homelessness. Intentional peer support 
(IPS) is fostered and developed by professional organisations, 
formalising this process.
1 Barker and Maguire (2017)
Harm reduction (OST, 
NSP, BBV)
Two important harm reduction interventions for injecting 
drug users are OST (to reduce drug dependence and injecting 
frequency) and the provision of clean injecting equipment through 
NSPs (to reduce unsafe injecting, i.e. sharing used syringes).
1 Turner et al. (2011)
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The included papers varied in terms of their inclusion 
of populations of interest (people who used drugs 
and who were homeless). Some of the reviews 
focused specifically on this population (e.g. Carver 
et al., 2020; Kertesz et al., 2009; Torres Del Estal & 
Álvarez, 2018). Others focused on people who were 
homeless and had COSMHAD (e.g. Brunette et al., 
2004; O’Campo et al., 2009), or on people who were 
homeless with mental health problems only, which 
either could include substance use disorder as a 
type of mental health problem, or include a large 
proportion of people with problem substance use 
due to the high comorbidity of substance use and 
mental health problems (e.g. Benston, 2015). Still 
others focused on people who were homeless as the 
primary population of interest, where substance use 
was secondary (e.g. Hwang et al., 2005), due to the 
high overlap of those two issues. 
It is important to note that even in some of the 
reviews which focus on a specific population, such 
as those who were homeless, there were differences 
between the studies included in those reviews in the 
proportion of participants who were homeless. For 
this reason, some of the reviews adopted minimum 
percentages for inclusion. For example, Barker and 
Maguire (2017) only included studies which had a 
minimum of 30% of people who were homeless in 
their samples. Definitions of homelessness also varied 
between the reviews and between the individual 
studies they included. For example, Wright and 
Tompkins (2006) describe homelessness as a complex 
concept, embracing many types of insecure housing 
status, including ‘rooflessness’, which covers “rough 
sleepers, newly arrived immigrants, and victims of 
fire, floods, or violence” (Wright & Tompkins, 2006,  
p. 286) and ‘being houseless’, whereby people may be 
“living in emergency and temporary accommodation, 
including hostels; and those released from psychiatric 
hospitals, custodial establishments, or foster homes 
with nowhere to go” (Wright & Tompkins, 2006,  
p. 286). This definition of homelessness also includes 
people living in insecure, inadequate, overcrowded, 
or substandard accommodation, such as those 
staying with friends or relatives on a temporary basis, 
tenants under notice to quit, those whose security 
is threatened by violence, and ‘squatters’. This is a 
very broad definition of homelessness, in contrast 
with Hwang et al. (2005), for example, who defined 
‘homeless persons’ as “individuals who lack a fixed, 
regular, and adequate night-time residence, including 
people living in supervised shelters or places not 
intended for human habitation” (Hwang et al., 2005, 
p. 311), which would exclude those in overcrowded 
accommodation or those who are ‘couch-surfing’. 
Notably, Wright and Walker (2006), who included six 
studies in their review, commented that only one of 
their included studies explicitly defined homelessness, 
with the other studies using sampling frames of those 
residing in homeless hostels and shelters.
The largest number of reviews (n=6) focused on 
housing interventions, including HF initiatives (Baxter 
et al., 2019; Beaudoin, 2016; Benston, 2015; Chambers 
et al., 2017; Kertesz et al., 2009; Pleace & Quilgars, 
2013). Of these, four focused on HF initiatives – an 
approach to ending homelessness that focuses on 
providing immediate, permanent, low-barrier, non-
abstinence-based supportive housing for individuals 
with lived experience of homelessness. Baxter et 
al. (2019) investigated the effects of HF approaches 
on the health and well-being of adults who were 
homeless, or were at risk of homelessness, by 
performing a systematic review and a meta-analysis 
of randomised controlled trials (RCTs). Beaudoin 
(2016) aimed to investigate the effectiveness of 
HF in response to the needs of people who are 
homeless and who have mental health or substance 
use problems by undertaking a systematic review of 
Canadian and international literature. Kertesz et al. 
(2009) reviewed studies of HF and of more traditional 
rehabilitative recovery interventions (which they 
termed ‘linear’),4 focusing on the outcomes obtained 
by both approaches specifically for people who 
are homeless and who have problem substance 
use. Pleace and Quilgars (2013) conducted a rapid 
evidence assessment (REA) of the international 
evidence regarding the success of HF services in 
promoting the healthcare integration and the social 
and economic integration among people who were 
formerly homeless and using HF services. The 
remaining two housing reviews examined permanent 
supportive housing (Benston, 2015), and supportive 
housing and recovery housing (Chambers et al., 2017). 
Benston (2015) evaluated the best available research 
in the USA on permanent supportive housing 
programmes for people who were homeless and 
had mental health problems, and the effect of these 
programmes on housing status and mental health. 
Chambers et al. (2017) conducted a systematic 
review of the evidence on housing interventions for 
‘housing-vulnerable’ adults and their relationship 
to well-being; populations of interest included (but 
were not limited to) those who were homeless or 
4 Kertesz et al. (2009) define linear programmes as “programmes 
that move stepwise from rehabilitation settings to permanent 
domiciles” (Kertesz et al., 2009, p. 500). Linear approaches 
have different designs, but most assume that a return to long-
term, stable housing requires the restoration of behavioural 
self-regulation and the capacity to interact in a constructive 
social environment, and that tangible resource needs must be 
addressed in order to ensure the person’s engagement and 
attendance (Zerger, 2002). 
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had a history of homelessness, people with a history 
of mental health problems, people with a learning 
disability, refugees and recent immigrants, young 
people leaving care, and ex-prisoners.
Four of the remaining reviews focused on 
interventions for people with COSMHAD (Brunette et 
al., 2004; Minyard et al., 2019; O’Campo et al., 2009; 
Sun, 2012). Brunette et al. (2004) conducted a review 
of research on residential programmes for people 
with mental health problems and problem substance 
use, with 5 of the 10 included studies focusing on 
people who are homeless. O’Campo et al. (2009) 
focused on community-based services for adults 
who are homeless and experiencing COSMHAD using 
a realist approach to synthesising evidence. Sun 
(2012) discussed strategies for helping people with 
COSMHAD based on a (non-systematic) literature 
review. Lastly, Minyard et al. (2019) performed a rapid 
realist synthesis regarding treatment services for 
people with COSMHAD. The participants were people 
who currently or had previously used drugs and who 
were homeless or at risk of homelessness.
Three of the papers focused on substance use 
treatment specifically (Bates et al., 2017; Carver et 
al., 2020; Pleace, 2008). These papers included a 
meta-ethnography conducted to synthesise research 
reporting views on substance use treatment by 
people experiencing homelessness (Carver et al., 
2020); an REA of international literature on effective 
substance use services for people who are homeless, 
reviewing best practice in other countries in order 
to determine if there were any lessons for Scotland 
(Pleace, 2008); and a review of reviews on the 
effectiveness of interventions related to the use of 
illicit drugs – including prevention, harm reduction, 
treatment, and recovery – which was not specific to 
people who are homeless, but did seek to highlight 
evidence on interventions for ‘high-risk’ groups, 
including people who are homeless and use drugs 
(Bates et al., 2017).
Two papers investigated healthcare treatments 
and interventions in general (Wright & Tompkins, 
2006; Hwang et al., 2005), and one focused on ED 
interventions (Formosa et al., 2019). Wright and 
Tompkins (2006) aimed to examine how healthcare 
services can effectively meet the healthcare 
needs of people who are homeless. They critically 
examined the international literature pertaining 
to the healthcare of people who are homeless 
and discussed the effectiveness of the identified 
treatment interventions. Those interventions 
included primary prevention interventions; 
management of drug/alcohol dependence; 
medically supervised injecting centres; and sexual 
health promotion. Hwang et al. (2005) conducted 
a systematic review of interventions to improve 
the health of people who were homeless. These 
included interventions for people with mental health 
problems (15 studies), problem substance use (13 
studies), and COSMHAD (7 studies). Formosa et 
al. (2019) focused specifically on ED interventions. 
The authors performed a systematic review which 
included studies of homeless patients (or studies 
where the majority of participants were homeless 
patients) recruited at the ED level. They aggregated 
and reviewed the literature on ED interventions that 
improved health and/or access to the SDOH for 
homeless patients. These interventions included 
case management, HF initiatives, substance use 
interventions, ED-based resource desks, and ED 
compassionate care. 
Two reviews focused specifically on case 
management interventions. de Vet et al. (2013) 
reviewed the literature on standard case 
management (SCM), intensive case management 
(ICM), ACT (which is also a subgroup of case 
management), and critical time intervention (CTI) 
for homeless adults. Their seven outcome domains 
included service use, housing, health (physical and 
mental), substance use (alcohol and drugs), societal 
participation, quality of life (QoL), and intervention 
cost (service expenses and cost-effectiveness). 
Torres Del Estal and Álvarez (2018) focused on 
interventions for the management of substance use 
in people who were homeless that were delivered by 
the community/nurses, categorising the interventions 
as ‘case management’ and ‘other’. The authors noted 
that, in many of the studies reviewed, nurse-led 
interventions were not detailed; they described the 
nursing role within the programme in general terms 
only, but not specifically the interventions. However, 
some of the identified ‘other’ nurse-led interventions 
were, for example, described as multidisciplinary 
teams performing street outreach. The review 
identified the existence of specific interventions 
aimed at specific subpopulations of the homeless 
population (such as women); for example, structured 
group sessions and community therapy, as well as 
mobile outreach units and administration of NSPs or 
injection supervision. 
Penzenstadler et al. (2019) focused on ACT. Their 
review aimed to assess the effectiveness of ACT 
for patients with problem substance use on several 
measures, including substance use, treatment 
engagement, hospitalisation rates, QoL, housing 
status, medication compliance, and legal problems. 
Wright and Walker (2006) focused on sexual health 
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promotion and examined the effectiveness of 
sexual health promotion interventions in homeless 
drug-using populations. A significant proportion 
of the included studies compared ‘traditional’ 
and ‘specialised’ multicomponent AIDS-focused 
programmes that involved group educational 
and practical elements. Other studies included 
counselling, as well as benefits/housing assistance. 
Turner et al. (2011) investigated the impact of harm 
reduction interventions on the incidence of HCV, 
specifically whether OST and NSPs can reduce HCV 
transmission among people who inject drugs. The 
primary outcome was new HCV infections. The 
secondary outcomes were based on self-reported 
injecting risk behaviour (namely needle sharing) in 
the last month and the mean number of injections 
in the last month. Lastly, Barker and Maguire (2017) 
investigated the effectiveness of IPS for people who 
are homeless (including people who were rough 
sleepers and those within services). IPS is termed 
‘intentional’ because it is fostered and developed 
by professional organisations and can include either 
mentorship support or mutual support. Therefore, 
interventions that are using IPS may be using peers 
as client mentors or an adjunct to to the services 
provided, such as combining peers and professionals 
in the delivery of services. Barker and Maguire (2017) 
acknowledge that IPS models are quite diverse, with 
the main common element being that peers share 
personal experiences with their clients and are 
viewed as distinct from professionals. 
4.4 Outcomes: treatment entry, 
engagement, and retention
Eleven of the included reviews mentioned treatment 
engagement and/or retention. However, overall, 
there is very little evidence on these outcomes. 
Reviews identify challenges to treatment completion 
among people experiencing homelessness where 
their other health and social needs have not been 
met (Pleace, 2008). In the USA, provision of support 
for this population can also run into difficulties 
because of the strict programme rules governing 
abstinence and other aspects of behaviour. Services 
may either fail to engage people at all, or there is a 
high level of attrition before treatment completion. 
Furthermore, in Pleace’s (2008) review, there was 
little evidence of some types of interventions, such 
as fixed-site detoxification, delivered outside of 
the USA. While success is often claimed by service 
providers, models such as fixed-site detoxification 
typically show high levels of attrition between 
programme stages, often because of requirements 
for abstinence and the intervention’s focus on 
substance use rather than on broader client needs 
(Pleace, 2008). 
Regarding housing interventions, Pleace and 
Quilgars (2013) identify that one of the criticisms of 
HF services is a lack of engagement with services 
among people who have very high levels of problem 
substance use, and conclude that, generally, 
HF studies indicate varying levels of community 
engagement of service users within any one project. 
They state that engagement with treatment – either 
provided directly by those HF services that have 
an ACT team and/or via ICM by all forms of HF 
service – is a goal of HF, but that while supported 
and encouraged through a harm reduction approach 
with a recovery orientation within HF, treatment 
engagement is ultimately self-determined. The 
authors also report that some of the studies in their 
review suggest that alternative approaches, such 
as linear residential treatment or staircase models, 
could achieve better results for outcomes such as 
substance use, since they actively pursue abstinence 
from drugs and alcohol. However, as noted above, 
staircase service models achieve only relatively low 
rates of success, often losing between 40% and 70% 
of participants due to strict regimes, participants 
becoming ‘stuck’, or participants being evicted from 
the services because they do not meet the criteria. 
Abstinence-based or detoxification services without 
any housing elements that attempt to treat drug 
and alcohol use while someone is still homeless are 
generally less successful than staircase services. 
Kertesz et al. (2009) report higher completion rates 
for a linear approach called the Birmingham model, a 
rigorous abstinence-contingent housing intervention 
lasting 6 months, with between 6 and 8 hours a day 
spent on behavioural treatment and employment 
training, including relapse prevention and rewards 
for achieving objectively defined recovery goals as 
determined by peers and a counsellor. Completion 
of the treatment is followed by a referral to housing. 
At the time of Kertesz et al.’s (2009) review, four 
RCTs and one meta-analysis of this model had 
been published and each trial varied aspects of the 
treatment (for example, treatment intensity) in order 
to attempt to identify which elements contributed to 
abstinence. In the most recent of those trials, 65% 
of the participants completed a programme lasting 
24 weeks (Milby et al., 2008), a figure somewhat 
comparable to the 12-month retention rate of 34–
56% in modified therapeutic communities (De Leon 
et al., 2000) which, in contrast to more traditional 
therapeutic communities, have lowered their social 
demands, reduced direct confrontation, enhanced 
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personal freedom, and provided greater social 
assistance, specifically to accommodate people who 
are homeless and experiencing COSMHAD.
Similar to criticisms of HF raised by Pleace and 
Quilgars (2013) in terms of engagement, Chambers et 
al. (2017) also report that all three of their included 
UK evaluations of HF identified that some service 
users had not benefited from the programme. 
Social isolation for service users living alone in 
self-contained accommodation was identified as 
one possible explanation for this. There was some 
evidence of increased engagement with medical 
treatment and mental health services, and also some 
reductions in drug and alcohol use among people 
who were using one HF service, although this was not 
the case for all people. Barriers included boredom 
and isolation, which were highlighted as problematic 
predominantly by the service users themselves, 
but also by some of the interviewed staff in the 
included studies. Evidence from qualitative studies 
also suggested engagement issues related to the fact 
that being in interim housing, and the consequent 
effects of this situation on therapeutic relationships 
and engagement with services, can be experienced 
as an unpredictable and volatile situation. Moreover, 
there was evidence of frustration among participants 
as a result of their situation, resulting in inconsistent 
attention to recovery goals. HF service providers 
experienced increased difficulty in integrating 
housing support with case management. On the 
other hand, in terms of facilitators, there was some 
evidence that structural aspects of the programme 
promoted engagement by enabling service users 
and case managers to create a shared narrative of 
their common experiences. The quality of social 
interactions between clients and providers was also 
vital for engagement and was influenced by how the 
case managers perceived the service users, as well 
as how the service users understood themselves to 
be perceived. Compared with ‘treatment first’ (TF) 
participants, HF participants in one study were found 
to have higher rates of retention in a methadone 
treatment programme.
Regarding people with COSMHAD, Brunette et al. 
(2004) reported potential advantages of integrated 
residential programmes that were modified to meet 
the needs of those with mental health problems. 
However, study quality was generally weak, 
including significant participant crossover between 
interventions; skewed entry to the programmes due 
to differences in waiting periods or administrative 
requirements between programmes; small sample 
sizes; and high rates of dropout. Few studies 
provided evidence on which clients responded 
to residential programmes. Studies have included 
different groups – for example, people who have not 
been able to engage in or benefit from outpatient 
treatment, people who are homeless, and those 
just released from prison or from hospitals. Besides 
homelessness, the personal characteristics of people 
with COSMHAD who benefited from residential 
programmes were uncertain. There is limited 
research that has tried to identify which client factors 
might predict treatment retention, and it has not 
been possible to draw conclusions from the existing 
research. Only one study included in Brunette et al.’s 
(2004) review reported on this issue and showed that 
clients in the earlier stages of treatment (with lower 
levels of motivation) were more likely to drop out of 
the programme due to problem substance use. The 
authors concluded that greater levels of integration 
between mental health and problem substance 
use treatment seem to be associated with better 
engagement and retention in treatment.
Looking at case management approaches, de Vet et 
al. (2013) reported mostly non-significant findings 
regarding ICM but suggested that these results could 
have been attenuated by treatment non-adherence 
and lack of differential service utilisation between 
groups. They reported that, for example, 71% of 
participants assigned to shelter-based ICM services 
for men experiencing both substance use and 
homelessness did not complete the programme. On 
the other hand, Penzenstadler et al. (2019) highlight 
higher rates of treatment engagement and retention 
for ACT, as well as evidence of greater medication 
compliance. One reviewed study did not provide any 
information on treatment engagement but stated 
that contacts with patients were significantly higher 
in the ACT and IACT groups compared with controls. 
Higher fidelity to the ACT model appeared to improve 
outcomes. Overall, the authors concluded that ACT 
could be a promising approach that may be useful 
for promoting treatment engagement for people 
experiencing problem substance use. 
Other reviews with engagement and retention data 
include Hwang et al. (2005), which included two 
good-quality studies focused on the treatment 
of latent tuberculosis (TB) for people who were 
homeless. The authors report that, compared with 
usual care, a cash incentive increased attendance 
at an appointment for initial assessment of a 
positive tuberculin skin test, and that for people 
who experienced homelessness with latent TB 
receiving directly observed preventive therapy, 
cash incentives and non-cash vouchers at each 
visit were equally effective in increasing completion 
rates. Sun (2012) reported that there was some 
www.hrb.ie40
evidence that Motivational Interviewing (MI) and 
Motivational Enhancement Therapy (MET) increased 
treatment engagement during the short term for 
those experiencing homelessness and COSMHAD. 
There was also evidence of benefits from group MI 
in terms of increased attendance with aftercare 
and reduced alcohol consumption. Sun (2012) also 
identified evidence for combining MI with cognitive 
behavioural therapy (CBT) and family interventions 
for those experiencing schizophrenia and problem 
substance use. Regarding engagement in treatment 
for people with HIV, Bates et al. (2017) reported 
that adherence to highly active antiretroviral 
therapy (HAART) among people who used drugs was 
comparable to that among people who did not use 
drugs. However, people who used drugs and engaged 
in OST had increased adherence to HAART and 
better treatment outcomes, compared with people 
who used drugs who engaged in HAART alone. For 
people with HIV, there is also evidence in support of 
the use of directly administered antiretroviral therapy 
(DAART), both alone and integrated in medication-
assisted therapy, to improve treatment and outcomes 
related to BBV infections. In terms of people with 
chronic HCV, there were no significant differences 
in BBV treatment dropout between PWID and those 
who do not who received combination treatment 
for HCV (ribavirin plus recombinant, or pegylated 
interferon-α).
Lastly, Carver et al.’s (2020) review identified 
that how an intervention is delivered, rather than 
what type of intervention it is, is also important 
to consider. They suggested that for those 
experiencing homelessness and problem substance 
use, engagement with all forms of treatment or 
service can be particularly problematic due to 
the (real or perceived) judgemental attitudes of 
others and stigma (Wise & Phillips, 2013). Carver et 
al. (2020) conclude that, regardless of the service 
approach, staff must be non-judgemental, and that 
supportive relationships should be central. While 
interpreting their own findings, the authors suggest 
that the alliance-outcome relationship is one of the 
strongest and most robust documentable predictors 
of treatment success, making it one of the most 
important influences on individual psychotherapy 
outcomes (Horvath et al., 2011). Alliance quality can 
reflect the collaborative dimension of therapy, as well 
as the importance of practitioners responding non-
defensively to client behaviours. Carver et al. (2020) 
cite other authors, such as Meier, Barrowclough and 
Donmall (2005), who also reported similar findings 
in their reviews, further strengthening the notion 
of therapeutic alliance being a consistent predictor 
of engagement and retention in substance use 
treatment for this population. 
  
Taken together, the evidence suggests that 
engaging and retaining people who are homeless 
and have substance use problems in treatment 
can be difficult regardless of intervention 
type. There is evidence that ACT can lead to 
increased engagement rates for people who are 
homeless and use drugs, and that integrated 
services for people with COSMHAD lead to better 
engagement and retention than segregated 
treatments. Results regarding HF suggest that 
engagement can be difficult and that social 
isolation may be a problem for those using the 
service. Lastly, the evidence suggests that the 
way in which interventions are delivered can 
play a crucial role in treatment engagement and 
retention, with warmth, compassion, empathy, 
and lack of judgement from the workers or 
therapists being paramount.
  
4.5 Outcomes: successful 
completion of treatment
The included reviews provided little evidence on 
approaches to improve treatment completion. 
Six mentioned completion rates; however, only 
one presents data in the form of completion 
percentages (Kertesz et al., 2009), and one only 
provides completion percentages from one of its 
included studies (de Vet et al., 2013). Kertesz et al. 
(2009) provide some completion numbers for the 
Birmingham linear housing model. At the time, four 
RCTs and one meta-analysis of this model had been 
published. In the most recent of the trials, 65% of 
the participants completed a programme lasting 24 
weeks (Milby et al., 2008), a figure higher than the 
50% for social intervention studies and comparable 
to the 12-month retention rate of 34–56% in 
modified therapeutic communities (De Leon et al., 
2000). In the review of case management approaches 
by de Vet et al. (2013), five studies investigated 
the effects of ICM on homelessness or residential 
stability in substance-using populations. Only one 
of them reported a significantly better result for 
ICM than for the usual case management services. 
de Vet et al. (2013) report that participants were 
recruited from a homeless shelter and that those 
who received ICM were more satisfied than control 
participants, although only a minority (29%) of the 
ICM participants completed the programme.
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The remaining reviews which mentioned treatment 
completion rates included Wright and Tompkins’ 
(2006) review of primary care interventions. 
The authors reported that, at the time, primary 
prevention interventions to reduce the prevalence of 
infectious disease in PWID consisted of vaccinations. 
Their review suggests that people experiencing 
homelessness and also injecting drugs should 
be offered hepatitis A and B, tetanus, influenza, 
pneumococcus, and diphtheria vaccinations, and 
they report that an accelerated HBV immunisation 
schedule (with doses administered at 0, 7, and 
21 days, and a booster at 12 months) resulted in 
superior completion rates compared with traditional 
schedules with similar seroconversion rates. The 
same study is also included in the systematic review 
by Hwang et al. (2005), who also report information 
relating to interventions for people experiencing 
homelessness and who have TB, finding that a cash 
incentive increased attendance at an appointment 
for initial assessment of a positive tuberculin skin 
test. In people experiencing homelessness with latent 
TB receiving directly observed preventive therapy, 
cash incentives and non-cash vouchers at each visit 
were equally effective in increasing completion rates 
in young people who were homeless. However, the 
review does not specify whether the people in those 
studies were also experiencing problem substance 
use as well as homelessness, and thus conclusions 
cannot be made regarding the effectiveness of cash 
incentives for this subpopulation. 
Regarding peer support interventions, Barker and 
Maguire (2017) reported that their included IPS 
studies show baseline data for 1,829 participants 
and complete data for 1,341 participants. There 
was a loss to follow-up of 488 participants (27%), 
which was considered low, but this attrition affected 
interpretation of study results. The authors report 
that one study suffered such extreme attrition from 
its control group that Barker and Maguire (2017) 
completely excluded those data from the report, 
although the percentage dropout was not reported. 
Lastly, in relation to people with COSMHAD, Brunette 
et al. (2004) reported that five studies examined 
short-term (lasting 6 months or fewer) residential 
programmes. Integrated approaches were associated 
with higher rates of programme completion (exact 
rates not reported by Brunette et al., 2004), but 
substance use outcomes were not different between 
the groups. Regarding people with COSMHAD, 
the authors suggest that treatment in parallel and 
separate mental health and substance use systems 
was ineffective (Brunette et al., 2004). Parallel 
treatment results in fragmentation of services, non-
adherence to interventions, dropout from treatment 
(exact numbers not reported), and service exclusions, 
because treatment programmes remain focused 
rigidly on single diagnoses and clients are unable to 
negotiate the separate systems or to make sense 
of disparate messages regarding treatment and 
recovery (Brunette et al., 2004).
4.6 Treatment outcomes
The included papers (n=22) discussed a wide range 
of outcomes, including those relating to substance 
use (reduction in drug and alcohol use; relapse 
rates; enrolment in substance use treatment; opioid 
overdose rates; mean injecting frequency; and drug-
related deaths), housing, as well as ‘other’ outcomes, 
for example well-being/QoL, psychopathological 
symptomatology, criminal justice system involvement, 
and societal integration. For the purpose of this 
review, the treatment outcomes are grouped into 
substance use outcomes, housing outcomes, and 
‘other’ outcomes (Sections 4.6.1–4.6.3). Four of the 
included reviews (Brunette et al., 2004; Carver et al., 
2020; O’Campo et al., 2009; Sun, 2012) focus on the 
elements of successful treatment rather than, or in 
addition to, investigating types of specific treatments. 
For the purpose of this review, these are grouped 
into ‘components of good practice’ and presented in 
Section 4.7.
4.6.1 Treatment outcomes: substance use
Substance use outcomes were reported in all 22 
reviews. Pleace (2008), in his REA of international 
literature on effective substance misuse services 
for people who are homeless, examined a range 
of approaches/services. Two forms of transitional 
housing were identified; the first, single-site 
transitional housing, is more common in Scotland 
(the country of focus for the review) and other 
countries in the UK. The second is the ‘staircase’ or 
‘continuum of care’ (CoC) model, which uses multiple 
stages of accommodation and services. Other 
approaches included fixed-site detoxification, where 
services operate from a fixed site, such as a drop-in 
clinic or a day centre, or employ a residential setting; 
preventive services (including rent deposit schemes, 
housing advice, family reconciliation services, and 
various forms of debt counselling and financial 
management); joint working and case management 
based on interagency working and delivering floating 
support; and a variety of housing interventions. 
These included the Pathways to Housing model, 
which provides dedicated specialist workers and 
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offers open-ended support, with housing secured 
for the service users as quickly as possible and not 
being conditional on compliance with substance use 
or mental health services; permanent supportive 
housing, whereby all schemes take the form of 
shared, supportive housing, in which residents either 
have self-contained studio flats, bedsits, or rooms; 
and preventive tenancy sustainment services, using 
floating support services or transitional housing.
Pleace’s (2008) review highlighted difficulties in 
assessing outcomes of services due to a lack of 
information regarding which specific outcomes 
were measured. The evidence for case management 
and joint working models among people who 
are homeless and use drugs is limited. Models of 
case management, while following shared general 
principles of operation, tend to differ markedly in the 
details of their operation, making a review of any one 
set of working practices difficult. The available USA 
research evidence indicated that case management 
tends to have limited success. There is little evidence 
on the effectiveness of single-site transitional 
housing delivered outside the USA. HF models 
were largely viewed as more effective than the CoC 
model in the USA. There was no significant evidence  
base relating to permanent supportive housing for 
people who are homeless with a history of problem 
substance use. It is not clear how successful these 
services are at harm reduction or supporting 
homelessness. Lastly, in this review, the evidence on 
homelessness prevention services was mixed. The 
prevention services identified also tended not to be 
focused on problem substance use.
Pleace and Quilgars (2013) looked at the available 
evidence on the effectiveness of HF services, 
and based on the main studies on HF, suggested 
that, overall, service utilisation is associated with 
stabilisation of drug and alcohol issues, rather than 
significant reductions or increases in use. They 
concluded that there is no evidence that substance 
use increased following rehousing. When comparing 
one approach to HF (Pathways to Housing) with 
CoC in the USA, there was no significant difference 
between HF participants and the control group on 
either alcohol or drug use at 24 or 48 months post 
intervention. Another approach (the Collaborative 
Initiative to Help End Chronic Homelessness across 
11 sites in the USA) observed small but statistically 
significant improvements in alcohol and drug use 
over 24 months. Examining HF in Europe, the authors 
present mixed findings, with some studies finding 
a reduction in substance use among participants, 
while in others, substance use remained unchanged. 
Additional analysis of the Collaborative Initiative 
to Help End Chronic Homelessness approach 
showed no difference in alcohol or drug use over 
time between those participants who were placed 
immediately into housing, compared with those who 
were in transitional housing (staircase services) prior 
to permanent housing. However, the former group 
reported experiencing more choice around treatment. 
Other research undertaken in the USA has suggested 
that closely following the Pathways to Housing 
philosophy also seemed to have some beneficial 
effects on drug use. Reductions and cessation of 
use of opioids was associated with services closely 
reflecting the philosophy of Pathways to Housing. 
Both Baxter et al. (2019) and Beaudoin (2016) found 
that HF produced no clear differences in substance 
use when compared with normal service provision. 
Two of the studies included by Baxter et al. (2019) 
reported substance use outcomes, with data from 
one of them showing no significant differences in 
either alcohol or drug use at 24 months follow-up, 
but a greater reduction of heavy alcohol use (defined 
as using alcohol on more than 28 days in 6 months) 
during the 48-month study period in intervention 
groups compared with control groups, with no 
clear difference in drug use. Pooling two age-range 
subgroups of the second of the included studies 
showed a very small overall difference in self-reported 
problem substance use in favour of HF; however, 
both groups saw decreases in reported problems. 
Beaudoin (2016) found no differences between those 
involved in HF interventions and those accessing 
traditional psychosocial interventions. Although the 
findings do not show evidence for the effect of HF 
on substance use, the approach still has benefits in 
terms of housing for those with complex needs, as 
participants were able to retain their tenancies.
Benston (2015) and Chambers et al. (2017) examined 
permanent supportive and recovery housing, 
respectively, both with mixed findings. Benston (2015) 
found mixed clinical and substance use outcomes 
when analysing research in the USA on permanent 
supportive housing programmes for people who are 
homeless and have mental health problems. In some 
studies, reductions in substance use were reported 
among those provided with housing compared 
with controls, while in other studies, substance use 
declined or did not change in both the experimental 
and control conditions. Chambers et al. (2017) found 
some evidence of the effectiveness of recovery 
housing, but the authors deemed this to be of limited 
applicability to other settings, as all of the included 
research studies were conducted in the USA. This 
was largely because healthcare and benefits systems 
in the USA are unique. Moreover, some of the 
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studies investigated services offered to armed forces 
veterans through the United States Department of 
Veterans Affairs. In other countries, drug treatment 
services for armed forces, navy, and air force 
personnel would not necessarily be the provision of 
recovery houses specifically for veterans. At the time 
of publication of Chambers’ et al.'s (2017) review, 
one recovery house, Oxford House, had been set up 
outside the USA in the UK, and a study found that it 
benefited the small number of residents, suggesting 
that a larger trial could be useful (Majer, Beers, & 
Jason, 2014). Chambers et al.'s (2017) suggest that 
the Oxford House model could be replicated in the 
UK and offered to people recovering from alcohol 
or substance use disorders (SUDs) as an alternative 
to HF that would allow users to live in an abstinent 
community. Overall, a key finding from Chambers 
et al. (2017) was that recovery houses can improve 
personal well-being through promoting abstinence 
from alcohol or drugs, but that not everybody 
benefits. The authors noted, however, that the 
strength of evidence for well-being outcomes was 
low or very low.
Bates et al.’s (2017) review of reviews provides a 
synthesis of international research on responses to 
problem drug use and reports findings relating to 
several different interventions. Regarding mentoring 
interventions, the authors reported that there 
was low-quality, review-level evidence suggesting 
no benefit of such interventions, specifically for 
adolescents who were homeless, when the mentoring 
intervention was delivered in combination with drug 
use treatment. It should be noted that the findings 
were based on a small number of studies with a 
low total population. When looking at interventions 
for people with HIV who used drugs, Bates et al. 
report that for people who used drugs, HAART in 
combination with OST leads to better outcomes 
than only using HAART alone and not engaging in 
OST. The authors also suggest that there is evidence 
supporting DAART, both alone and integrated in 
medication-assisted therapy to improve treatment 
and health outcomes for people with HIV. The 
findings regarding both contingency management and 
nurse-delivered interventions in relation to treatment 
and health outcomes were inconsistent, although the 
authors authors indicate that these interventions are 
likely to be promising. The authors also concluded 
that individuals who received harm reduction 
approaches such as OST were significantly more likely 
to reduce drug use compared with controls, but that, 
overall, there is no significant evidence to support 
the idea that harm reduction interventions lead to 
a reduction in needle sharing for people who use 
drugs. 
Regarding harm reduction interventions, and 
specifically impact on needle sharing, Turner et al. 
(2011) pooled UK-based evidence to estimate the 
impact of needle and syringe programmes and OST 
on the incidence of HCV in people who inject drugs. 
The authors generated individual binary measures 
for OST and NSP coverage (receiving/not receiving 
OST, and high versus low NSP coverage (100% 
versus <100% needles per injection)). The primary 
outcome was new HCV infections, based on recently 
acquired infection (for cross-sectional studies) 
and incident infection (for cohort studies). The 
secondary outcomes were based on self-reported 
injecting risk behaviour, namely needle sharing, in 
the last month and the mean number of injections 
in the last month. The authors pooled the data and 
adjusted for factors that influence HCV incidence 
and may affect intervention effectiveness, such as 
gender and homelessness. In the pooled data, new 
HCV infections were significantly higher among 
women, crack cocaine injectors, and homeless 
injecting drug users, but there was no evidence that 
the interventions’ effects (i.e. risk of HCV associated 
with NSPs and OST) varied. The authors concluded 
that full harm reduction, defined as receiving both 
OST and high NSP coverage, was associated with a 
reduction in self-reported needle sharing by 48% 
and mean injecting frequency by 20.8 injections per 
month. 
This suggests that harm reduction approaches aiming 
to reduce needle sharing may need to be delivered 
in combination with each other rather than in 
isolation. Wright and Tompkins (2006) also reported 
on effective interventions for drug dependence 
and concluded that these include adequate oral 
OST, tetanus and hepatitis A and B immunisation, 
safer injecting advice, and access to NSPs. They 
suggested that there was emerging evidence for the 
effectiveness of supervised injecting sites for people 
who are homeless who inject drugs, as well as for the 
peer distribution of take-home naloxone, in reducing 
drug-related deaths. There was also some evidence 
that assertive outreach programmes for those with 
mental health problems, supportive programmes to 
aid those with the motivation to address problem 
alcohol use, and informal interactive programmes 
to promote sexual health can lead to lasting health 
gains. One core theme appeared to be that the type 
of community intervention is less important than 
the fact that an intervention is offered. Residential 
interventions, however, appeared to lead to greater 
reductions in drug use than community interventions, 
which, according to USA-based literature, are better 
able to retain users in services but do not yield 
high abstinence rates. This seems to be especially 
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common for ACTs. The literature included in Wright 
and Tompkins’ (2006) review also suggested that 
therapeutic communities for people experiencing 
COSMHAD result in greater drug use reductions than 
community interventions (although both modalities 
reduce drug use). 
Hwang et al. (2005) performed a systematic review 
of interventions to improve the health of people 
who were homeless. Studies of any intervention 
provided in primary care, or to which homeless 
patients could be referred, were eligible for inclusion, 
and interventions included case management 
services and/or supportive housing; ACT; the 
Access to Community Care and Effective Services 
and Supports programme; post-detoxification 
stabilisation; abstinence-contingent work therapy; 
intensive residential treatment; other preventive 
health interventions for substance dependence; 
cash incentive schemes; educational programmes; 
and outreach initiatives. The authors concluded 
that coordinated programmes for homeless adults 
with mental health problems or problem substance 
use generally resulted in better health outcomes 
than usual care. Other results were mixed, with 
studies looking at high- versus low-intensity case 
management finding no significant differences in 
mental health or substance use outcomes. However, 
studies of case management and other substance 
use-related therapies reported reduced alcohol and 
drug use compared with usual care. 
For people experiencing COSMHAD, substance 
use outcomes were not significantly different 
when comparing housing and support services 
with a less intensive intervention. However, there 
was some support for psychosocial rehabilitation 
and a multifactorial programme of behavioural, 
abstinence-contingent, housing, and work therapy 
interventions in reducing substance use, and for 
education programmes in reducing injection drug 
use specifically among homeless women. Formosa 
et al. (2019) also examined a range of interventions, 
including case management, HF, substance use 
interventions (including extended-release naltrexone 
and opioid overdose education), ED-based resource 
desks, and ED compassionate care. The authors 
found limited evidence for these interventions in 
reducing substance use or in supporting enrolment 
in treatment. However, as mentioned earlier, full 
data from this review could not be extracted, and 
therefore no definite conclusions can be reached.
In terms of case management interventions more 
specifically, de Vet et al. (2013) investigated the 
effectiveness of various forms of case management 
for adults who are homeless. Regarding SCM, all 
the included studies recruited people who were 
homeless and used substances, except for one study 
conducted in the UK among people with severe 
mental health problems. The findings provided some 
evidence that SCM is effective for this subpopulation 
in reducing problem substance use, and that it 
seems to be more beneficial than usual care for 
people who are homeless who use substances. The 
samples in studies of ACT consisted of people who 
were homeless and had COSMHAD; people with 
mental health problems; veterans with problem 
substance use; and ex-prisoners with mental health 
problems. For all subpopulations, findings were 
largely non-significant or inconsistent. CTI was found 
to be significantly better than usual care in reducing 
substance use among people who were homeless 
with mental health problems (leaving either a 
homeless shelter or an inpatient care for veterans). 
Torres Del Estal and Álvarez (2018) compared case 
management with other nurse-led intervention 
models. The authors state that case management is 
most commonly the first option for the management 
of substance use in people experiencing 
homelessness and conclude that it can lead to a 
reduction in substance use in this population. The 
identified literature also highlights case management 
as an effective option, either as a single intervention 
or in combination with others. Regarding other 
intervention models, when nurses work within 
interdisciplinary teams, they perform assessments, 
monitoring, and administration of the treatment using 
evaluation and motivation tools. This action model, 
according to Torres Del Estal and Álvarez (2018), is 
based on cooperation and teamwork, generates 
beneficial results, accelerates recovery, and 
guarantees patient safety. The review of the literature 
shows that programmes which combine case 
management and interventions carried out in the 
context of interdisciplinary teams (nursing, medicine, 
psychology, and public health) have better results 
than standard interventions. However, Penzenstadler 
et al. (2019), who evaluated the effect of ACT for 
individuals experiencing problem substance use, 
concluded that the results were mixed in terms of 
substance use outcomes, despite the services all 
using the key principles of ACT in their approach: 
community-based services, assertive engagement, 
high intensity of services, small caseloads, 24-hour 
responsibility, a team approach, and multidisciplinary 
working. 
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One of the reviews examined the effectiveness of 
sexual health promotion interventions for people 
experiencing homelessness and using drugs (Wright 
& Walker, 2006). The authors found that a significant 
proportion of the included studies compared 
‘traditional’ and ‘specialised’ multicomponent 
AIDS-focused programmes that involved group 
educational and practical elements. Other studies 
included counselling, as well as benefits/housing 
assistance. Programmes offered HIV education; 
alcohol and drug counselling; benefits and housing 
assistance; a ‘traditional’ intervention of an AIDS 
videotape and a 1-hour group session (covering AIDS 
education, HIV testing, condom use, sterilising kits 
for injecting equipment, and a list of community 
resources). There was an overall concordance 
between the included studies that such interventions 
resulted in increased knowledge of drug issues. The 
interventions also initially led to a reduction in drug 
use. There was, however, no concordance between 
the included studies regarding whether the effect of 
the intervention was sustained over a 2-year follow-
up period.
Four of the identified reviews only report minimal 
details on substance use outcomes. Barker and 
Maguire (2017) found some positive effects of IPS 
on substance use, with an overall reduction in harm 
related to substance use, including drug and alcohol 
use, relapse, amount of money spent on substances, 
and number of days using drugs or alcohol. Kertesz 
et al. (2009) report that several linear programmes 
cite reductions in ‘addiction severity’; however, 
this is not expanded on. Brunette et al. (2004) 
found that longer-term residential programmes 
had better substance use outcomes, including 
better engagement and retention in treatment 
than short-term programmes. Lastly, in the Minyard 
et al. (2019) review, there was some evidence for 
the effectiveness of an integrated COSMHAD day 
programme in reducing hospitalisation and substance 
use rates. 
4.6.2 Treatment outcomes: housing
Six of the identified reviews focused on housing 
interventions specifically (Baxter et al., 2019; 
Beaudoin, 2016; Benston, 2015; Chambers et al., 2017; 
Kertesz et al., 2009; Pleace & Quilgars, 2013). 
However, one of these reviews primarily reported on 
substance use and mental health outcomes rather 
than on housing outcomes and therefore will not be 
discussed in this section (Pleace & Quilgars 2013). A 
further three of the remaining included reviews also 
reported on housing outcomes in addition to their 
main outcomes of focus (Barker & Maguire, 2017; 
de Vet et al., 2013; Formosa et al., 2019). In total, 
housing outcomes were reported in nine of the 
included reviews. 
In terms of housing interventions, Baxter et al. (2019) 
and Beaudoin (2016) focused on evaluations of HF 
specifically. Baxter et al. (2019) reviewed the effects 
of HF on the health and well-being of adults who are 
homeless or at risk of homelessness and performed 
a meta-analysis of RCTs. Their definition of HF was 
“providing the homeless person with access to 
housing through assistance in locating and entering 
housing and subsistence of rental costs to maintain 
permanent tenancy” (Baxter et al., 2019, p. 379). The 
provided housing was defined as “intended to be 
permanent, with no intention by providers to end 
or transfer tenancy; counting sustained tenancy as 
the intended outcome; tenancy not contingent on 
adherence to treatment or substance abstinence; 
and with housing being rapid, with the process 
of securing and entering housing initiated at first 
contact with the homeless person and with the 
aim of beginning tenancy promptly” (Baxter et al., 
2019, p. 379). This systematic review found that HF 
resulted in large improvements in housing stability. 
In all the included studies, intervention participants 
spent more days housed and were more likely to be 
housed at 18–24 months since intervention. Beaudoin 
(2016) compared HF’s effectiveness with traditional 
psychosocial interventions, such as case management 
and programmes based on the ‘treatment first’ 
approach. Any programme based on the HF 
approach was assessed, including those programmes 
with ‘add-ons’, such as HF plus outreach. Regular-
intensity HF interventions were also compared with 
intensive HF interventions, or with HF interventions 
coupled with specialised services. Similar to Baxter et 
al. (2019), all the studies included in Beaudoin’s (2016) 
review found that participants in programmes based 
on the HF approach spent more time in housing 
and less time on the street than treatment-as-usual  
participants. In two of the three included studies, 
people who had access to a programme based on 
the HF approach spent less time being homeless and 
more time in housing than those who accessed more 
traditional psychosocial interventions. 
Kertesz et al. (2009) reviewed studies of HF and more 
traditional rehabilitative recovery interventions, 
focusing on the outcomes of both these approaches 
for people who are homeless and have problem 
substance use. The review included various HF 
interventions. For example, the New York Pathways 
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to Housing programme offers optional continuous 
support from an ACT team, available 24 hours a day, 7 
days a week, including community-based substance 
use treatment, mental health care and general 
medical care, and vocational services. Clients were 
required to participate in a money management 
programme, to pay 30% of their income towards 
rent, and to meet with staff twice a month. This 
approach emphasised consumer choice and the 
reduction of harm from substance use (Greenwood 
et al., 2005). Another example was San Francisco’s 
Direct Access to Housing (DAH) programme 
(Corporation for Supportive Housing, n.d.) offering 
apartments in multi-unit residential buildings and on-
site services, including case management, primary 
medical care, and mental health treatment. Tenants 
were required to spend 30–50% of their income 
on rent. DAH tenants were not allowed to sell drugs 
or to use drugs or alcohol in any common area, but 
abstinence was not a requirement. In contrast, the 
‘linear’ approach (Ridgway & Zipple, 1990) generally 
makes rehabilitative treatment, typically residential, 
a prerequisite for permanent housing in either a 
subsidised or a private setting (including a return to 
family). For individual clients, failure to comply with 
the rules and requirements produced consequences 
that varied with the programme’s philosophy and 
resources and could include restriction of privileges, 
transfer to more closely supervised settings, or 
administrative discharge. Kertesz et al. (2009) 
conclude that, according to reviews of comparative 
trials and case series reports, HF reports document 
excellent housing retention (despite the limited 
amount of data at the time), specifically pertaining 
to people who are homeless and experience severe 
problem substance use. They also highlight that 
several linear programmes have shortcomings in 
long-term housing success and retention, such as 
the fact that providers of treatment services rarely 
control or influence the allocation of permanent 
housing resources, and as a result, treatment does 
not always lead to housing, even when the treatment 
is effective.
Benston (2015) analysed the best available research 
in the USA on permanent supportive housing 
programmes for people who were homeless and 
who had mental health problems, and the effect of 
these programmes on housing status and mental 
health. The reviewed studies defined, designed, 
and implemented supportive housing in a variety 
of ways. Most of the studies did not specifically 
refer to their experimental housing conditions as 
‘supportive housing’, instead using a variety of terms 
such as HF, ‘comprehensive housing’, ‘evolving 
consumer households’, ‘integrated housing’, and 
‘full-service partnerships’. The studies defined 
case management in a variety of ways, including 
‘intensive case management’, ‘intensive clinical 
case management’, and ‘comprehensive case 
management’, and implemented it alongside 
‘traditional case management’. The studies found 
that most participants placed in experimental 
housing programmes with case management 
support remained in housing for at least 1 year, or 
experienced more days housed than homeless, 
relative to a comparison group. The review identified 
statistically significant results from studies which 
supported the hypothesis that the preferred housing 
intervention outperformed a control condition. 
Chambers et al. (2017) conducted a systematic review 
of the evidence on housing interventions for housing-
vulnerable adults, and its relationship to well-being. 
These interventions included HF interventions, 
recovery housing, supportive housing, and specific 
housing approaches for those experiencing 
homelessness and mental health problems, including 
ex-prisoners, or vulnerable young people. HF was 
defined as providing immediate access to housing 
without preconditions, with support from either 
mobile teams or on-site services. The authors 
found moderate-strength evidence for a positive 
effect of supportive housing on housing stability, 
and strong evidence that HF could improve 
housing stability, with a range of factors identified 
which influenced the effectiveness of HF. These 
included fidelity to core components, and whether 
the service is delivered in one place (single site/
congregate) or across separate apartments 
(scattered). A neurocognitive study included in the 
review suggested that for people without a history of 
problem substance use, executive function improved 
with group living in the congregate/single-site 
model and declined for those living in independent 
apartments. Other studies compared well-being 
outcomes from single-site/congregate models with 
scattered-site HF and indicated that residence in 
independent apartments was significantly associated 
with greater independence and greater occupational 
functioning. It was also significantly associated with a 
greater subjective sense of choice. Similarly, Baxter 
et al. (2019) reported that in one of their included 
studies, participants housed together in dedicated 
accommodation blocks experienced greater  
improvements than those in scattered-site housing 
in the areas of mental health, QoL, and problem 
substance use, among other outcomes. 
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A systematic review of the effectiveness of case 
management approaches for people who were 
homeless performed by de Vet et al. (2013) reported 
some evidence that SCM was effective in improving 
housing stability for people who were homeless and 
using substances. On the other hand, for the same 
subgroup, findings regarding the effectiveness of ICM 
were mixed or inconsistent. There was also evidence 
of a positive effect of ICM on housing outcomes for 
people experiencing homelessness, including those 
with mental health problems. However, the authors 
noted that more research is needed before any 
conclusions can be drawn about the consistency of 
these findings. Regarding ACT, the samples in de Vet 
et al.’s (2013) included studies consisted of people 
who were homeless with COSMHAD or mental health 
problems; veterans who used substances; and ex-
prisoners with mental health problems. Results of 
the review indicated that ACT improved the housing 
stability of people with mental health problems, as 
well as those with COSMHAD, to a greater degree 
than less proactive case management models. 
All included reviews found ACT to be superior to 
other services, including other models of case 
management, in helping people who were homeless 
with mental health problems to achieve housing 
stability. Lastly, the effectiveness of CTI was examined 
specifically for people who were homeless with 
mental health problems, with one group leaving a 
homeless shelter and the other leaving inpatient care 
for veterans. For both groups, CTI was significantly 
better than usual services in supporting housing 
stability.
Two other reviews reported housing outcomes. 
Formosa et al. (2019) reviewed the literature on ED 
interventions that improved health and/or access 
to the SDOH for people who were homeless. The 
interventions included case management, HF, 
substance use interventions, ED-based resource 
desks, and ED compassionate care. Eight studies 
sought to improve access to housing: two were HF 
initiatives and the other six demonstrated significant 
reductions in homelessness and increased access to 
stable housing. However, full data extraction was not 
possible, as data from this review are only available 
in the form of a conference abstract, meaning that 
no definite conclusions can be reached from this 
review. Lastly, Barker and Maguire (2017) evaluated 
the effectiveness of IPS for people who are homeless, 
with all but one of the included studies reporting 
some positive effects of IPS regarding improvements 
in homelessness. These were reported as decreases 
in the number of homeless days and reduced relapse  
to homelessness.
4.6.3 Treatment outcomes: other
Thirteen studies examined outcomes other than 
housing or substance use. These included health and 
well-being outcomes, such as QoL and frequency 
of use of health services (including EDs), as well 
as outcomes relating to crime, incarceration, and 
participation in community life.
In terms of housing interventions, Baxter et al. (2019) 
found that the effects of HF on health and well-being 
outcomes were unclear in the short term, and there 
were no clear differences in terms of mental health 
or QoL compared with treatment as usual (TAU). 
However, the authors found that HF participants 
showed a clear reduction in non-routine use of 
healthcare services over TAU, which they suggest 
may be an indicator of improvements in health. 
Beaudoin (2016) assessed the effectiveness of HF and 
also found largely non-significant or mixed results 
relating to QoL and satisfaction, crime, incarceration, 
participation in community life, and victimisation. 
Overall, the results indicated that the HF approach 
does not lead to more positive effects on mental and 
physical health and does not increase social support 
more than access to usual services or traditional 
psychosocial interventions. 
On the other hand, based on the findings of 
Chambers et al. (2017), there appears to be strong 
evidence that HF can improve measures of physical 
health in the short term for adults who are homeless 
or at risk of being homeless. Evidence was classed as 
moderate for positive effects on personal well-being, 
mental health, and locality-related well-being (i.e. 
well-being related directly to one’s living situation and 
conditions), and for absence of effect on personal 
finance and community well-being. The strength of 
the evidence for other outcomes was rated as low or 
very low. The authors classified a range of complex 
interventions as “other interventions for people 
with mental/physical health problems” (Chambers 
et al., 2017, p. 2). A key finding was that while these 
interventions provided an opportunity for recovery, 
not everyone benefits. This suggests that outcomes 
may be dependent on baseline health status, rather 
than type of intervention. Finally, the authors 
examined interventions for other specific groups 
of housing-vulnerable people. Of seven studies 
on ex-prisoners, five were from the UK, suggesting 
relatively high transferability/applicability to similar 
settings. The main outcome examined in the studies 
was reduction in offending, which could be linked to 
both community and individual well-being, although 
the results on re-offending outcomes were mixed. 
Three UK studies of housing interventions for 
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vulnerable young people showed generally positive 
outcomes for well-being, but the studies were small, 
short-term, and generally uncontrolled. There was a 
general lack of evidence around measures related to 
community well-being and around cost-effectiveness 
of the interventions investigated. Lastly, Benston’s 
(2015) review of permanent supportive housing 
programmes for people experiencing homelessness 
with additional mental health problems in the USA 
reported mixed clinical and substance use outcomes. 
It found support for a hypothesis that experimental 
housing can reduce can reduce mental health 
symptoms when compared with a control condition.
Regarding case management interventions, 
Penzenstadler et al. (2019) found evidence of a positive 
effect of ACT on hospitalisation rates for people with 
problem substance use. de Vet et al. (2013) found 
little evidence that SCM could lead to a differential 
effect on service utilisation for people experiencing 
homelessness and problem substance use, with some 
evidence that SCM is effective for this homeless 
subpopulation in removing employment barriers. 
However, only a few of these results were replicated 
for the sample of people who were homeless with 
concurrent mental health problems. The evidence 
base for ICM was limited, with the findings being non-
significant or mixed in all outcome categories except 
for access to public assistance. Study quality ratings 
and service utilisation data suggested that these 
largely non-significant findings could be the result 
of treatment non-adherence and lack of between-
group differentiation in the services received. For 
all subpopulations, findings in the other outcome 
categories were largely non-significant or inconsistent. 
Although ACT appeared to influence patterns 
of mental health service use, most studies did 
not show a differential effect on mental health 
outcomes, although there was some evidence 
regarding improvement in symptom severity. There 
was evidence that CTI was significantly better than 
usual services in reducing mental health symptoms 
(as well as substance use) among those who are 
homeless with mental health problems. There were 
also associations between CTI and improved level of 
housing stability and the length of hospital, shelter, 
and other institutional stays. CTI achieved better 
long-term results than TAU, with similar associated 
costs. CTI was the least researched model in de 
Vet et al.’s (2013) review, so results from further 
studies are needed in order to reach any definite 
conclusions. Nevertheless, the findings are promising. 
Across the four different models of case management 
examined, case management generally seemed 
to have a positive impact on housing stability and 
patterns of service use. Findings about any effects 
on variables measuring health, societal participation, 
and QoL were largely non-significant. Torres Del Estal 
and Álvarez (2018) noted that case management can 
be successful in terms of reducing substance use, 
as well as improving QoL and access to healthcare 
among people who are homeless with problem 
substance use. Throughout the review, the existence 
of specific interventions for certain subgroups of the 
homeless population, such as women, suggested that 
structured group sessions and community therapy, 
addressing the social sphere, and reducing non-
adaptive social behaviours related to substance use 
can be successful. Hwang et al. (2005) reported that 
intensity of case management led to no difference in 
health-related outcomes.
Hwang et al. (2005) also found that coordinated 
programmes for homeless adults with mental health 
problems or problem substance use generally result 
in better health outcomes, including mental health 
and substance use outcomes, than usual care. This 
was a finding similar to that of Minyard et al. (2019), 
who found some evidence for the effectiveness 
of an integrated COSMHAD day programme for 
adults experiencing homelessness in reducing both 
hospitalisation and substance use rates. Hwang et 
al. (2005) also reported that studies focusing on 
immunisation and smoking cessation specifically for 
people who are homeless and use drugs suggested 
positive outcomes on health, including smoking 
abstinence. For COSMHAD, there were improvements 
in terms of time spent in hospital, but not in terms 
of mental health or substance use outcomes. There 
was also some evidence that cash incentives were 
effective in increasing adherence to TB screening and 
in improving completion rates; education initiatives 
improved HIV risk behaviours in runaway youth; 
outreach services reduced primary care utilisation in 
homeless families and children; and compassionate 
care from a visiting volunteer at ED reduced 
subsequent ED visits.
Wright and Walker (2006) reported that the 
relationship between sexual promotion interventions 
and psychosocial outcomes appeared to be complex. 
Broadly speaking, the interventions seemed to 
improve psychosocial functioning. The duration 
of the intervention appeared to be less important 
than the fact that an intervention used interactive 
methods, such as group work, videotapes, role-
playing, or games. These findings concur with 
evaluations of generic HIV prevention programmes, 
which showed that programmes focusing on 
attitudinal and behaviour change using informal 
methods were the most effective at reducing sexual 
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risk (Coleman & Ford, 1996). In another review, 
Wright and Tompkins (2006) examined morbidity, 
mortality, primary care provision, primary prevention 
interventions, and sexual health promotion. 
Internationally, there are differing models and 
services aimed at providing healthcare for people 
who are homeless. The authors report that there is 
some evidence that assertive outreach programmes 
for those with mental health problems, and informal 
programmes to promote sexual health, can lead to 
lasting physical and/or mental health gains.
Regarding harm reduction interventions, in Turner 
et al.’s (2011) review, the primary outcome was new 
HCV infections based on recently acquired infection 
(for cross-sectional studies) and incident infection 
(for cohort studies). Both receiving OST and high 
NSP coverage (100% versus <100% needles per 
injection) were associated with a reduction in new 
HCV infections. Full harm reduction (with participants 
being on OST plus having access to high NSP 
coverage) reduced the odds of new HCV infections 
by nearly 80%. 
Lastly, regarding peer interventions, Barker and 
Maguire (2017) found that all included studies 
reported some positive effects of IPS in terms 
of overall QoL, reductions in drug/alcohol use, 
improved mental/physical health, and increased 
social support. Common elements of IPS were 
identified from the included studies, suggesting 
that IPS works through components of shared 
experience, role modelling, providing social support, 
and increasing attendance/interest. Those four 
components are thought to moderate overall QoL 
through the eight outcomes reported. While there 
is mixed evidence regarding the effectiveness of the 
various interventions on mental health, well-being, 
and other outcomes, this suggests that integration 
of services and holistic treatment for people with 
comorbidities and COSMHAD leads to better 
psychosocial and substance use outcomes than 
treatment provided in ‘silos’. 
4.7 Components of good practice 
Carver et al.’s (2020) meta-ethnography found 
that both harm reduction and abstinence-based 
treatments were considered effective by recipients. 
In several studies, participants preferred harm 
reduction-oriented services where they had 
opportunities to set individualised goals, rather than 
being required to achieve and maintain abstinence. 
Harm reduction services provide a crucial way of 
engaging those who found high-threshold services 
inaccessible by meeting people where they are at 
(International Harm Reduction Association, 2009), 
yet participants in the meta-ethnography reported 
that abstinence-based treatments should also be 
made available for when people are open to this 
and ready to stop active use. The findings of this 
review highlight that people who are homeless and 
who are experiencing problem substance use desire 
an integrated approach to treatment, rather than 
separating treatments into either harm reduction 
or abstinence-based approaches. The authors 
report that, overall, participants considered five 
components key to effective treatment: the provision 
of a facilitative service environment, compassionate 
and non-judgemental support, adequate time 
in treatment, choices regarding treatment, and 
opportunities to (re)learn how to live. Interventions 
that were of longer duration and offered stability to 
service users were valued, particularly by women. 
Carver et al. (2020) developed a new model through 
the synthesis of 21 studies to provide a higher-
level understanding of the key components of 
effective problem substance use treatment for those 
experiencing homelessness. The model highlights the 
need for the five key components to be delivered 
within the context of good relationships, with person-
centred care, and with an understanding of the 
complexity of people’s lives.
Sun’s (2012) review discusses strategies for helping 
people who are homeless and who have COSMHAD 
and aims to provide practitioners with a framework 
and strategies for helping this client population. The 
author reports four components of this framework: 
ensuring an effective transition for individuals with 
COSMHAD from an institution (such as a hospital, 
foster care, prison, or a residential programme) into 
the community, which is particularly important for 
clients who were previously homeless, impoverished, 
or at risk of homelessness; increasing the resources 
of people who are homeless and who have COSMHAD 
by helping them apply for government entitlements 
or supported employment; linking individuals to 
supportive housing, including HF options rather 
than only treatment-first options, and being flexible 
in meeting their housing needs; and engaging 
individuals in treatment for COSMHAD, incorporating 
modified ACT, MI, CBT, contingency management, 
and COSMHAD-specialised self-help groups.
O’Campo et al. (2009), in their realist review of 
community-based services for people experiencing 
homelessness and COSMHAD, identified 10 distinct 
community-based or community-linked programmes 
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that employed a variety of approaches, including 
ACT, provision of housing, integrated mental 
health and substance use treatment, and a holistic 
approach through which many of the clients’ life 
needs were supported. Most programmes delivered 
a combination of programme strategies or took 
different approaches to the same strategies – for 
example, different models of housing provision in 
the Pathways to Housing model compared with 
Community Connections; and different degrees of 
fidelity to the ACT model between programmes. 
Many of the studies identified motivation for, and 
maintenance of, behaviour change as a central 
factor for success. Called ‘client’s choice’ in some 
programmes, this feature ensured that clients’ 
choices would be respected, regardless of whether 
these choices were consistent with treatment 
priorities. Clients were perceived as autonomous 
individuals and experts in their own lives who 
should make their own decisions. For instance, in 
the Pathways to Housing programme, not only was 
the provision of housing not tied to mental health 
or substance use treatment, but clients also chose 
their apartments and neighbourhoods, in addition 
to making decisions about treatment. Clients of 
the Choices Centre similarly had significant input 
into staffing decisions, as well as into programme 
elements, which resulted in a programme that was 
maximally tailored to their own needs. Data from 
Pathways to Housing showed that clients’ sense of 
mastery and their perceived level of choice were 
mediators in the causal pathway between housing 
and psychiatric symptoms. Thus, the beneficial 
effects that the Pathways to Housing programme 
and the provision of independent housing first had 
on psychiatric symptoms were attributed to the 
enhanced sense of mastery and control that clients 
experienced as part of their treatment.
Traditionally, therapeutic communities for substance 
use treatment have been characterised by a 
treatment philosophy of ‘right living’ and ‘community 
as method’ delivered in long-term residential 
programmes, largely directed and managed by 
clients. This model has emphasised a reliance on 
confrontational group therapy, treatment phases, and 
a hierarchy based on tenure in the programme and 
community roles (De Leon, 2000). Confrontational 
group therapy is a treatment based on the theory 
that verbal confrontation is the most effective way 
to treat problem substance use and that feedback 
should be provided to clients about their thoughts, 
feelings, and behaviour (Forrest, 1982). The premise 
is that clients have defence mechanisms that must 
be broken, and only then can progress be made 
with recovery (Hall, 1993). Tactics such as intentional 
humiliation, coercion, ultimatums, withdrawal of 
services, and verbal aggression have been frequently 
used with this approach and it has been used both 
in peer group and professional settings (Hall, 1993; 
White & Miller, 2007). It is widely acknowledged 
now that this model is ineffective, and that it in 
fact causes more harm to clients (White & Miller, 
2007). A review by Brunette et al. (2004) examined 
residential programmes for people with COSMHAD. 
They found that in terms of therapeutic communities, 
an important feature is the modification of the 
traditional confrontational approach to a more 
supportive, less intensive approach. Programmes 
rated by participants as being high in ‘support’, 
‘involvement’, and ‘task orientation’ factors were 
associated with better outcomes, although it is 
not clear how these characteristics translated 
into specific programme components. In addition, 
specific modifications over the different stages of 
recovery – with a focus on slower, more concrete 
substance use counselling, more flexibility in 
treatment, fewer participant responsibilities for 
community governance, and more support and 
guidance from staff – were also highlighted. Brunette 
et al. (2004) concluded that other specific features of 
residential programmes were not clear.
4.8 Chapter summary 
The aim of this chapter was to present the findings 
from the systematic review of reviews that examined 
which interventions are effective in engaging people 
who are homeless and use drugs in treatment 
services, and in facilitating their retention in 
treatment. Overall, the quality of the included 
reviews was moderate. Most of the reviews were 
undertaken in the UK, but nearly all the reviews (n=19) 
were international in focus. Even though the focus of 
the reviews was international, the majority of primary 
studies were undertaken in the USA, which may 
affect the generalisability of the findings to non-USA 
contexts. The papers included in the review were 
diverse in terms of their primary focus. 
Regarding engaging and retaining people who are 
homeless and have drug problems in treatment, 
the evidence suggests that this can be difficult, 
regardless of intervention type. There is evidence 
that ACT can lead to increased engagement rates for 
people who are homeless and use drugs, and that 
integrated services for people with COSMHAD lead 
to better engagement and retention than segregated 
treatments. Results regarding HF suggest that 
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engagement can be difficult, and that social isolation 
may be a problem for those using the service. Lastly, 
evidence suggests that the way in which interventions 
are delivered can play a crucial role in treatment 
engagement and retention, with warmth, compassion, 
empathy, and lack of judgement from the workers 
or therapists being paramount. Regarding treatment 
completion, only a few reviews reported rates 
of successful treatment completion and, where 
presented, this seems to be below 50%. 
Regarding substance use, our findings indicate that, 
firstly, there are many diverse interventions available 
for people experiencing homelessness and drug 
problems. Overall, the evidence suggests that the 
more integration there is between programmes and 
services (as opposed to parallel service provision) 
when dealing with people who have comorbidities, 
the better the outcomes. There is some evidence 
suggesting that harm reduction approaches can 
lead to decreases in drug-related risk behaviour, 
such as needle sharing, although the evidence is 
limited. Lastly, the evidence regarding substance use 
outcomes and HF seems to indicate that, while HF 
does not lead to significant changes in substance use, 
there are positive outcomes in terms of housing, as 
tenancy retention is very high. 
Regarding housing outcomes, the evidence from 
the included reviews all supports the HF approach 
in terms of its effectiveness in increasing housing 
stability and retention, but there are issues relating 
to programme fidelity and type/model of HF housing. 
There is some evidence that supportive housing 
can also have a positive effect on housing stability. 
Interestingly, IPS can lead to a decrease in number 
of days spent homeless, and to a reduction in 
‘relapse’ to homelessness. A range of models of case 
management can be effective in improving housing 
outcomes, particularly for people experiencing 
homelessness and mental health problems, for whom 
ACT may be particularly effective.
Some treatment outcomes that were not related 
to substance use or housing were also reported. 
These related primarily to mental health and well-
being outcomes, with mixed evidence regarding the 
effectiveness of the different interventions studied. 
Lastly, looking at components of best practice, 
evidence from the included reviews suggests that 
flexibility is needed in treatment approaches, and 
that support should be tailored to the person. If 
possible, a combination of approaches should be 
used to offer choices to people who may not be 
ready for abstinence. Service providers need to be 
supportive and the treatment needs to be integrated, 
comprehensive, holistic, and person-centred in 
order to increase effectiveness. Optimal duration 
needs to be considered, with evidence suggesting 
that longer treatment leads to better outcomes, as 
well as being preferred by the service users.
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5.1 Chapter overview 
This chapter pulls together the high-level messages 
from each part of this review in order to help 
make connections between the respective parts. It 
describes the strengths and limitations of the study. 
It then discusses some of the most notable research 
gaps that exist, ending with recommendations for 
policy and practice. 
5.2 Key messages from all study 
components 
Recent data show that illicit drug use in the general 
population has increased in Ireland since 2010. 
Cannabis is the most used illicit drug overall, and 
approximately 19,000 people use opioids across the 
country (EMCDDA, 2019b). Data for the prevalence 
and patterns of drug use indicate that substance 
use is more commonly reported among people who 
are homeless than among the general population, 
and alcohol, cannabis, heroin, and benzodiazepines 
are the most commonly reported substances used 
by people who are homeless (Good Shepherd 
Services & Simon Community, 2011; Keogh et al., 
2015; Mayock & Sheridan, 2012; O’Reilly et al., 2015). 
Polysubstance use is common within the homeless 
population, particularly with illicit drugs and alcohol. 
Simultaneous use of prescribed methadone, 
prescribed sedatives, and prescribed antipsychotics 
is common, as is simultaneous use of illicit and 
prescribed benzodiazepines (O’Reilly et al., 2015). The 
number of drug-related deaths in Ireland rose each 
year from 607 in 2010 to 786 in 2017 (HRB, 2019a). 
More than one-half of poisoning deaths were linked 
to polysubstance use (HRB, 2019a). Overall, the total 
number of drug treatment cases in Ireland increased 
to 10,664 in 2019 (HRB, 2020) – the highest number of 
recorded cases in the 10-year period between 2010 
and 2020. The number of people who are homeless 
and have accessed drug treatment services rose from 
581 in 2012 to 1,173 in 2019 (HRB, 2020). 
Since data on existing treatment types are limited, 
our mapping of available services aimed to synthesise 
the wide range of services that exist to meet the 
needs of people who experience homelessness 
and use drugs in Ireland. Although the review 
has categorised services by their primary focus, 
organisations often provide a range of services to 
holistically meet an individual’s needs. However, 
it is currently unclear by what pathways people 
who are homeless and use drugs are referred to 
services, and information on partnership working is 
limited. This possibly makes service provision appear 
more fragmented than it is. There is also limited 
information about specific outcomes relating to 
services and limited evidence of what works best for 
this population. 
The systematic review of reviews focused on the 
intersection of homelessness and drug use and 
assessed the evidence base regarding treatment 
and intervention options for this population. Several 
reviews are available regarding interventions for 
people who are homeless, as well as for people with 
problem substance use. However, it is important to 
acknowledge that, despite high rates of substance 
use in the population of people who experience 
homelessness, not every individual who is homeless 
uses substances. This is why, despite a large number 
of studies having been undertaken on these topics 
independently, only a relatively small number of 
reviews have been included in this review (22 papers 
published between 2004 and 2020). Some of the 
reviews focused on people who are homeless who 
5
Discussion and conclusions
Evidence review of drug treatment services for people who are homeless and use drugs 53
have COSMHAD, or on all people who are homeless 
and, often by chance, including substantial numbers 
of people with problem substance use as well. This  
presents a difficulty in drawing conclusions on 
effective approaches for populations experiencing 
both homelessness and problem substance use. 
As this specific group of individuals often has very 
complex needs, including other challenging social 
problems and health comorbidities (Fitzpatrick-Lewis 
et al., 2011), it is important to acknowledge that the 
type of support required is also likely to be complex, 
multifaceted, nuanced, and highly person-centred, 
rather than focused on responding to one challenge 
in isolation. People are of course all individuals with 
their own particular experiences, needs, and wishes 
with respect to health and treatment ‘offers’. 
This review of reviews reported on the breadth of 
interventions applicable to people who experience 
homelessness and have problem drug use, with 
diverse primary foci, ranging from specific housing 
interventions (which may subsequently impact on 
problem substance use) to interventions designed 
to help reduce or cease substance use, to harm 
reduction interventions for PWID. The evidence 
in support of the effectiveness of these various 
interventions is mixed. Moreover, the quantity 
and quality of the evidence varies between the 
interventions and treatments. For example, there 
are six reviews investigating housing interventions, 
but only one looking at the effect of OST and NSPs. 
A further complexity exists that should be borne in 
mind. Even the reviews which specifically explored 
the experiences of people who were homeless 
included heterogeneous study populations. For 
example, Barker and Maguire (2017) report on the 
effectiveness of IPS for people who are homeless, but 
the samples of the studies included in their review 
had to have a minimum of 30% of the population 
of interest. This then makes it more challenging to 
confidently conclude that the intervention worked 
specifically for those who were homeless when only 
a minority of the participants met the criteria for 
inclusion. With this in mind, we included a more 
stringent minimum percentage of 40%, which 
substantially reduced the body of selected evidence 
(without this minimum percentage, this review could 
have presented findings from an additional 12 reviews). 
5.3 Strengths and limitations
Throughout the review, steps were taken to enhance 
methodological rigour: all stages of searching, 
screening, quality appraisal, data extraction, and 
analysis were checked for accuracy by at least two 
people. Another strength lies in the fact that we have 
captured and supplemented the quantitative reviews, 
with some more in-depth qualitative data looking 
specifically at what the targeted recipients of any of 
those interventions themselves believe works (and 
what does not). The most recent of those (Carver et 
al., 2020) is one of only four systematic reviews which 
looks specifically at the subpopulation of people 
who are homeless (the others are Kertesz et al., 
2009; Torres Del Estal & Álvarez, 2018; and Wright & 
Walker, 2006). An additional strength lies in the fact 
that some non-English reviews were included (these 
were published in Spanish and French and translated 
via Google Translate, as the quality of translation was 
deemed appropriate). 
Issues with the quality of some of the included 
reviews have been noted throughout the report. 
For example, a few of the included reviews were not 
systematic and did not report how many papers were 
included/excluded, or on what grounds. This means 
that the evidence presented in those studies should 
be classified as of low quality. It is also important to 
acknowledge that problematic substance use can 
take many forms and the appropriate treatment 
will vary accordingly. The length of treatment and 
the outcomes that can be expected will also differ. 
Moreover, it is important to note that some of the 
included reviews are relatively old (the earliest 
being published in 2004), meaning that the included 
primary studies in such reviews were even older. It is 
difficult to say how relevant these findings are today 
and what has changed, especially if no newer reviews 
were included on the same topic. For example, 
the review by Wright and Walker (2006) is the only 
one of the included reviews which investigated 
the effectiveness of sexual health promotion 
interventions for those experiencing homelessness 
and problem drug use. The review authors concluded 
that there were only very limited data available to 
inform sexual health promotion policy and practice. 
While it is likely that further individual studies have 
subsequently been published, these have not yet 
been collated in reviews. Moreover, reviews regarding 
other relevant interventions of interest have not 
been captured by this search (e.g. safe consumption 
rooms; take-home naloxone interventions to 
prevent drug-related deaths), which creates gaps 
in evidence. Furthermore, although reviews were 
www.hrb.ie54
published internationally, most primary studies 
were conducted in the USA or Canada, which may 
limit the transferability of the findings to Ireland. 
Comparing the support and treatment options for 
those experiencing homelessness between Irish 
and North American contexts may be difficult given 
the substantial differences in systems for housing, 
healthcare (including substance use treatment), 
criminal justice, and welfare payments.
It is also important to note that interventions 
may be context-specific, or that certain contexts 
may influence the interventions and/or their 
effectiveness. For example, Pleace (2008) notes 
that one important contextual factor relates to the 
number of people requiring the service (e.g. is it 
economically justified?), or whether integration of 
existing services would be more justified or suitable. 
Similarly, whether an intervention will work will also 
depend on existing networks and whether there 
is support for joint working. The availability and 
extent of welfare systems, social care and healthcare 
systems, general economic conditions, housing and 
labour markets, and waiting lists for social rented 
housing are all also identified as potentially having an 
impact on the effectiveness of interventions. Pleace 
and Quilgars (2013) also identify the availability and 
extent of welfare, social care, and healthcare systems 
as influencing the effectiveness of interventions. 
They also note that available funds and costs can be 
influential and report that, in some USA research, 
HF has been shown to be cheaper than staircase 
services, suggesting that it may therefore be 
preferable. Similarly, the success of other existing 
approaches can be important; if they are not 
successful, a new approach may be more welcomed. 
Pleace and Quilgars (2013) also draw attention to 
the existing debate on whether specialised health 
services should separate and isolate people who 
experience homelessness or whether it would be 
better to try to enable them to use mainstream 
public health services. It is important to keep these 
contextual issues in mind when evaluating the 
effectiveness of the various interventions and the 
applicability of the findings to the Irish setting.
5.4 Research and evidence gaps
Our review investigated the available evidence for 
three main outcomes: treatment entry, engagement, 
and retention; successful completion of treatment; 
and treatment outcomes for people who experience 
homelessness and problem substance use. Despite 
a large number of studies having been undertaken 
on these topics independently, only a relatively 
small number of reviews have been included in this 
review. Many of the included reviews included very 
small samples, or predominantly focused on either 
homelessness or substance use, making it difficult 
to draw conclusions on effective approaches for 
populations experiencing both. More research is 
needed about the needs of this population, with a 
caveat and an acknowledgement that this group is 
not homogenous.
Regarding treatment engagement and retention for 
people who are homeless and use drugs, data from 
the included reviews suggest that both engagement 
and retention can be problematic, regardless of 
intervention type. However, there appears to be a 
research and evidence gap regarding this, with only 
11 of the included reviews mentioning treatment 
engagement and/or retention and, when doing so, 
providing only limited evidence on these outcomes. 
Limited data are available on successful treatment 
completion, and there is a lack of health economics 
studies examining the cost-effectiveness of these 
approaches. Other reviews and studies referred to 
high attrition rates, yet did not provide data. It is 
therefore difficult to draw conclusions about the 
success of treatments and interventions without 
taking into account completion rates.
Across the included reviews, the most data were 
available regarding treatment outcomes. However, 
the body of research for some of the intervention 
approaches is larger and more recent than others. 
Some of the reviews are more than a decade old 
and the quality of some reviews varies, with a few 
not being classed as systematic and scoring low 
on the quality assessment. In addition, even the 
highly rigorous systematic reviews of good quality 
may include low-quality data from primary studies 
within them. Only one review (Wright & Walker, 2006) 
investigated sexual health promotion interventions 
for people who are homeless and use drugs. This 
review highlighted the gaps in the evidence base 
at the time of publication, and the opportunities 
for further research. In particular, all of Wright and 
Walker’s (2006) included studies were conducted 
in the USA, where the nature and experience of 
homelessness can differ from European contexts. 
This remains a notable evidence gap, as there is a 
lack of research on sexual health interventions for 
this population (Savage, 2016). Similarly, only one of 
the included reviews investigated peer support as a 
potential intervention for people who are homeless 
(Barker & Maguire, 2017), but this review did not 
specifically address this population. More research 
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into peer support for this specific population is 
needed, particularly into the evidence from Barker 
and Maguire (2017) that suggests clear benefits 
regarding homelessness outcomes, as well as some 
support for positive effects on problem substance 
use outcomes. Since the publication of Barker and 
Maguire’s (2017) systematic review, a more recent 
systematic review regarding peer interventions for 
people who are homeless and experience problem 
substance use has been published (Miler et al, 2020). 
Both Miler et al. (2020) and the current review 
conclude that more research is needed in order to 
clearly define peer interventions and ascertain their 
impact on homeless populations, and on the peers 
themselves.
The authors of the most recent of the included 
reviews on case management (Penzenstadler et al., 
2019) suggest that there is some evidence that those 
with high inpatient service use benefit most from 
the assertive approach of ACT, and that a similar 
high-need user group among people experiencing 
problem substance use might benefit most from 
this intervention. However, this needs to be studied 
more in depth. Future studies should investigate 
the effective ‘ingredients’ of ACT, which would help 
to conceptualise a specific ACT model that may be 
more effective. Further research is also needed to 
examine which types of clinical interventions might 
help difficult-to-engage patients with problem 
substance use in order to innovate treatment 
approaches and reach out to patients. There also 
appears to be a lack of uniformity in the outcomes 
examined and in the standardisation of measurement 
instruments, as well as variation in service provision 
between countries and settings; therefore, future 
studies on case management should be designed 
carefully. Moreover, according to de Vet et al. (2013), 
several important outcomes have not been subjected 
to sufficient scientific evaluation as only a few 
publications in their review included outcomes 
related to QoL, societal participation, physical health, 
or community integration. Therefore, only when 
the evidence gaps have been addressed will it be 
possible to establish which case management models 
or which specific components of these models are 
most suitable to accompany housing as part of a 
rapid-rehousing approach to homelessness. 
There is a gap in evidence regarding optimal policies 
on discharge planning for statutory agencies, which 
can impact on continuity of care (Burt et al., 2004). 
Although there is evidence regarding the positive 
effects of integration of services and care for people 
experiencing COSMHAD, research is still needed in 
terms of establishing the effective components of 
integrated programmes of support. 
Evidence regarding housing interventions suggests 
that different housing interventions may suit different 
groups. Overall, these may not have a huge impact on 
substance use (although they do not make it worse), 
but they but provide stability and probably have a 
bigger impact on substance use if other efforts are 
made to help service users engage with substance 
use services. Moreover, there is currently a lack 
of studies that have investigated the relationship 
between improvements in housing and well-being 
for the individual or the community. Chambers et al. 
(2017) suggest that this may reflect both limitations 
of the evidence base (relatively few high-quality 
studies reporting on core well-being outcomes) and 
the complexity of the relationship between housing 
and well-being for vulnerable people with complex 
needs. In terms of evidence gaps and implications for 
research, their review suggested that there is a need 
for further high-quality evaluations of interventions. 
There is a particular requirement for well-designed 
economic evaluations and studies focusing on the 
well-being dimensions that have been relatively 
under-researched to date – for example, links 
between housing interventions and education and 
skills outcomes, and community well-being outcomes. 
Regarding HF more specifically, reviews which 
report on housing outcomes largely support the 
HF approach in terms of its effectiveness; however, 
further work is needed in relation to programme 
fidelity and the type of HF housing model (scattered 
versus single site). Further research is also needed 
on the potential benefits of social networks in 
congregate HF settings and whether these extend 
to service users with problem substance use. Other 
studies suggest that HF residents in scattered 
models experience increased isolation compared 
with residents in congregate models. Moreover, 
more research is needed regarding the impact of 
HF on substance use, and in assessing the long-
term effects of improved housing stability on health 
outcomes. Beaudoin (2016) suggests that it is not 
currently possible to determine the best modalities 
and components to integrate into HF programmes, in 
terms of intensity of interventions, types of housing, 
and types of stakeholder teams, as the required level 
of evidence is currently unavailable. 
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Only one review (Turner et al., 2011) specifically 
examined harm reduction, and not specifically 
for people who are homeless. Therefore, despite 
evidence suggesting that NSPs, especially if combined 
with OST, were effective in reducing the incidence of 
HCV for PWID, and given the high background HCV 
risk in some populations, the question remains on 
what levels of OST and NSP coverage (and behaviour 
change) are required in order to reduce HCV 
prevalence in people who are homeless (and how to 
achieve this). A number of relevant harm reduction 
interventions that could be used for this group are 
therefore missing from this report, especially in 
relation to drug-related deaths. 
Evidence from Carver et al. (2020) suggests that more 
research is required in order to identify the optimal 
length of treatment duration for those experiencing 
homelessness and problem substance use. It is 
important to note that this work identified that lengthy 
treatment and aftercare was preferred by service 
users themselves. However, this view was far less 
prominent in primary author conclusions, suggesting 
that the importance of stability may be underreported 
in the literature, subsequently leading to the gap in 
knowledge regarding optimal treatment length.
5.5 Recommendations for policy 
and practice development
5.5.1 Intersection of homelessness and 
problem substance use
The systematic review of reviews focused specifically 
on the intersection of homelessness and substance 
use (with a main focus on drugs; however, some of 
the included reviews focused both on drugs and 
alcohol) and aimed to assess the evidence base 
regarding treatment and intervention options for 
this group of people. However, only 4 out of the 
22 included reviews specifically examined this 
population. Other reviews focus on interventions 
for people who are homeless or for people with 
problem substance use. But it is important to 
acknowledge that, despite high rates of substance 
use in the homeless population, not every individual 
who is homeless uses substances, and not every 
individual who is experiencing problem substance 
use is homeless. This is a specific group of people 
with needs specific to their situation, which may 
be more complex (and therefore more challenging 
to tackle) than for people with only one of those 
problems in isolation. Due to this lack of research 
and/or evidence syntheses focusing on this specific 
population, it may be misleading or inaccurate 
to base policy and service recommendations for 
this group on evidence which was not collected 
specifically for them. Therefore, the most important 
research recommendation stemming from 
this systematic review of reviews is to conduct 
more research pertaining to the intersection of 
homelessness and substance use specifically. 
5.5.2 Lack of homogeneity 
It is vital to acknowledge that people who are 
homeless and experience problem substance use are 
not a homogenous population. There are many more 
specific subgroups within this group, such as people 
who are homeless and experience COSMHAD. Their 
needs, understandably, will be even more complex 
than for the more ‘general’ population of people 
who are homeless and experience problem drug 
use. Moreover, gender, ethnicity, sexual orientation, 
and sexual identity may all play a role in how an 
individual who is homeless and experiences problem 
substance use seeks and responds to any treatment 
or intervention, and what other needs these 
individuals may have (for example, a woman and 
mother who is homeless and experiences problem 
substance use will have more needs than a non-
parent man in similar situation). As noted by Carver 
et al. (2020), there are many missing voices both in 
their meta-ethnography, and in this present review 
of reviews. This adds an extra layer of uncertainty 
regarding the application of any of the findings to the 
wider population of people with homelessness and 
problem substance use concerns. We recommend 
that, in order to ensure that what we currently 
believe works for most people who are homeless 
and experience problem substance use applies to 
those missing voices too, more research, particularly 
qualitative research, should be conducted.
5.5.3 Tailored treatment versus ‘ingredients’ of 
success 
To add another layer of complexity, it is important 
to remember that all people who are homeless 
and experience problem substance use, regardless 
of race and gender or any extra health needs, are 
individuals, with different circumstances, needs, 
wants, and preferences. As Carver et al. (2020) 
note, they are also likely to have different needs 
and desires relating to their substance use at 
different time points and their choices regarding 
treatment may change over time, depending on 
circumstances. There is a fine line between trying to 
establish the ‘ingredients of success’ of treatments 
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and interventions to ensure that the largest number  
of people can benefit, and assuming that one size 
fits all. We believe this to be one of the biggest 
challenges in terms of successful service provision: 
trying to balance establishing the most successful 
components of any treatment with ensuring that the 
treatment can be person-specific. How can we make 
sure that treatment is tailored to the individuals’ 
needs and that there are choices provided to 
ensure preferences are taken into account and to 
strengthen the service users’ sense of mastery of 
their own lives to foster improvements in self-esteem 
and well-being? Pleace (2008) similarly believes the 
importance of not falling into the trap of one size fits 
all, arguing that treatment failure often stems from 
the service providers not recognising the breadth 
and complexity of individual needs. 
Due to the importance of choice for service 
users, we believe that a truly flexible system which 
provides both harm reduction and abstinence-
based approaches is recommended for people 
experiencing homelessness. As it is vital that any 
treatment provision is tailored to individuals’ needs, 
in agreement with Pleace’s (2008) recommendations, 
we urge the service providers to set realistic service 
outcomes for individual service users, taking into 
account their circumstances and therefore placing 
any kind of demands on them accordingly without 
setting them up for failure. 
However, we do acknowledge the need of service 
providers to establish key components or ‘most 
successful ingredients’ of interventions to try to 
reach and help the largest numbers of people in 
need. The difficulty is therefore in balancing the 
‘everyone is different’ approach and the ‘what 
works best for whom in what context’ approach with 
trying to establish the common ingredients that are 
universal that make a positive difference. Between 
and within the included reviews, we note a large 
variation in service provision of the various models. 
For example, there are different types of HF, different 
case management models, and various ‘combination 
treatments’. Moreover, there are issues relating 
to context or place; for example, Benston (2015) 
concludes that, except for some types of HF, the 
reviewed studies on housing are all unique to their 
environments. 
One of the problems we have noted is the lack 
of standardisation of measures and outcomes 
which makes it difficult to make meaningful 
comparisons between different types of service 
models. We recommend that outcome measures 
are standardised and that more research directly 
comparing models of treatment, particularly in 
RCTs, is conducted. For example, with two of the HF 
reviews raising concerns regarding potential well-
being implications of scattered versus congregate 
HF models, these should be compared using 
standardised measures. It would also be helpful for 
policy-makers and service providers to be given 
more evidence regarding any cost evaluations of 
those models too.
5.5.4 Optimal length of treatment and stability 
Currently, treatment for problem substance use 
can be relatively short, with a minimum of 3 months 
being recommended. However, Pleace (2008) and 
Carver et al. (2020) stress the importance of stability 
related to longer treatment durations. This need for 
longer-term treatment duration is not surprising, 
given the myriad of challenges of those experiencing 
homelessness and problem substance use, and it 
is also consistent with findings from other studies 
in which extended treatment is associated with 
improved outcomes (e.g. Conners et al., 2006). 
There is a need for development and evaluation 
of longer-term treatment and aftercare models, 
to avoid relapse, enhance stability, and enhance 
the likelihood of a range of positive outcomes. It is 
important to note that Carver et al.’s (2020) meta-
ethnography identified the requirement for lengthy 
treatment and aftercare as a strong view from 
participants. However, it was far less discernible 
within original author interpretations, suggesting that 
the importance of stability may be underreported in 
the literature. Interestingly, the authors also suggest 
that stability may be perceived differently when 
considering harm reduction and abstinence-based 
treatment, as those authors who noted the need 
for stability in the studies included in the meta-
ethnography were all writing about harm reduction 
approaches.
The desire of service users for longer-lasting support 
conflicts with the reality of services globally, where 
austerity and systematic underfunding and cuts 
to services put pressure on services to discharge 
people as quickly as possible. In agreement with 
Pleace (2008) and Carver et al. (2020) we suggest 
that, firstly, more research is conducted to identify 
the optimal length of treatment duration for those 
experiencing homelessness and problem substance 
use, and, secondly, that there is a need for a secure 
funding base to enable the interventions and 
treatment to be prolonged once optimal duration is 
established.
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5.5.5 Importance of staff: compassionate and 
non-judgemental approach 
Evidence suggests that the way in which services 
and treatment are delivered can be more important 
than the type of treatment provided, and that good-
quality positive relationships between the service 
users and staff are vital for success. It is therefore 
paramount that services prioritise good relationships 
between staff and service users, and that staff 
receive training and help if needed to ensure they 
can provide a person-centred approach and a 
genuine understanding of individuals’ complex lives. 
As there needs to be a non-judgemental attitude 
with genuine respect for service users’ choices, this 
may be something that needs to be continuously 
encouraged at an organisational level and periodically 
evaluated (by gaining service users’ perspectives). 
This also resonates with the concept of PIEs; a 
psychological framework designed to ensure that 
services respond to the needs of those experiencing 
homelessness, which understands people’s coping 
strategies, including problem substance use, as a 
response to past traumatic experiences and their 
ensuing emotional impact (Johnson & Haigh, 2010). 
The physical environment and staff training are 
two key components of PIEs (Keats et al., 2012). 
Alongside staff training, service providers can also 
make improvements to their environment to increase 
support through, for example, the use of flexible drop-
ins, or improved dining facilities (Keats et al. 2012).
5.5.6 Integration and partnership working 
Problem substance use treatment for those 
experiencing homelessness is a complex issue as 
multiple morbidity is common and this requires 
a complex, flexible, interagency response in 
addressing barriers to provision and ensuring 
effective multiagency working so that people who 
are homeless can access the full range of health 
and social care services. This has been a common 
recommendation among the papers included in this 
review of reviews. 
Partnership working and integrated care are 
important aspects of service delivery when working 
with people who are homeless who use drugs. 
Partnership working is also an important part of 
trauma-informed care (Sweeney et al., 2016). In their 
systematic review of what works in inclusion health, 
Luchenski et al. (2018) conclude that partnership 
working is essential to achieve the best results for 
marginalised populations. Such work helps to ensure 
long-term continuity of care (Luchenski et al., 2018). 
Integrated care is the “organisation and management 
of health services so that people get the care they 
need, when they need it, in ways that are user 
friendly, achieve the desired results and provide 
value for money” (Darker, 2014, p. 17). In practice, 
this means that services are easy to navigate, with 
good communication between healthcare workers 
at all levels of the system. They should involve 
partnership working across traditional professional 
boundaries and strong alliances between health and 
social care organisations (Darker, 2014). Integrated 
care is particularly important for people who are 
homeless, who often fall through the cracks of 
healthcare (Maness & Khan, 2014). People who are 
homeless are more likely to engage with services 
that are flexible and integrated (Maness & Khan, 
2014; Mills, Burton & Matheson, 2015). Integrated 
care for people who are homeless is increasing in 
recognition, with the National Institute for Health and 
Care Excellence (NICE) in the UK in the process of 
developing guidance on such care, with a recognition 
of the need for joined-up health and social care 
that considers people’s social, emotional, mental, 
and physical well-being, as well as other care and 
support needs (National Institute for Health and 
Care Excellence, 2020). As Carver et al. (2020) noted 
in their paper, for some individuals, standalone 
interventions may facilitate engagement with 
treatment but are unlikely to enable individuals to 
maintain their recovery. For many, their housing 
situation complicates their ability to engage in 
treatment, so providing services that address their 
substance use along with other needs is vital. This is 
why interventions such as transitional housing and 
HF, which provide individuals with a home to live in 
as well as access to a range of health and support 
services, may be of special benefit to this population.
5.5.7 Harm reduction 
A continuum of services and approaches should 
be made available and offered without judgement. 
People experiencing homelessness should not feel 
that the only way to access a safe space is in settings 
in which abstinence is expected or enforced. Instead, 
substance use services and treatment settings 
need to support people to use substances safely, 
as required, without any assumption of continued 
abstinence. 
One of the included reviews (which did not focus 
specifically on people who use drugs) looked 
specifically at harm reduction approaches and 
concluded that NSPs, especially if combined with 
OST, were effective in reducing the incidence of 
HCV (Turner et al., 2011). This review supports 
recommendations within the UK, Europe, and 
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globally on the need to expand NSPs and OST to 
prevent HCV infection. Nonetheless, even with 
high coverage, some participants still injected or 
became infected. Given the high background HCV 
risk in some populations, the question remains on 
what levels of OST and NSP coverage (and behaviour 
change) are required to drive down HCV prevalence 
(and whether these are sustainable). The evidence 
base needs to be strengthened and extended in 
two ways. First, Turner et al. (2011) suggest that 
their findings need to be corroborated, and the 
number of studies or public health surveillance 
programmes that measure HCV incident infections 
and intervention exposure increased. In this way, 
surveillance will move from describing disease 
prevalence or burden to evaluating and monitoring 
intervention impact. Secondly, they suggest the 
need to address and monitor the population 
impact of different levels of intervention coverage; 
that is, to compare HCV incidence between PWID 
with different levels of intervention exposure 
and consider what combination of interventions, 
including HCV treatment, are most likely to make 
sustained and substantial reductions in HCV 
transmission in the population.
5.5.8 Housing interventions 
Reducing or stopping drug and alcohol use, as well as 
any related harm associated with it, for people who 
are homeless is a complex process. It is likely that 
expecting near-immediate, large-scale reductions in 
drug and alcohol use from HF services is unrealistic 
(Pleace & Quilgars, 2013). A central question when 
considering the role of HF services in enhancing 
health is how far the service model has to go in order 
to be judged a ‘success’. Arguments have been made 
by the founder of Pathways to Housing suggesting 
that while it may be desirable for HF services to 
form the core response to chronic homelessness, 
there should be scope to also use alternative service 
models if they might suit a particular individual 
better, such as ‘tolerant staircase models’. However, 
since chronic homelessness is extremely complex, 
both in terms of drug and alcohol use, and also more 
generally, the flexible and choice-led approach used 
by HF services may be advantageous. HF could be 
enhanced in respect of health and social integration 
by recognising that different ’levels’ of success will 
be achieved when promoting and enabling better 
health and social integration. For some people using 
HF, there may be maximum success. For others there 
may be some movement towards better health and 
greater social integration, but that distance may vary 
and there may be limits to how far it is realistic for 
them to go. Once the likelihood of variable outcomes 
is accepted, attention can then be paid to how 
outcomes in health and social integration can be 
enhanced. Clear recognition that achievable goals 
may vary between each person using a HF service is 
the first step to becoming more precise about what 
these services can achieve. Then, setting goals in 
relation to health and social integration outcomes 
should be defined, set, monitored, and tested using 
validated measures.
Evaluation of the relative contribution of the key 
principles of HF to its effectiveness would be an 
important next step, according to Pleace and 
Quilgars (2013). In addition, a clearer differentiation 
and comparison of the treatments broadly grouped 
under TAU could show whether better interventions 
exist for certain groups. This was also implied by 
Kertesz et al. (2009) who suggested that future 
research should evaluate both HF and ‘linear’ 
approaches, preferably in RCTs, with appropriate 
measures for both problem substance use and 
housing outcomes, as well as an analysis of how 
interventions apply to the vulnerabilities and 
preferences of individual clients. As mentioned 
earlier, we also recommend that scattered versus 
congregate HF models are compared with each other.
5.5.9 Interventions for people with COSMHAD 
One of the key issues identified from this review of 
reviews regarding people with COSMHAD in relation 
to residential treatments is the need for statutory 
agencies to establish rules to ensure a well-executed 
discharge plan that links an institution that discharges 
an individual with the community that takes in the 
individual. This ties in with the previously mentioned 
need for stability and continuity of care. There 
seems to be consistent evidence across the included 
reviews suggesting that integration of care and 
communication between various treatment agencies 
is important. 
Recently, Minyard et al. (2019) recommended that 
incentives in payment should be created to providers 
for integrating care of individuals with COSMHAD. 
They also suggest that when developing service 
payment agreements, deliverables that recognise the 
long path to recovery should be included. Moreover, 
policy-makers should analyse the system as it 
relates to access to psychological services and align 
providers with service needs, and also examine the 
payment structure for peer mentors, coaches, and 
instructors. Lastly, they suggest that policy-makers 
should explore how resources can be allocated to 
support a holistic approach to care (e.g. housing, 
supportive employment). Building a knowledgeable, 
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integrated workforce which keeps the individual at 
the centre; developing a common language among 
different provider types, consumers, and families; 
examining training models; and building in time 
to support provider training and cross-training to 
increase competence, confidence, and a culture 
of hope should all be paramount. In agreement 
with Minyard et al. (2019) we also recommend the 
creation of a learning community among the current 
integrated programmes in order to learn from each 
other. We suggest that conducting a realist review 
of integrated treatments for people with COSMHAD 
could be beneficial in terms of improving current 
programmes and building others.
5.5.10 Case management 
The reviews evaluating various case management 
approaches report mixed results. However, taken 
together as ‘case management-type interventions’, 
there is evidence to support it as an effective 
intervention both when applied on its own 
and when combined with other interventions 
such as contingency management with positive 
reinforcement or incentives, art therapy, and 
health prevention and promotion programmes. 
Torres Del Estal and Álvarez (2018) recommend case 
management as an intervention model for both 
nurse-led and/or multidisciplinary teams working 
with people who are homeless and experience 
problem substance use. They recommend the 
promotion of such interventions at street level, with 
outreach and mobile units. They conclude that it 
is important not only to treat problem substance 
use as a preventable individual practice, but also 
in the context of health prevention and promotion 
programmes, where these are addressed as risk 
factors for subsequent disease. de Vet et al. (2013) 
also suggest that practitioners could employ case 
management to assist people who are homeless with 
improving their housing stability and changing their 
service use patterns. By far the most research to 
date has been conducted focusing on ACT, which has 
consistently produced positive effects on housing 
stability as well as being found to be cost-effective. 
Higher fidelity to the ACT model appears to improve 
results. However, this model seems to be suitable 
mainly for those experiencing homelessness and 
mental health problems or COSMHAD, who also have 
multiple and complex needs. The benefit of this 
assertive approach seems to increase the higher 
the inpatient service use (Penzenstadler et al., 2019), 
but this needs to be studied further. CTI has also 
produced promising results and seems to be more 
applicable for a variety of settings and populations 
because of its practical and time-limited nature. 
In order to inform policy-makers, carefully designed 
experimental trials should be conducted among 
different subgroups of people who are homeless 
comparing the various types of case management 
models directly, using uniform and standardised 
measures. Only when the evidence gaps have been 
addressed will it be possible to establish which case 
management models or which specific components 
of these models are most suitable to accompany 
housing, as part of a rapid-rehousing approach to 
homelessness for specific homeless subgroups. 
5.5.11 Peer-led or peer-involved interventions 
Peer support refers to a process whereby individuals 
with lived experience of a particular phenomenon 
provide support to others by explicitly drawing on 
their experience of this situation. Peer support 
started in mental health settings in the 1970s 
and has since moved into other areas including 
homelessness, criminal justice, substance use 
treatment, and physical health. Peer support 
stemmed from the mental health recovery 
movement which rejected what was considered 
to be an outdated and stigmatising medical model 
for mental health treatment (Mead, Hilton & Curtis, 
2001). The number of peer interventions has 
continued to increase globally, and the value of 
such interventions is increasingly recognised, for 
example in recommendations for peer involvement 
within international guidelines. In a state-of-
the-art systematic review by Miler et al. (2020), 
peer support models were explored. The authors 
analysed 62 papers and identified a range of peer 
support interventions at the intersection between 
homelessness and problem substance use (Miler et 
al., 2020). There was evidence that peer support 
interventions were associated with positive outcomes 
in terms of substance use (alcohol, tobacco, and/
or drugs), housing status, employment, physical 
health, and QoL (Miler et al., 2020). The qualitative 
studies included in the review highlighted the positive 
impacts on service users and peers, for example in 
terms of a sense of community and better access 
to treatment (Miler et al., 2020). Several challenges 
were identified in terms of vulnerability, authenticity, 
boundaries, stigma, and having their involvement 
valued (Miler et al., 2020). The authors conclude 
that peers should continue to be involved in such 
services and that their contributions are valued, well 
supported, and compensated (Miler et al., 2020). 
Peer support is increasingly gaining in credibility 
and popularity, alongside strategic policy 
acknowledgement (Scottish Government, 2018) and 
the connections between the lived experiences 
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of both homelessness and problem substance 
use are becoming more visible in social research. 
However, only one of the reviews included in this 
systematic review of reviews focused on peer 
support interventions for people who are homeless 
(and this was not specific to those who also have 
problem substance use). Despite this limited quantity, 
the results of their review were very promising, 
showing clear benefits of peer involvement (Barker 
& Maguire, 2017). Furthermore, since the completion 
of the evidence synthesis in this systematic review of 
reviews, a recent state-of-the-art review has been 
published (Miler et al., 2020), providing a systematic 
search and synthesis of literature examining use 
of peer support models within services for people 
impacted by homelessness and problem substance 
use specifically. Despite a marked increase in 
publication of studies on peer support in the past 
couple of years, only 23 of the 62 papers included 
in Miler et al.‘s (2020) review focused explicitly on 
the intersection of homelessness and problem 
substance use, rather than merely including these 
groups of clients in their study samples. Even then, 
the 23 papers varied greatly in the numbers of 
included samples of interest, particularly people with 
lived experience of homelessness. This, yet again, 
highlights the gap in research and, subsequently, 
in the evidence base regarding people at the 
intersection of homelessness and problem substance 
use specifically.
Similar to the findings of Barker and Maguire (2017) 
(and having also included Barker and Maguire (2017) in 
their review), most of the studies included by Miler et 
al. (2020) reported at least some positive outcomes 
of peer-led/peer-staffed interventions, including 
an overall reduction in substance use-related harm; 
reductions in drug and alcohol use; reductions in 
cigarette use and increased smoking cessation; 
improvements in homelessness status; and psycho-
socioeconomic benefits such as improved health, 
return to work, and greater community engagement 
leading to improvements in QoL. A small proportion 
of the included studies reported modestly positive 
outcomes only, or no differences from standard 
treatment or other existing interventions. These 
findings echo those from reviews of the effectiveness 
of peer support for those with substance use 
problems. 
Qualitative studies in Miler et al.’s (2020) review 
emphasised that peers can have positive impacts on 
the lives of their clients, and that the clients can also 
benefit the peer workers themselves. For example, 
for some peers, the involvement in the projects 
helped them to abstain from their own drug use. 
However, despite the identified benefits, there are 
also challenges that peer workers commonly face 
in their roles, including vulnerability, authenticity, 
boundaries, stigma, and having their involvement 
valued. There is an increasing recognition of the 
unique position of peers, including their ability to 
create a special type of rapport based on shared 
experience and lack of judgement, and their ability to 
gain trust. Many peers and professionals understand 
how valuable this is in engaging people with multiple 
social and health inequalities and connecting them to 
wider supports and services.
Embedding peers in services has implications for 
research, policy, and practice, and these require 
careful consideration. Peer workers commonly lack 
standard workplace benefits, including access to 
support services, training opportunities, fair pay 
and conditions, and career progression (Miler et 
al., 2020). This needs to be addressed, although we 
acknowledge that this will necessarily be resource 
dependent and require cultural changes to take 
place to value the role of peer workers more highly. 
Furthermore, our recommendation regarding peer 
support interventions for people at the intersection 
of homelessness and problem substance use is to 
address methodological issues in research studies in 
order to enable us to distinguish the effects of peer 
recovery support from other support activities and 
to tackle the inconsistencies in the definitions of 
peer workers and recovery coaches. 
5.6 Chapter summary 
This chapter has sought to make connections 
between the respective components of this 
study. Based on the study findings, a number of 
recommendations for policy and practice were 
presented, alongside the main strengths and 
limitations of the study, and evidence gaps. Final ‘key 
messages’ from this study are provided below. 
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Key messages 
» There is a lack of international research on 
effective interventions for people who are 
homeless who experience problems with 
substance use. There is also a lack of research, 
and a lack of Irish research in particular, which 
examines this intersection in depth.
» People who are homeless and experience 
problem substance use are not a homogenous 
population. More research, particularly qualitative 
research, should be conducted to explore the 
‘missing voices’.
» It is important that treatment for this population 
group is needs-led and person-centred. However, 
most research has examined complete treatment 
interventions and service models, and there is a 
lack of evidence on the effect of tailoring these. 
» Treatment failure often stems from the service 
providers not recognising the breadth and 
complexity of individual needs.
» Due to the importance of choice for service users, 
a flexible system which provides opportunities 
for both harm reduction and abstinence-based 
approaches is recommended.
» Consensus on outcome measures (including 
treatment outcomes and treatment completion 
indicators for this population) should be reached 
to help research standardisation, and to support 
meaningful comparisons between interventions.
» Research is required on the optimal length 
of treatment for this population. This has 
implications for practice, as research findings may 
lead to a need to secure funding for extended 
periods of treatment.
» The findings highlight the importance of 
integration between different services, especially 
for people who are homeless and who experience 
COSMHAD.
» How interventions are delivered (non-judgemental, 
compassionate), providing choices, and respecting 
service users’ preferences for approach, is an 
important determinant of success. 
» In the review research studies there are 
insufficient data regarding treatment retention and 
completion available and/or synthesised.
» Housing interventions, especially HF, lead to 
improvements in housing outcomes, but evidence 
regarding HF interventions and health and well-
being outcomes is mixed. Evidence suggests that 
HF does not impact on substance use outcomes.
» Case management-type interventions can be 
effective, but ACT seems suitable primarily for 
those experiencing homelessness and mental 
health problems or COSMHAD.
» Peer support interventions have the potential to 
lead to positive housing, substance use, and well-
being outcomes, but care needs to be taken when 
embedding peers into services due to common 
challenges that they experience in such roles. 
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Appendix 1.  
PICOS
Populations
People experiencing homeless and drug use (including polysubstance use)
Range of drugs used both problematically and/or recreationally, including PIEDs
Adults (over 18 years, with no upper age limit)
Interventions
Problem drug use treatment (including polysubstance use)
Harm reduction approaches
Interventions in primary care for drug use







Reduced overdoses (fatal and non-fatal)
Reduced drug-related  harm
Improved quality of life
Improved health outcomes
Study design
Review (including systematic review, meta-analysis, evidence synthesis, realist review, mixed methods review, qualitative synthesis, 
meta-epidemiology, integrative review, umbrella review, critical interpretative synthesis) 
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Organisation/author Webpage/article
Bates (2017) The drugs situation in Ireland: an overview of trends from 2005 to 2015
Duffin el al. (2020) Street tablet use in Ireland. A Trendspotter study on use, markets, and harms
EMCDDA (2020a) Key epidemiological indicators
EMCDDA (2019) Ireland Drug Country Report 2019
Good Shepherd Services & Simon 
Community (2011)
Women’s health and homelessness in Cork
Hay et al. (2017) Estimating the prevalence of problematic opiate use in Ireland using indirect statistical methods
Health Research Board (HRB) National Drugs Library
HRB (2016) National Drug-Related Deaths Index 2004 to 2014 data
HRB (2019) National Drug-Related Deaths Index 2008 to 2017 data
HRB (2017) National Drug Treatment Reporting System 2009 to 2015 data
HRB (2019) National Drug Treatment Reporting System 2012 to 2018 drug data
HSE Review of Needle Exchange Provision in Ireland
Keogh et al. (2015) Health and use of health services of people who are homeless and at risk of homelessness who 
receive free primary health care in Dublin
Mayock & Sheridan (2012) Women’s journeys to homelessness: key findings from a biographical study of homeless women 
in Ireland
National Advisory Committee on 
Drugs and Alcohol (NACDA) (2016)
Prevalence of drug use and gambling in Ireland and drug use in Northern Ireland. Bulletin 1
O’Reilly et al. (2015) Homelessness: An unhealthy state. Health status, risk behaviours and service utilisation among 
homeless people in two Irish cities
Appendix 2.  
Sources for trend analysis 
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Appendix 3.  
Relevant data sources 
Table of organisations searched for mapping of current service provision
Statutory services Third sector services Organisations that specify that they 
provide specialist substance use services 
for people who are homeless 
Health Service Executive (HSE) Addiction Services Other HSE partners listed on 
the HSE website
Ana Liffey Drug Project
HSE Adolescent Addiction Service YMCA Ireland Cuan Mhuire
Substance Abuse Service Specific to Youth (SASSY) Threshold Suaimhneas
Soilse Crosscare Daisyhouse
Youth Drug and Alcohol Service (YoDA) Focus Ireland Focus Ireland
HSE Social Inclusion programme Salvation Army Static, outreach and pharmacy needle 
exchange services
Local and Regional Drug and Alcohol Task Forces Daisyhouse Simon Communities
Prescribing services (including opioid therapies) Depaul Merchants Quay Ireland
Static, outreach, and pharmacy needle exchange 
services
Narcotics Anonymous Peter McVerry Trust
Planned medically supervised injecting facility at 
Merchants Quay
Cuan Mhuire Safetynet
Society of St. Vincent de Paul Salvation Army
Ana Liffey Drug Project HSE Social Inclusion programme




Organisations identified through relevant stakeholders
Statutory services Third sector services 
Cuan Dara Inpatient Therapeutic Detoxication Centre (HSE) Sophia Housing
Keltoi Residential Treatment Centre (HSE) HAIL (Housing Association for Integrated Living) 
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Appendix 4.  
Search strategy
MEDLINE




5 (rough adj sleep*).ti,ab,kw. 
6 "street person".ti,ab,kw. 
7 "street people".ti,ab,kw. 
8 vagrant*.ti,ab,kw. 
9 "no fixed abode".ti,ab,kw. 
10 (transient adj3 (people or person* or adult* 
or man or men or woman or women
or individual* or population* or group* or 
communit*)).ti,ab,kw. 
11 (shelter adj (seek* or using or need*)).ti,ab,kw. 
12 "shelter use".ti,ab,kw. 
13 "unstabl* hous*".ti,ab,kw. 
14 unshelter*.ti,ab,kw. 
15 ((emergency or temporary or overnight or 
housed or intermittent or night) adj




19 ((without or lack) adj2 (home* or housing or 
house)).ti,ab,kw. 
20 or/1-19 
21 ((Drug* or substance* or polydrug or "poly-
drug" or "legal high*" or
 psychoactive* or "psycho-active*" or 
psychotropic*) adj4 (use* or abus* or misuse* 
or
 "mis-use*" or refus* or problem* or taking or 
take* or experiment* or
 addict*)).ti,ab,kw. 
22 ((ketamine or speed or spice or cocaine or 
crack or mushroom* or solvent* or
 inhalant or "nitrous oxide" or "laughing gas" or 
benzodiazepine* or tranquiliser* or
 tranquilizer* or opioid* or opiate*or 
hallucinogen* or "anabolic steroid*" or 
gabapentin
 or pregabalin or etizolam or valium) adj4 (use* 
or abus* or misuse* or "mis-use*" or
 refus* or problem* or taking or take* or 
experiment* or addict*)).ti,ab,kw. 
23 (Cannab* or marijuana or skunk or ecstasy or 
MDMA or LSD or "lysergic acid
 diethylamide" or amphetamine* or 
amfetamin* or mephedrone or mkat or 
"meow
 meow" or meth or methamphetamine or 
methamfetamin* or psychedelic* or pcp or
 phencyclidine or "anabolic steroid*" or ped 
or peds or pied or pieds or "performance
 enhancing" or "image enhancing" or heroin or 
poppers or "amyl nitrate" or "butyl
 nitrate" or "new psychoactive drug*" or "novel 
psychoactive drug*" or "novel
 psychoactive substance*" or NPS or "harm 
reduction" or detox*).ti,ab,kw. 
24 exp Street Drugs/ 
25 exp Designer Drugs/ 
26 exp Marijuana Abuse/ 
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27 exp Drug-Seeking Behavior/ 
28 exp Performance-Enhancing Substances/ 
29 exp Substance-Related Disorders/ 
30 exp Amphetamine-Related Disorders/ 
31 exp Cocaine-Related Disorders/ 
32 exp Inhalant Abuse/
33  exp Marijuana Abuse/ 
34 exp Opioid-Related Disorders/ 
35 exp Phencyclidine Abuse/ 
36 exp Substance Abuse, Intravenous/ 
37 exp Marijuana Smoking/ 
38 exp Drug Users/ 
39 or/21-38 
40 20 and 39 
41 limit 40 to (meta analysis or "systematic 
review") 
42 "systematic review".ti,ab,kw. 
43 "evidence synthesis".ti,ab,kw. 
44 "realist review".ti,ab,kw. 
45 "realist synthesis".ti,ab,kw. 
46 "meta analysis".ti,ab,kw. 
47 "mixed methods review".ti,ab,kw. 
48 "meta-synthesis".ti,ab,kw. 
49 "mixed methods synthesis".ti,ab,kw. 
50 meta-epidemiology.ti,ab,kw. 
51 "qualitative synthesis".ti,ab,kw. 
52 ("meta-epidemiolog*" or meta-ethnograph*).
ti,ab,kw. 
53 "cochrane review".ti,ab,kw. 
54 "integrative review".ti,ab,kw. 
55 "umbrella review".ti,ab,kw. 
56 "critical interpretive synthesis".ti,ab,kw. 
57 or/42-56 
58 40 and 57 
59 41 or 58 
60 from 59 keep 1-101
CINAHL
S1 (MH "Homeless Persons") OR (MH 
"Homelessness")
S2 TI homeless* OR AB homeless* OR SU 
homeless*
S3 TI undomiciled OR AB undomiciled OR SU 
undomiciled
S4 TI houseless* OR AB houseless* OR SU 
houseless*
S5 TI (rough NEAR sleep*) OR AB (rough NEAR 
sleep*) OR SU (rough NEAR sleep*)
S6 TI "street person" OR AB "street person" OR 
SU "street person"
S7 TI "street people" OR AB "street people" OR 
SU "street people"
S8 TI vagrant* OR AB vagrant* OR SU vagrant*
S9 TI "no fixed abode" OR AB "no fixed abode" 
OR SU "no fixed abode"
S10 TI ( (transient N3 (people or person* or adult* 
or man or men or woman or women or 
individual* or population* or group* or 
 communit*)) ) OR AB ( (transient N3 (people or 
person* or adult* or man or men or woman 
or women or individual* or population* or 
group* or communit*)) ) OR SU ( (transient 
N3 (people or person* or adult* or man or 
men or woman or women or individual* or 
population* or group* or communit*)) )
S11 TI ( (shelter N (seek* or using or need*)) ) OR 
AB ( (shelter N (seek* or using or need*)) ) OR 
SU ( (shelter N (seek* or using or need*)) )
S12 TI "shelter use" OR AB "shelter use" OR SU 
"shelter use"
S13 TI "unstabl* hous*" OR AB "unstabl* hous*" 
OR SU "unstabl* hous*"
S14 TI unshelter* OR AB unshelter* OR SU 
unshelter*
S15 TI ( ((emergency or temporary or overnight or 
housed or intermittent or night) N (shelter* or 
hostel*)) ) OR AB ( ((emergency or temporary 
or overnight or housed or intermittent 
or night) N (shelter* or hostel*)) ) OR SU ( 
((emergency or temporary or overnight or 
housed or intermittent or night) N (shelter* or 
hostel*)) )
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S16 TI roofless* OR AB roofless* OR SU roofless*
S17 TI destitute OR AB destitute OR SU destitute
S18 TI runaway* OR AB runaway* OR SU runaway*
S19 TI ( ((without or lack) N2 (home* or housing or 
house)) ) OR AB ( ((without or lack) N2 (home* 
or housing or house)) ) OR SU ( ((without or 
lack) N2 (home* or housing or house)) )
S20 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR 
S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 
OR S15 OR S16 OR S17 OR S18 OR S19
S21 TI ( ((Drug* or substance* or polydrug or 
"poly-drug" or "legal high*" or psychoactive* 
or "psycho-active*" or psychotropic*) N4 
(use* or abus* or misuse* or "mis-use*" or 
refus* or problem* or taking or take* or 
experiment* or addict*)) ) OR AB ( ((Drug* 
or substance* or polydrug or "poly-drug" or 
"legal high*" or psychoactive* or "psycho-
active*" or psychotropic*) N4 (use* or 
abus* or misuse* or "mis-use*" or refus* or 
problem* or taking or take* or experiment* 
or addict*)) ) OR SU ( ((Drug* o...
S22 TI ( ((ketamine or speed or spice or cocaine 
or crack or mushroom* or solvent* or 
inhalant or "nitrous oxide" or "laughing 
gas" or benzodiazepine* or tranquiliser* or 
tranquilizer* or opioid* or opiate*or 
 hallucinogen* or "anabolic steroid*" or 
gabapentin or pregabalin or etizolam or 
valium) N4 (use* or abus* or misuse* or 
"mis-use*" or refus* or problem* or taking 
or take* or experiment* or addict*)) ) OR AB 
( ((ketamine or speed or spice or cocaine or 
crack or mushroom* or solvent* or inhalant...
S23 TI ( (Cannab* or marijuana or skunk or 
ecstasy or MDMA or LSD or "lysergic 
acid diethylamide" or amphetamine* or 
amfetamin* or mephedrone or mkat or 
"meow meow" or meth or methamphetamine 
or methamfetamin* or psychedelic* or pcp 
or phencyclidine or "anabolic steroid*" or 
ped or peds or pied or pieds or "performance 
enhancing" or "image enhancing" or heroin 
or poppers or "amyl nitrate" or "butyl nitrate" 
or "new psychoactive drug*" or "novel 
psychoactive drug*" or "novel psychoactive 
substance*"...
S24 (MH "Street Drugs+")
S25 (MH "Designer Drugs")
S26 (MH "Substance Abusers+")
S27 (MH "Drug-Seeking Behavior")
S28 (MH "Substance Use Disorders+")
S29 (MH "Inhalant Abuse")
S30 (MH "Substance Dependence+")
S31 (TI ("harm reduction" or detox*)) OR (AB 
("harm reduction" or detox*)) OR (SU ("harm 
reduction" or detox*))
S32 S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR 
S27 OR S28 OR S29 OR S30 OR S31
S33 S20 AND S32
S34 TI "systematic review" OR AB "systematic 
review" OR SU "systematic review"
S35 TI "evidence synthesis" OR AB "evidence 
synthesis" OR SU "evidence synthesis"
S36 TI "realist review" OR AB "realist review" OR 
SU "realist review"
S37 TI "realist synthesis" OR AB "realist synthesis" 
OR SU "realist synthesis"
S38 TI "meta analysis" OR AB "meta analysis" OR 
SU "meta analysis"
S39 TI "mixed methods review" OR AB "mixed 
methods review" OR SU "mixed methods 
review"
S40 TI "meta-synthesis" OR AB "meta-synthesis" 
OR SU "meta-synthesis"
S41 TI "mixed methods synthesis" OR AB "mixed 
methods synthesis" OR SU "mixed methods 
synthesis"
S42 TI "qualitative synthesis" OR AB "qualitative 
synthesis" OR SU "qualitative synthesis"
S43 (TI ("meta-epidemiolog*" or "meta-
ethnograph*")) OR (AB ("meta-epidemiolog*" 
or "meta-ethnograph*")) OR (SU ("meta-
epidemiolog*" or "meta-ethnograph*"))
S44 TI "cochrane review" OR AB "cochrane 
review" OR SU "cochrane review"
S45 TI "integrative review" OR AB "integrative 
review" OR SU "integrative review"
S46 TI "umbrella review" OR AB "umbrella review" 
OR SU "umbrella review"
S47 TI "critical interpretive synthesis" OR AB 
"critical interpretive synthesis" OR SU "critical 
interpretive synthesis"
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S48 S34 OR S35 OR S36 OR S37 OR S38 OR S39 
OR S40 OR S41 OR S42 OR S43 OR S44 OR 
S45 OR S46 OR S47
S49 S33 AND S48
S50 S20 AND S32
S51 S49 OR S50
Embase





5. (rough adj sleep*).ti,ab,kw. 
6. "street person".ti,ab,kw. 
7. "street people".ti,ab,kw. 
8. vagrant*.ti,ab,kw. 
9. "no fixed abode".ti,ab,kw. 
10. (transient adj3 (people or person* or adult* 
or man or men or woman or women or 
individual* or population* or group* or 
communit*)).ti,ab,kw. 
11. (shelter adj (seek* or using or need*)).
ti,ab,kw. 
12. "shelter use".ti,ab,kw. 
13. "unstabl* hous*".ti,ab,kw. 
14. unshelter*.ti,ab,kw. 
15. ((emergency or temporary or overnight or 





19.  ((without or lack) adj2 (home* or housing or 
house)).ti,ab,kw. 
20. or/1-19 
21. ((Drug* or substance* or polydrug or "poly-
drug" or "legal high*" or psychoactive* or 
"psycho-active*" or psychotropic*) adj4 
(use* or abus* or misuse* or "mis-use*" or 
refus* or problem* or taking or take* or 
experiment* or addict*)).ti,ab,kw. 
22. ((ketamine or speed or spice or cocaine 
or crack or mushroom* or solvent* or 
inhalant or "nitrous oxide" or "laughing 
gas" or benzodiazepine* or tranquiliser* 
or tranquilizer* or opioid* or opiate*or 
hallucinogen* or "anabolic steroid*" or 
gabapentin or pregabalin or etizolam or 
valium) adj4 (use* or abus* or misuse* or 
"mis-use*" or refus* or problem* or taking or 
take* or experiment* or addict*)).ti,ab,kw. 
23. (Cannab* or marijuana or skunk or 
ecstasy or MDMA or LSD or "lysergic 
acid diethylamide" or amphetamine* or 
amfetamin* or mephedrone or mkat or 
"meow meow" or meth or methamphetamine 
or methamfetamin* or psychedelic* or pcp 
or phencyclidine or "anabolic steroid*" or 
ped or peds or pied or pieds or "performance 
enhancing" or "image enhancing" or heroin 
or poppers or "amyl nitrate" or "butyl nitrate" 
or "new psychoactive drug*" or "novel 
psychoactive drug*" or "novel psychoactive 
substance*" or NPS or "harm reduction" or 
detox*).ti,ab,kw. 
24.  exp street drug/ 
25.  exp designer drug/ 
26. exp cannabis addiction/ 
27. exp drug seeking behavior/ 
28. exp performance enhancing substance/ 
29. exp drug dependence/ 
30. exp amphetamine dependence/ 
31. exp cocaine dependence/ 
32. exp inhalant abuse/ 
33. exp opiate addiction/ 
34. exp phencyclidine abuse/ 
35. exp substance abuse/ 
36. exp cannabis smoking/ 
37. exp drug abuse/ 
38. or/21-37 
39. 20 and 38 
40. limit 39 to (meta analysis or "systematic 
review") 
41. "systematic review".ti,ab,kw. 
42. "evidence synthesis".ti,ab,kw. 
43. "realist review".ti,ab,kw. 
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44. "realist synthesis".ti,ab,kw. 
45. "meta analysis".ti,ab,kw. 
46. "mixed methods review".ti,ab,kw. 
47. "meta-synthesis".ti,ab,kw. 
48. "mixed methods synthesis".ti,ab,kw. 
49. "qualitative synthesis".ti,ab,kw. 
50. ("meta-epidemiolog*" or meta-ethnograph*).
ti,ab,kw. 
51. "cochrane review".ti,ab,kw. 
52. "integrative review".ti,ab,kw. 
53. "umbrella review".ti,ab,kw. 
54. "critical interpretive synthesis".ti,ab,kw. 
55. or/41-54 
56. 39 and 55 
57. 40 or 56
PscyINFO




5. (rough adj sleep*).ti,ab,id. 
6. "street person".ti,ab,id. 
7. "street people".ti,ab,id. 
8. vagrant*.ti,ab,id. 
9. "no fixed abode".ti,ab,id. 
10. (transient adj3 (people or person* or adult* 
or man or men or woman or women or 
individual* or population* or group* or 
communit*)).ti,ab,id. 
11. (shelter adj (seek* or using or need*)).
ti,ab,id. 
12. "shelter use".ti,ab,id. 
13.  "unstabl* hous*".ti,ab,id. 
14. unshelter*.ti,ab,id. 
15. ((emergency or temporary or overnight or 





19. ((without or lack) adj2 (home* or housing or 
house)).ti,ab,id. 
20. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 
11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19
21. ((Drug* or substance* or polydrug or "poly-
drug" or "legal high*" or psychoactive* or 
"psycho-active*" or psychotropic*) adj4 
(use* or abus* or misuse* or "mis-use*" or 
refus* or problem* or taking or take* or 
experiment* or addict*)).ti,ab,id. 
22. ((ketamine or speed or spice or cocaine 
or crack or mushroom* or solvent* or 
inhalant or "nitrous oxide" or "laughing 
gas" or benzodiazepine* or tranquiliser* 
or tranquilizer* or opioid* or opiate*or 
hallucinogen* or "anabolic steroid*" or 
gabapentin or pregabalin or etizolam or 
valium) adj4 (use* or abus* or misuse* or 
"mis-use*" or refus* or problem* or taking or 
take* or experiment* or addict*)).ti,ab,id. 
23. (Cannab* or marijuana or skunk or 
ecstasy or MDMA or LSD or "lysergic 
acid diethylamide" or amphetamine* or 
amfetamin* or mephedrone or mkat or 
"meow meow" or meth or methamphetamine 
or methamfetamin* or psychedelic* or pcp 
or phencyclidine or "anabolic steroid*" or 
ped or peds or pied or pieds or "performance 
enhancing" or "image enhancing" or heroin 
or poppers or "amyl nitrate" or "butyl nitrate" 
or "new psychoactive drug*" or "novel 
psychoactive drug*" or "novel psychoactive 
substance*" or NPS or "harm reduction" or 
detox*).ti,ab,id. 
24.  exp Drug Abuse/ 
25. exp Designer Drugs/ 
26. exp Drug Dependency/ 
27. exp Marijuana Usage/ 
28. exp Drug Seeking/ 
29. exp Drug Addiction/ 
30. exp Performance Enhancing Drugs/ 
31. exp "Substance Use Disorder"/ 
32. exp Inhalant Abuse/ 
33. exp "Substance Use Treatment"/ 
34. or/21-33 
35. 20 and 34 
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36. "systematic review".ti,ab,id. 
37. "evidence synthesis".ti,ab,id. 
38. "realist review".ti,ab,id. 
39. "realist synthesis".ti,ab,id. 
40. "meta analysis".ti,ab,id. 
41. "mixed methods review".ti,ab,id. 
42. "meta-synthesis".ti,ab,id. 
43. "meta-synthesis".ti,ab,id. 
44. "qualitative synthesis".ti,ab,id. 
45.  ("meta-epidemiolog*" or meta-ethnograph*).
ti,ab,id. 
46. "cochrane review".ti,ab,id. 
47. "integrative review".ti,ab,id. 
48. "umbrella review".ti,ab,id. 
49. "critical interpretive synthesis".ti,ab,id. 
50. 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 
44 or 45 or 46 or 47 or 48 or 49 
51. 35 and 50 
CDSR





#5 (rough NEAR sleep*):ti,ab 
#6 "street person":ti,ab 
#7 "street people":ti,ab 
#8 vagrant*:ti,ab 
#9 "no fixed abode":ti,ab 
#10 (transient NEAR/3 (people or person* or 
adult* or man or men or woman or women
 or individual* or population* or group* or 
communit*)):ti,ab 
#11 (shelter NEAR (seek* or using or need*)) 
#12 "shelter use":ti,ab 
#13 "unstabl* hous*":ti,ab 
#14 unshelter*:ti,ab 
#15 ((emergency or temporary or overnight or 
housed or intermittent or night) NEAR




#19 ((without or lack) NEAR/2 (home* or housing 
or house)):ti,ab 
#20 {OR #1-#19} 
#21 ((Drug* or substance* or polydrug or "poly-
drug" or "legal high*" or
 psychoactive* or "psycho-active*" or 
psychotropic*) NEAR/4 (use* or abus* or 
misuse* or
 "mis-use*" or refus* or problem* or taking or 
take* or experiment* or
 addict*)):ti,ab 
#22 ((ketamine or speed or spice or cocaine or 
crack or mushroom* or solvent* or
 inhalant or "nitrous oxide" or "laughing gas" or 
benzodiazepine* or tranquiliser* or
 tranquilizer* or opioid* or opiate*or 
hallucinogen* or "anabolic steroid*" or 
gabapentin
 or pregabalin or etizolam or valium) NEAR/4 
(use* or abus* or misuse* or "mis-use*" or
 refus* or problem* or taking or take* or 
experiment* or addict*)):ti,ab 
#23 (Cannab* or marijuana or skunk or ecstasy or 
MDMA or LSD or "lysergic acid
 diethylamide" or amphetamine* or 
amfetamin* or mephedrone or mkat or 
"meow
 meow" or meth or methamphetamine or 
methamfetamin* or psychedelic* or pcp or
 phencyclidine or "anabolic steroid*" or ped 
or peds or pied or pieds or "performance
 enhancing" or "image enhancing" or heroin or 
poppers or "amyl nitrate" or "butyl
 nitrate" or "new psychoactive drug*" or "novel 
psychoactive drug*" or "novel
 psychoactive substance*" or NPS or "harm 
reduction" or detox*):ti,ab 
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#24 MeSH descriptor: [Street Drugs] explode all 
trees 
#25 MeSH descriptor: [Designer Drugs] explode all 
trees 
#26 MeSH descriptor: [Marijuana Abuse] explode 
all trees 
#27 MeSH descriptor: [Drug-Seeking Behavior] 
explode all trees 
#28 MeSH descriptor: [Performance-Enhancing 
Substances] explode all trees 
#29 MeSH descriptor: [Substance-Related 
Disorders] explode all trees 
#30 MeSH descriptor: [Amphetamine-Related 
Disorders] explode all trees 
#31 MeSH descriptor: [Cocaine-Related 
Disorders] explode all trees 
#32 MeSH descriptor: [Inhalant Abuse] explode all 
trees 
#33 MeSH descriptor: [Marijuana Abuse] explode 
all trees
#34 MeSH descriptor: [Opioid-Related Disorders] 
explode all trees 
#35 MeSH descriptor: [Phencyclidine Abuse] 
explode all trees 
#36 MeSH descriptor: [Substance-Related 
Disorders] explode all trees 
#37 MeSH descriptor: [Marijuana Smoking] 
explode all trees 
#38 MeSH descriptor: [Drug Users] explode all 
trees 
#39 (Gordon, Grimmer et al. -#38) 
#40 #20 AND #390 
PROSPERO
#1  MeSH DESCRIPTOR Homeless Persons 
EXPLODE ALL TREES
#2 homeless* or undomiciled or houseless* or 
"rough sleep*" or shelter or "street person" 
or "street people" or vagrant* or "no fixed 
abode" or shelter or "unstabl* hous*" or 
hostel* or unshelter* or roofless* or destitute 
or runaway* or "without home*" or "without 
housing" or "without house" or "lack home*" 
or "lack housing" or "lack house"
#3 #1 OR #2
#4  Drug* or substance* or polydrug or "poly-
drug" or "legal high*" or psychoactive* 
or "psycho-active*" or psychotropic* or 
ketamine or speed or spice or cocaine 
or crack or mushroom* or solvent* or 
inhalant or "nitrous oxide" or "laughing 
gas" or benzodiazepine* or tranquiliser* 
or tranquilizer* or opioid* or opiate*or 
hallucinogen* or "anabolic steroid*" or 
gabapentin or pregabalin or etizolam or 
valium or Cannab* or marijuana or skunk 
or ecstasy or MDMA or LSD or "lysergic 
acid diethylamide" or amphetamine* or 
amfetamin* or mephedrone or mkat or 
"meow meow" or meth or methamphetamine 
or methamfetamin* or psychedelic* or pcp 
or phencyclidine or "anabolic steroid*" or 
ped or peds or pied or pieds or "performance 
enhancing" or "image enhancing" or heroin 
or poppers or "amyl nitrate" or "butyl nitrate" 
or "new psychoactive drug*" or "novel 
psychoactive drug*" or "novel psychoactive 
substance*" or NPS or "harm reduction" or 
detox* 
#5 MeSH DESCRIPTOR Street Drugs EXPLODE 
ALL TREES 
#6 MeSH DESCRIPTOR Designer Drugs EXPLODE 
ALL TREES  
#7 MeSH DESCRIPTOR Marijuana Abuse 
EXPLODE ALL TREES  
#8 MeSH DESCRIPTOR Drug-Seeking Behavior 
EXPLODE ALL TREES  
#9 MeSH DESCRIPTOR Performance-Enhancing 
Substances EXPLODE ALL TREES 
#10 MeSH DESCRIPTOR Substance-Related 
Disorders EXPLODE ALL TREES  
#11 MeSH DESCRIPTOR Amphetamine-Related 
Disorders EXPLODE ALL TREES  
#12 MeSH DESCRIPTOR Cocaine-Related 
Disorders EXPLODE ALL TREES  
#13 MeSH DESCRIPTOR Inhalant Abuse EXPLODE 
ALL TREES
#14 MeSH DESCRIPTOR Marijuana Abuse 
EXPLODE ALL TREES 
#15 MeSH DESCRIPTOR Opioid-Related Disorders 
EXPLODE ALL TREES 
#16 MeSH DESCRIPTOR Phencyclidine Abuse 
EXPLODE ALL TREES
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#17 MeSH DESCRIPTOR Substance Abuse, 
Intravenous EXPLODE ALL TREES 
#18 MeSH DESCRIPTOR Marijuana Smoking 
EXPLODE ALL TREES 
#19 MeSH DESCRIPTOR Drug Users EXPLODE ALL 
TREES 
#20 #19 OR #18 OR #17 OR #16 OR #15 OR #14 OR 
#13 OR #12 OR #11 OR #10 OR #8 OR #9 OR 
#7 OR #6 OR #5 OR #4 
#21 #3 AND #20
Epistemonikos
(homeless* OR undomiciled OR houseless* OR 
"rough sleep*" OR shelter OR "street person" 
OR "street people" OR vagrant* OR "no fixed 
abode" OR transient OR "unstabl* hous*" OR 
hostel* OR unshelter* OR roofless* OR destitute 
OR runaway* OR "without home*" OR "without 
housing" OR "without house" OR "lack home*" OR 
"lack housing" OR "lack house") AND (Drug* OR 
substance* OR polydrug OR "poly-drug" OR "legal 
high*" OR psychoactive* OR "psycho-active*" OR 
psychotropic* OR ketamine OR speed OR spice OR 
cocaine OR crack OR mushroom* OR solvent* OR 
inhalant OR "nitrous oxide" OR "laughing gas" OR 
benzodiazepine* OR tranquiliser* OR tranquilizer* 
OR opioid* OR opiate*or hallucinogen* OR 
"anabolic steroid*" OR gabapentin OR pregabalin 
OR etizolam OR valium OR Cannab* OR marijuana 
OR skunk OR ecstasy OR MDMA OR LSD OR 
"lysergic acid diethylamide" OR amphetamine* 
OR amfetamin* OR mephedrone OR mkat OR 
"meow meow" OR meth OR methamphetamine 
OR methamfetamin* OR psychedelic* OR pcp 
OR phencyclidine OR "anabolic steroid*" OR ped 
OR peds OR pied OR pieds OR "performance 
enhancing" OR "image enhancing" OR heroin OR 
poppers OR "amyl nitrate" OR "butyl nitrate" OR 
"new psychoactive drug*" OR "novel psychoactive 
drug*" OR "novel psychoactive substance*" OR NPS 
OR "harm reduction" OR detox* OR "drug* use*" 
OR "drug* abuse*" OR "drug* misuse" OR "drug* 
mis-use*" OR "drug* addict*" OR "drug* taker" OR 
"drug taking" OR "drug* problem*" OR "substance* 
use*" OR "substance* abuse*" OR "substance* 
misuse" OR "substance* mis-use*" OR "substance* 
addict*" OR "substance* problem*" OR "substance* 
taker" OR "substance taking" OR polydrug OR 
"poly-drug" OR "legal high*" OR psychoactive* OR 
"psycho-active*" OR psychotropic*) 

























 1. Homeless also retrieves records with homelessness
 2. Cannot search using truncation *
 3. This database cannot process long search strings
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NIHR Journals Library cannot process long search strings, so 
each term was searched separately
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Appendix 5.  




Review (including systematic review, meta-analysis, evidence 
synthesis, realist review, mixed methods review, qualitative 
synthesis, meta-epidemiology, integrative review, umbrella 




People experiencing homelessness and drug use (including 
polysubstance use)
Range of drugs used problematically and/or recreationally, 
including performance and image enhancing drugs
Adults (aged 18 years or over, with no upper age limit)
People who are not deemed homeless; alcohol use only 
Non-drug use 
People aged under 18
Interventions
Problem drug use treatment (including polysubstance use)
Harm reduction approaches
Interventions in primary care for drug use
Interventions in mental health settings for drug use
Residential rehabilitation
Detoxification




Reduced overdoses (fatal and non-fatal)
Reduced drug-related harm
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Appendix 6.  
Final inclusion decisions 
for identified papers



















use but explored 
cost analyses 
and various 
clinical and social 
outcomes.
Systematic review 
of the type and 
effectiveness of 
interventions to 
reduce the number 









Only 3/11 looked 
at homelessness 
and substance use 
(together).
Three of the 11 studies 
reported clinical outcomes, 
and each of these tested 
case management. One 
study demonstrated a 
significant reduction both in 
alcohol use and drug use 12 
months after intervention, 
another study identified 
a reduction in alcohol 
use but no difference in 
psychiatric symptoms 24 
months after intervention. 
The third study did not 
find differences in either 
drug or alcohol use. Social 
outcomes were reported in 
the same three studies. All 









– population of 










its Use with the 
Homeless.
IPS for the 
homeless.
Systematic review; 
at least 30% 
participants in 
each study have to 
be homeless. Ten 
studies.
Ten studies. The samples 
had high rates of substance 
use and it was generally 
found that a peer 
intervention reduced harm 
related to addiction. Half 
of the included studies 
report positive outcomes in 
reducing drug and alcohol 
use and reducing relapse 






















































status, and family 
reunification.
Systematic review, 
six studies. Had to 
include “homeless 
families” defined 
as (a) parent(s) – 
mothers, fathers, 
or other primary 
caretakers (e.g. 
grandparents) – 
accompanied by at 
least one child aged 
under 18 years; (b) 
pregnant mothers; 
and (c) children 
aged under 18 years 
accompanied by at 
least one parent.
Rates of parental mental 
health and substance 
use were underreported 
because several of the 
programmes excluded 
families with these 
problems. For example, 
in one study, 89% of 
transitional housing 
programmes did not 
enrol families with active 
substance use issues, 
22% required at least 
6 months of sobriety 
before admission, and 
some required one year 
or more. Because of 
major differences in the 
programmes, insufficient 
information about the 
nature of the interventions, 
and methodological 
limitations in the evaluation 
design of individual studies, 
inferential conclusions 
about programme 







and youth which 
we have decided 
to exclude in 
our inclusion/
exclusion criteria. 
Not much data 
on substance 
























RCTs for the 
effects of HF 
on health and 
well-being. 
Extracted data 




and quality of 
life; substance 
use; non-routine 






The impact of HF on 
most short-term health 
outcomes was imprecisely 
estimated, with varying 
effect directions. No clear 
difference in substance 
use was seen. Intervention 






























the HF approach 
be effective in 
response to 
the needs of 
homeless people 
with mental health 




The HF approach has 
effects similar to those 
of usual services and 
traditional psychosocial 
interventions on mental 
health, physical health, and 
substance use. None of 
the included studies found 
a significant difference 
between HF and non-HF 







mental health or 
substance use 
problems.
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research in the 








mental illness and 
the effect of these 
programmes on 
housing status and 
mental health.
Systematic review, 14 
studies.
Seven of the 14 studies 
reported mixed clinical and 
substance use outcomes. 
One study reported that 
the experimental housing 
condition was associated 
with a reduction in 
substance use; another 
found no difference in 
substance use because 
substance use declined 
in both conditions. Four 
studies found that the 
preferred housing condition 
did not yield any advantage 
in clinical outcomes 
over the comparison or 
control condition, either 
because no improvements 
were found or because 
both experimental and 














we are aware 
that there is a 





































or a qualitative 
evidence synthesis 
with a well-defined 
control group were 
eligible for inclusion. 
Thirteen studies 
met the inclusion 
criteria, with six 
studies contributing 
data on three 
independent studies. 
In total, 10 studies 
were included in the 
review.
Analyses did not reveal 
any statistically significant 
differences for the 
primary outcome of 
drug use between 12-
step programmes and 
the alternative set of 
interventions. The results 
of this review suggest that 
12-step interventions to 
support illicit drug users are 
as effective as alternative 
psychosocial interventions 
in reducing drug use.
Review 
excluded.




was a secondary 
outcome, 
because “None 





(Bøg, 2017, p. 35).
Brunette et al. 
(2004)






















of 10 focused on 
homeless people.
Ten controlled studies 
suggest that greater levels 
of integration of substance 
abuse and mental health 




50% of the 
studies are about 
homeless people. 
All studies report 
on substance use 
outcomes.
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Participants in all types 
of interventions had a 
preference for harm 
reduction-oriented 
services and considered 
treatment effective when 
it provided a facilitative 
service environment; 
compassionate and non-
judgemental support; time; 
choices; and opportunities 
to (re)learn how to live. 








are relevant to 
our question.
Carver  


























Participants in all types 
of interventions had a 
preference for harm 
reduction-oriented 
services and considered 
treatment effective when 
it provided a facilitative 
service environment; 
compassionate and non-
judgemental support; time; 
choices; and opportunities 
to (re)learn how to live. 








are relevant to 
our question.
Chambers  
et al.  
(2017)
Systematic 

















to improving the 
lives of adults who 
are vulnerable 
in relation to 




adults). Did not 









or carers, and 
providers of housing 
services. Studies 
had to include 
an intervention 
designed to avoid 
homelessness or 
unstable housing and 
report outcomes 




included those who 
were homeless 
or had a history 
of homelessness, 
people with a 
history of mental 
illness, people with 
a learning disability, 
refugees and recent 
immigrants, young 
people leaving care, 
and ex-prisoners.
Strong evidence that HF can 
improve housing stability 
and measures of physical 
health in the short term. 
Evidence was classed as 
moderate for positive 
effects on personal well-
being, mental health, and 
locality-related well-being 
(i.e. well-being related 
directly to one’s living 
situation and conditions) 
and for absence of effect 
on personal finance and 
community well-being. 
Strength of evidence 
for other outcomes was 
rated as low or very low. 
Research identified a range 
of factors that can affect 
the effectiveness of HF, 
including fidelity to core 
components and whether 
the service is delivered in 
one place or service users 
are dispersed in separate 
apartments. Other complex 
interventions provide an 
opportunity for recovery 
but not everyone benefits.
Review 
included.
Focus is on 
people who 
are homeless 
or at risk of 
homelessness 
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de Vet  






































literature on SCM,  
ICM, Assertive 
Community 
Treatment (ACT), and 





from 1985 to 2011 
and found 21 RCTs or 
quasi-experimental 
studies comparing 
case management to 
other services.
Four studies of SCM, 
whose participants were 
homeless people with 
substance use problems, 
assessed substance use 
outcomes, as reported in 
three articles. All but one 
found differential effects, 
suggesting that SCM was 
significantly more effective 
than referral to community 
services in reducing alcohol 
and drug use among 
homeless substance users. 
Four of six studies of the 
effect of ICM on alcohol 
or drug use did not show 
a positive impact. Five 
studies, which produced 
eight articles with alcohol 
and drug use outcomes, 
concluded that ACT did 
not significantly affect 
substance use or related 
problems. One study on 
CTI looked at substance 
use variables. In a sample 
of mentally ill homeless 
veterans, those offered 
CTI improved more with 
regard to alcohol and drug 
use than participants who 
received usual services. 
Furthermore, participants 
in the CTI group spent less 
money on these substances.
Review 
included.









the health and 
housing status 
of homeless 








that have been 
shown to improve 
the health of 
homeless people, 
with focus on the 




of five electronic 
databases, a hand 
search of grey 
literature and 
relevant journals, 
and contact with 
experts. Eighty-four 
studies. 
For homeless people with 
mental illness, provision 
of housing upon hospital 
discharge was effective 
in improving sustained 
housing. For homeless 
people with substance 
abuse issues or concurrent 
disorders, provision of 
housing was associated with 
decreased substance use, 
relapses from periods of 
substance abstinence, and 
health services utilisation, 
and increased housing 
tenure. Abstinence-
dependent housing was 
more effective in supporting 
housing status, substance 
abstinence, and improved 
psychiatric outcomes 
than non-abstinence-
dependent housing or 
no housing. Provision of 
housing also improved 
health outcomes among 





It seems unclear 
how many papers 
actually looked 
at homeless 
people who use 
substances. A 
table seems to 
list 12 papers 
under this 
heading but 
review only talks 
about 10/84 
studies because 
of quality (74 
were low quality). 


















and review the 










patients (or majority 
homeless patients) 
that recruited 
patients at the 
level of the ED. 
Included studies 
had a control group 
or were a pre-/
post-intervention 
trial, and measured 
outcomes that 
reflected the health 
(including access 




included case management, 
HF initiatives, substance 
use interventions, ED-
based resource desks, and 
ED compassionate care. 
Eight studies sought to 
improve access to housing; 
two were HF initiatives (all 
patients housed). The other 
six studies demonstrated 
significant reductions 
in homelessness and 
increased access to stable 
housing. Six of 13 studies 
focused on homeless 
patients using substances. 
One evaluated extended-
release naltrexone and 
found the intervention 
feasible in a homeless 
demographic. Three case 
management interventions 
reported reductions in 
alcohol and substance use 
and enrolment in substance 
abuse treatment. One study 
evaluated opioid overdose 
education as a harm 
reduction initiative but 








people who use 
substances.
Hwang  



















from 1988 to 2004 
met inclusion 
criteria (use of an 
intervention, use of 
a comparison group, 
and the reporting 
of health-related 
outcomes).
For homeless people 
with mental illness, case 
management linked to 
other services was effective 
in improving psychiatric 
symptoms, and assertive 
case management was 
effective in decreasing 
psychiatric hospitalisations 
and increasing outpatient 
contacts. For homeless 
people with substance 
abuse problems, case 
management resulted 
in greater decreases in 









Twenty of 45 





























A review but not 
systematic as it does 
not report how 
many studies were 
included.
According to reviews of 
comparative trials and 
case series reports, HF 
reports document excellent 
housing retention, despite 
the limited amount of data 
pertaining to homeless 
clients with active and 
severe addiction. Several 
linear programmes cite 
reductions in addiction 
severity but have 
shortcomings in long-







who use drugs 
but the study 
does not report 
how many papers 
were included in 
the review, so low 
quality.
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prevention, housing and 
social determinants, and 
‘other’ interventions. 
Identified numerous 
interventions to improve 
physical and mental 
health, and substance use; 
however, evidence is scarce 
for structural interventions, 
including housing, 
employment, and legal 
support that can prevent 








but only 14% 
(11/77) are about 
homelessness 
and only 3 




use. The studies 
on substance use 
do not report on 
homelessness. 










review on the 
acceptability of 








the factors that 
influence the 
acceptability of 




























that individuals were 
marginalised, dehumanised, 
and excluded by their lived 
homelessness experience. 
Lived experience of 
homelessness influenced 
attitudes towards health and 
social service professionals 
and sometimes led to 
reluctance to accept 
interventions. Physical 
and structural violence 
intersected with low self-
esteem, depression, and 
homeless-related stigma. 
Positive self-identity 
facilitated links to long-term 
and integrated services, 















as young as 14 
years old. 
O’Campo  
































why and how they 








elements that lead 
to improvements 
in mental health 













experiencing CDs that 
employed a variety of 
approaches including 
ACT, provision of housing, 
integrated mental health 
and substance use 
treatment, and a holistic 
approach through which 
many of the clients’ life 
needs were supported. 
Most programmes 
delivered a combination of 
programme strategies or 
took different approaches 
to the same strategies. Many 
of the studies identified 
autonomy as a central 
factor in motivation for and 



























Aims to assess 
the effectiveness 
of ACT for 
patients with 











Systematic review of 
ACT interventions 
for patients with SUD 
by analysing RCTs 
published before 
June 2017 found 





using five datasets 
were included in the 
meta-analysis.
Two of five datasets 
included homeless patients 
and two of five datasets 
included patients with high 
service use. The results 
of the very few existing 
RCTs are mixed. Treatment 
engagement was higher 
for ACT in four datasets. 
Substance use reduced only 
in half of the datasets, of 
which only one showed a 




































may also be 
shaped by housing 
programmes.
Not a systematic 
review – pooled 
analysis of three 
separate RCTs of 
CM.
Those who accessed 
housing programmes 
submitted a higher 
percentage of negative 
samples (75%) compared to 
those who did not access 
housing programmes 
(67%). Regardless of 
housing status, CM was 
associated with longer 
durations of abstinence 
and treatment retention. 
No interactive effects of 
housing and treatment 
condition were observed 
(p>0.05). Results suggest 
that those who accessed 
housing programmes during 
substance abuse treatment 
benefit from CM to a 
comparable degree as their 






who use drugs; 
however, in terms 
of methodology, 
it was not a 
systematic review 
but a pooled 
analysis of three 
datasets. 















for clients with 
COSMHAD. One of 
the three studies 
is a ‘homelessness 
study’.
Paper presents a 
meta-analysis of 
data from three 
studies examining 
the effectiveness 
of MTC treatment 
for clients with 
COSMHAD. Measures 








Moderate, significant, and 
consistent effects across 
the studies favouring the 
MTC emerged for the 
substance abuse domain. 
Specifically, significant MTC 
treatment effects emerged 
for substance abuse and 
employment in Study 1 
(homeless people), for 
substance abuse, crime, 
and employment in Study 
2 (offenders), and for 
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housing and work 
therapy and day 
treatment (DT) 








(2 and 6 months). 
The clinical trials 
were conducted 
from 1990 to 2006 
in Birmingham, 
Alabama, with a total 
of 644 homeless 
persons with primary 
crack cocaine 
addiction.
The results of the meta-
analysis show that both CM 
and DT are beneficial in 
producing abstinence, but 
the CM treatment appears 









However, it was 
a meta-analysis 
and not a review.
Smith  















SUDs. At the 
core of CRA is 
the belief that 
an individual’s 
environment 




drinking and drug 
use.
Review but not 
systematic. Talks 
about evidence 
for the CRA split 
into: meta-analytic 





illicit drug studies; 
and Community 
Reinforcement 
and Family Training 
(CRAFT).
One study explicitly called 

























Aim was to 
undertake a 
systematic 




















building. Types of 
services included 
case management, 
clinics, and mobile 
or static services. 
Service providers 
included all health 
professionals.
Systematic review, 
six studies included. 
The methodologies 
included the 
following: RCTs (2), 
quasi-experimental 
(3), and comparative 
study (1). Due 
to the diversity 
of the designs, 
measurement tools, 
interventions, and 
outcomes of these 
studies, narrative 
synthesis was used 
to appraise their 
effectiveness.
Study interventions such 
as structured education 
and support sessions (with 
and without advocates 
or support persons) and 
therapeutic communities 
reduced psychological 
distress and healthcare use, 
improved self-esteem, and 
reduced drug and alcohol 
use within some limitations.
Cognitive behavioural 
therapy (CBT) influenced 
drug and alcohol behaviours 
of women. Negotiation 
skills and coping methods 
for the challenges of street 
life helped women make 
decisions about drug 
and alcohol use, sexual 
risk behaviours, and the 









– across the six 
















the basis of a 
literature review.
Literature review 
on databases. Does 
not state how many 
studies included, 
so not a systematic 
review – not 
following PRISMA 
guidelines.
Four components emerged 
from a literature review: 
(1) ensuring an effective 
transition for individuals 
with COSMHAD from 
an institution (such as a 
hospital, foster care, prison) 
into the community; (2) 
increasing the resources 
of homeless individuals 
with COSMHAD by helping 
them apply for government 
entitlements or supported 
employment; (3) linking 
homeless individuals to 
supportive housing, as 
opposed to only treatment-
first options, and being 
flexible in meeting their 
housing needs; and 
(4) engaging homeless 
individuals in COSMHAD 
treatment, incorporating 
modified ACT, Motivational 





Does not state 
how many studies 
were included, 
thus low quality.
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mixed design studies, 
both primary and 
secondary. Articles 
published in the last 
10 years, written 
in English, French, 
or Spanish. Fifteen 
articles included. 
Results divided into case 






people who use 
substances.
Turner et al. 
(2011)
The impact 




therapy on the 
incidence of 
hepatitis C virus 
in injecting drug 























sharing and the 
mean number of 
injections in the 
last month).
Meta-analysis and 
pooled analysis, with 
logistic regression 
allowing adjustment 




United Kingdom (UK) 
studies included. 
Between 32% and 
62% “homeless in 
the past year” in the 
study samples.
Using pooled data from the 
UK, demonstrated that harm 
reduction interventions 
(namely OST and high NSP 
coverage) can reduce HCV 
transmission among PWID. 
Full harm reduction was 
associated with a reduction 
in self-reported needle 
sharing by 48% and mean 





























between 1993 and 
2003, focusing 
on the effects 
of different 










Results show that several 
studies have reported 
positive effects, but 
only some RCTs have 
demonstrated the 
effectiveness of case 
management compared 
with other interventions. 
Longitudinal effects of this 
intervention remain unclear. 
Review 
excluded.
27% look at 
homeless people.
www.hrb.ie98










the health needs 
of homeless 
people?




pertaining to the 
healthcare of 
homeless people 




Review and synthesis 
of current evidence. 
Does not say how 
many papers/
studies included, but 
searched databases. 
Effective interventions for 
drug dependence include 
adequate oral opiate 
maintenance therapy, 
hepatitis A and B and 
tetanus immunisation, 
safer injecting advice, 
and access to needle 
exchange programmes. 
There is emerging evidence 
for the effectiveness of 
supervised injecting rooms 
for homeless injecting drug 
users and for the peer 
distribution of take-home 
naloxone in reducing 
drug-related deaths. 
There is some evidence 
that assertive outreach 
programmes for those with 
mental ill health, supportive 
programmes to aid those 
with motivation to address 
alcohol dependence, and 
informal programmes to 
promote sexual health can 
lead to lasting health gains.
Review 
included.
Quality is an 
issue; paper does 




is a lot of data 
reported in 






and drug use 






Objective of this 
research project 
was to examine 
the effectiveness 















users. Of 99 papers 
identified, only 6 
fulfilled the inclusion 
criteria.
Interventions which seek 
to effect attitudinal and 
behavioural change through 
interactive methods such as 
role-playing, video games, 
and group work led to a 
self-reported reduction in 
both risk from drugs and 
sexual activity. The evidence 
for maintenance of risk 




Focus is not 
specifically on 
substance use – 
the interventions 
are about sexual 
health – but 
the population 
is homeless 
people who use 
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International evidence regarding interventions in 
primary care, mental health, and drug treatment 
settings for homeless people who use drugs: grey 
literature search
Scotland 
Scottish Health Action on Alcohol Problems 
Search ‘homeless’ or ‘homelessness’
2 results: 
Neither relevant for the review (one summary of a 
talk, one report on minimum unit pricing)
NHS Health Scotland  
Search ‘homeless’
23 results:  




(full text downloaded, but not relevant)
Search ‘homelessness’ and ‘drugs’ and ‘drug 
treatment’ and ‘substance use’
Nothing extra
Healthcare Improvement Scotland 
Search ‘homeless’ or ‘homelessness’
2 results:  
Nothing about drug treatment





Waugh, A., Clarke, A., Knowles, J., & Rowley, D. (2018). 
Health and homelessness in Scotland: research.
https://www.gov.scot/publications/health-
homelessness-scotland/ 
(full text downloaded) 
Scottish Government (2005) 
Health and homelessness standards. 
https://www.gov.scot/publications/health-
homelessness-standards/ 
(full text downloaded) (not relevant as it is not 
explicitly about substance use treatment)
Search ‘homelessness’ 
229 results:  
Scottish Government (2016)  
Understanding the patterns of use, motives, and 







Audit Scotland (2019)  




Pleace, N. (2008)  
Effective services for substance misuse and 





Scottish Government (2018)  
Rights, Respect and Recovery: Alcohol and drug 
treatment strategy. 
Appendix 7.  
Organisations included in 






Resources > All SDF Publications > homelessness and 
housing
4 results: 
Scottish Drugs Forum (2019)  




(full text downloaded) (since it is mostly a toolkit, this 
probably is not helpful)
Scottish Drugs Forum (2010)  
Effective services for substance misuse and 





Resources > All SDF Publications > drug prevention 
and treatment
Nothing extra
Resources > All SDF Publications > harm reduction
Nothing extra
University of Stirling Salvation Army Centre for 
Addiction Services and Research Online Library 
Search ‘homeless’ or ‘homelessness’ 
12 results:  
Weal, R., & Orchard, B. (2018)  
Dying on the streets: The case for moving quickly to 
end rough sleeping 
https://www.mungos.org/publication/dying/ 
(full text downloaded)
Pleace, N. (2008)  
Effective services for substance misuse and 





Australian Government (2007)  
Homeless SAAP clients with mental health and 





Sacks, J.Y., Sacks, S., Harle, M., & De Leon, G. (1999) 
Homelessness Prevention TC for Addicted Mothers.
Alcoholism Treatment Quarterly, 17 (1-2), 33-51. 
(full text downloaded)
Sacks, S., Skinner, D., Sacks, J., & Peck, A. (2002) 
Manual for Engaging Homeless Mentally Ill Chemical 




Keane, M. (2007) 
Social reintegration as a response to drug use in 
Ireland: An overview. Drugnet Ireland, 24, 5-6.
https://www.drugsandalcohol.ie/11438/  
(full text downloaded)
Reeve, K., & Batty, E. (2011)  
The hidden truth about homelessness Experiences of 




Chartered Institute of Housing (2012)  







Evidence review of drug treatment services for people who are homeless and use drugs 101
Yates, R., Anderson, I., Wilson, J., Wilson, M., & 
Freedman, L. (2001) 
Trouble Every Way I Turn: Homelessness & Substance 




Institute for Research and Innovation in Social 
Services  
Search ‘homeless’ or ‘homelessness’
847 results:
Decision to narrow search due to number of results > 
search ‘homeless’ and ‘drugs’
190 results: 
Decision to narrow search due to number of results > 
search ‘homeless’ and ‘drug treatment’
35 results:  
Allcock, A., & Smith, L. (2018)  








(full text downloaded) (SR on interventions for women 
with complex needs, includes homelessness and 
substance use but is not about specific treatment, 
more what is important components of an 
intervention).
United Kingdom
Royal College of Psychiatrists 
Search ‘homeless’ or ‘homelessness’
22 results:  
Nothing relevant to substance use treatment
Royal College of Physicians 
Search ‘homeless’ or ‘homelessness’
13 results: 
Nothing relevant to substance use treatment
British Psychological Society 
Search ‘homeless’ or ‘homelessness’ 
Policy > research and impact > search ‘homeless’ 
0 results
Public Health England 
Search ‘homeless’ or ‘homelessness’
1,214 results: 
Decision to narrow search due to number of results > 
search ‘homeless’ and ‘drugs’
132 results: 
Decision to narrow search due to number of results > 
search ‘homeless’ and ‘drug treatment’
9 results: 
Nothing relevant for the review
Pathway: The Faculty of Homeless and Inclusion 
Health
Search ‘homeless’ or ‘homelessness’
16 results: 
Dorney-Smith, S., Burridge, S., Bell, J., Ellis, J., & 
Snowball, L. (2017)  
Digital health inclusion for people who have 






Hewett, N., & Dorney-Smith, S. (2013)  






Gazey, A., Vallesi, S., Cumming, C., & Wood, L. (2018)  
Royal Perth Hospital Homeless Team: A Report on 





We Are With You (formerly Addaction) 
Search ‘homeless’ or ‘homelessness’
www.hrb.ie102
29 results:  
Nothing relevant for this review (all short, blog post-
type reports)
Crisis 
Search ‘drugs’ (the rationale being that it is a 
homelessness organisation, so it would not be helpful 
to search for ‘homeless’ or ‘homelessness’)
14 results:  
Thomas, B. (2012)  
Homelessness kills: An analysis of the mortality 






Search ‘drugs’ (the rationale being that it is a 
homelessness organisation, so it would not be helpful 
to search for ‘homeless’ or ‘homelessness’)
16 results:  
Shelter (2006) 










19 results:  
Finlayson, S., Boelman, V., Young, R., & Kwan, A. (2015) 
Saving lives, saving money. How homeless health 





Groundswell (2012)  





Gorton, S., Manero, E., & Cochrane, C. (2004) 
Listening to homeless people: Involving homeless 





Search ‘drugs’ (the rationale being that it is a 
homelessness organisation, so it would not be helpful 
to search for ‘homeless’ or ‘homelessness’)
26 results:  
Nothing relevant for this review (all short blog post-
type reports)
Homeless Link 
Search ‘drugs’ (the rationale being that it is a 
homelessness organisation, so it would not be helpful 
to search for ‘homeless’ or ‘homelessness’)
130 results:  
Decision to narrow search due to number of results > 
search ‘drug treatment’
3 results:  
Nothing relevant for this review (all short blog post-
type reports)
The Salvation Army 
Search ‘homeless’ or ‘homelessness’ 
663 results:  
Decision to narrow search due to number of results > 
search ‘homeless’ and ‘drugs’
108 results:  
Nothing relevant for this review (all short reports/
news reports, etc.
Centre for Homelessness Impact 
Evidence tools > Evidence and gap maps:
2 results: 
Relevant systematic reviews but no grey literature (all 
published in academic journals)
Republic of Ireland 
Health Service Executive Addiction Services
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Search ‘homeless’ or ‘homelessness’
648 results:  
Decision to narrow search due to number of results > 
search ‘homeless’ and ‘drugs’
2,091 results (this shows that Boolean searching does 
not work for this site)
Search ‘drug review’
6 results:  




Nothing relevant for this review
Threshold 
Publications > Reports 
20 results:  
Nothing relevant for this review
Crosscare 
Search ‘homeless’
2 results:  




Resource Hub > Publications and Partnerships > 
Research
25 results:  
Houghton, F.T., & Hickey, C. (2001) 
Caught in a trap. The Long-term Homeless: A Profile 







Our work > Reports & Publications
15 results:  
S3 Solutions (2019).  
Contextualized study of current trends of the alcohol 
and drug environment within the Western Trust area.
https://ie.depaulcharity.org/reports-publications 
(full text downloaded)
Ana Liffey Drug Project 
Resources > Research 
3 results:  
Nothing relevant for this review 
Resources > Reports 
15 results: 
Nothing relevant for this review
Merchants Quay Ireland  
Media Hub > Submissions and Policies 
3 results:  
Nothing relevant for this review
Peter McVerry Trust  
Search ‘drugs’ (the rationale being that it is a 
homelessness organisation, so it would not be helpful 
to search for ‘homeless’ or ‘homelessness’)
0 results 
Search ‘drug treatment’
1 result:  
Nothing relevant for this review
Safetynet 
Press (only available option for searching 
publications, reports, etc.)
19 results:  
Nothing relevant for this review
Simon Communities 
Publications > Research > Drugs research 
18 results:  
Good Shepherd Services & Simon Community (2011) 
Women’s Health and Homelessness in Cork: A Joint 
Snapshot Study of the Health and Related Needs of 






Health Research Board 
Publications > Alcohol & drugs > Deaths figure + 
Drugs research + Treatment figures 
77 results: 
Bates, G., Jones, L., Maden, M., Cochrane, M., 
Pendlebury, M., & Sumnall, H. (2017)  
The effectiveness of interventions related to the 
use of illicit drugs: prevention, harm reduction, 





Minyard, K., Manteuffel, B., Smith, C.M., Attell, B.K., 
Landers, G., Schlanger, M., & Dore, E. (2019) 
Treatment services for people with co-occurring 






Connolly, J., Foran, S., Donovan, A.M., Carew, A.M., & 
Long, J. (2008) 
Crack cocaine in the Dublin region: an evidence base 




Partnership for Health Equity  
Search ‘homeless’ or ‘homelessness’
41 results: 
O’Reilly, F., Barror, S., Hannigan, A., Scriver, S., Ruane, 
L., MacFarlane, A., & O’Carroll, A. (2015) 






Centre for Social Research in Health 
Search ‘homeless’ or ‘homelessness’
57 results:  
MacKenzie, D., McNelis, S., Flatau, P., Valentine, K., & 
Seivwright, A. (2017) 
The funding and delivery of programmes to reduce 






Bullen, J. (2017)  










Mission Australia (2012)  
The Michael Project, 2007-2010: New perspectives 





Mission Australia (2012)  
How homeless men are faring: Baseline report 





(full text downloaded) 
Mission Australia (2013)  
Home safe and sound: MISHA 12 month report.





Silins, E., Sannibale, C., Larney, S., Mattick, R., & 
Wodak, A. (2006)  





Roxburgh, A., Degenhardt, L., Larance, B., & 
Copeland, J. (2005)  
Mental health, drug use and risk among female 





Kinner, S., & Fischer, J. (2004)  
Queensland Drug Trends 2003: Findings from the 





McKetin, R., Kelly, E., Indig, D., & McLaren, J. (2004)  
Characteristics of treatment provided for 





Cogger, S., Dietze, P., & Lloyd, B. (2013)  
Victorian Drug Trends 2012: Findings from the Illicit 





42 results:  
Williamson, A., Darke, S., Ross, J., & Teesson, M. (2003) 
Cocaine use among the ATOS NSW sample: 






Canadian Institute for Substance Use Research 
(Canada) 
Publications & resources > ‘homeless’ key word 
search
27 results:  
Nothing relevant with regard to drug treatment for 
people who are homeless 
Search ‘homelessness’ 
21 results: 
Nothing relevant with regard to drug treatment for 
people who are homeless
Homeless Hub/Canadian Observatory on 
Homelessness (Canada) 
About us > COH Publications > Reports 
32 results: 
Falvo, N. (2011)  






European Monitoring Centre for Drugs and Drug 
Addiction 
Publications > topic > Treatment
11 results: 
European Monitoring Centre for Drugs and Drug 
Addiction (2016) 
How can contingency management support 




(full text downloaded) (probably not helpful, as it only 
mentions homelessness in the reference list)
Strang, J., Groshkova, T., & Metrebian, N. (2012) 




(full text downloaded) (probably not helpful, as it only 
mentions homelessness once in the full paper)
European Observatory on Homelessness 
Search ‘drugs’ (the rationale being that the 
organisation has a focus on homelessness, so it 
would not be helpful to search for ‘homeless’ or 
‘homelessness’)
121 results: 
Pleace, N., & Quilgars, D. (2013) 





Ceannt, R., Macdonald, S.H-F., Fenton, J., & Larkan, 
F. (2016)  
Circles Within Circles: Dublin’s Frontline Homeless 
Sector Workers Discuss the Intersectional Issues of 




Anderson, I., Baptista, I., Wolf, J., Edgar, B., 
Benjaminsen, L., Sapounakis, A., & Schoibl, H. (2006) 
The Changing Role of Service Provision: Barriers of 









National Drug Evidence Centre 
Our research > publications
76 results: 
None relevant for this review. Mostly published 
papers, book chapters, and posters. There are also 
some commissioned reports, but none in relation to 
homelessness.
USA




Nothing relevant for this review (all articles only 
mention homelessness one or two times, and not in 
relation to treatment)
Search ‘homelessness’ 
12 results:  
Nothing extra
United Nations Office on Drugs and Crime 
(UNODC) 
Topics > Drug prevention, treatment and care > 
Publications > Publications on prevention of drug 
use and treatment, care and rehabilitation of drug 
dependence
48 results: 
European Monitoring Centre for Drugs and Drug 
Addiction and United Nations Office on Drugs and 
Crime (2019)  
Drug treatment systems in the Western Balkans 
Outcomes of A Joint EMCDDA-UNODC Survey Of 









(full text downloaded) (only briefly mentions 
homelessness, does not go into much depth about 
specific treatment)
Drug Dependence Treatment: Role In The Prevention 
And Care Of HIV And AIDS. 
https://www.unodc.org/docs/treatment/111_HIV.pdf  
(full text downloaded) (only briefly mentions 
homelessness, does not go into much depth about 
specific treatment)
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United Nations Office on Drugs and Crime (2008). 





(full text downloaded) (only briefly mentions 
homelessness, does not go into much depth about 
specific treatment)
World Health Organization 
Search ‘homeless’ or ‘homelessness’
118 results: 
Nothing relevant to drugs/substance use, only natural 
disasters or reports on tuberculosis
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Appendix 8. JBI Critical 
Appraisal Checklist for 
Systematic Reviews and 
Research Syntheses
JBI Critical Appraisal Checklist for Systematic Reviews and Research Syntheses
Reviewer Date     
Author Year    Record Number
Yes No Unclear Not 
applicable
1. Is the review question clearly and explicitly stated?
2. Were the inclusion criteria appropriate for the review question?
3. Was the search strategy appropriate?
4. Were the sources and resources used to search for studies adequate?
5. Were the criteria for appraising studies appropriate?
6. Was critical appraisal conducted by two or more reviewers independently?
7. Were there methods to minimize errors in data extraction?
8. Were the methods used to combine studies appropriate?
9. Was the likelihood of publication bias assessed?
10. Were recommendations for policy and/or practice supported by the reported data?
11. Were the specific directives for new research appropriate?
Overall appraisal: Include Exclude Seek further info
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Appendix 10.  
Quality appraisal 
mediation 
Paper Reviewer 1 Reviewer 2 Reviewer 3 Final score
Beaudoin (2016) 11 7 11 11
Brunette et al. (2004) 7 4 4 4
Carver et al. (2020)5 9 9 9 8
Chambers et al. (2017) 10 11 11 11
Penzenstadler et al. (2019) 9 6 7 7
Wright and Tompkins (2006) 7 2 5 6
5 All reviewers gave an initial score of 9; however, the placement of the scores differed and warranted further discussion.
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Title Date Location 
(country)









Substance(s) Population details Intervention/
treatment overview
Outcome(s) summary Recommendations for 









































to review best 
practice in other 
countries and 
determine if there 
were any lessons 
for Scotland.
REA. Two broad 
searches were 
conducted: 


























a focus on 
homelessness 
and substance 
use (this could 
be alongside 
other subjects), 
if not about 
Scotland, 











all for people 
who use or 
had used 






People who use 
or had used 
drugs and who 
were at risk of 
homelessness, 




the review if 
service users did 
not meet these 
criteria.





floating support to 
















care (CoC), and 
other transitional 
housing models; 
4) The Pathways 
to Housing model; 
5) Permanent 
supportive housing 
(all schemes take 
the form of shared, 
supportive housing, 
in which residents 
either have self-
contained studio 
flats, bedsits, or 











The review describes the 
difficulty with measuring 
outcomes of services, 
as it is not clear in the 
included literature which 
specific outcomes have 
been measured and 
project/programme 
outcomes differ 
significantly. Given its 
extent, the evidence base 
on case management 
and joint working models 
specifically related 
to homelessness and 
people who use drugs 
is surprisingly thin. The 
available USA research 
evidence indicates that 
fixed-set detoxification 
services tend to have 
limited success. There 
is little evidence on the 
effectiveness of single-
site transitional housing 
in Scotland or elsewhere 
in the UK. HF models 
are largely viewed as 
more effective than the 
CoC model in the USA, 
but also have several 
conditions that are 
necessary to ensure that 
services could deliver 
good performance. 
There is not a significant 
evidence base relating to 
permanent supportive 
housing for people 
who are homeless with 
a history of problem 
substance use in the 
UK. It is not clear 
how successful these 
services are at harm 
reduction or supporting 
homelessness. In this 
review, the evidence on 
homelessness prevention 
services within Scotland 
is mixed. Prevention 
services identified also 
tended not to be focused 
on problem substance 
use.
1) Realistic service 
outcomes need to be 
set and these should 
be tailored to individual 
service users; 2) The reason 
for treatment failure is 
often due to placing too 
many demands on service 
users, not providing the 
right range of support, 
and, in particular, not 
recognising the breadth 
and complexity of needs. 
Harm reduction models 
appear to meet with more 
success, even if the goals 
do not meet ‘abstinence’ 
goals. Outcomes including 
harm reduction, sustainable 
housing, improved quality of 
life, and generally increased 
stability can be achieved, 
even for highly vulnerable 
individuals with challenging 
behaviour; 3) Abstinence-
based services can also 
be effective, even if only 
for a minority of homeless 
people with a history of 
substance use; 4) The 
evidence base suggests 
a need for a mixture of 
services; 5) Context needs 
to be taken into account. 
Outcomes in the service-
rich environments of cities 
may be different from what 
is practical and achievable 
in smaller cities, towns, 
and more rural areas; 6) 
Outcome monitoring is 
essential to good service 
design and management. 
Longitudinal monitoring of 
service outcomes should 
be undertaken where 
possible; 7) The evidence 
base suggests that service 
interventions may need to 
be prolonged, creating a 
need for a secure funding 
base; and 8) Modification of 
generic services may be the 
best option in areas where 
numbers of people who are 
homeless and with a history 
of substance use are low.
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Search strategy No. of total 
included 
studies






Substance(s) Population details Intervention/
treatment overview
Outcome(s) summary Recommendations for 















2013 The review was 
international 
in scope. It 
included papers 
published in 
English as well 
as articles in 
French.
What happens 




rehoused? REA of 
the international 
evidence on 










and using HF 





















out by a trained 
information 
specialist in the 




were run to 
identify the 
literature on 
the impacts of 
social, health, 
and community 
support in HF 
models. Firstly, 





was carried out. 
A second, more 
extensive set of 
searches aimed 
to identify 




















included all study 
designs.
All HF services, 





housing in the 
community. 
Treatment for 








People who were 
formerly homeless 
and using HF 
services.
HF services follow 
a harm reduction 
framework 
with a recovery 
orientation. It is 
acknowledged 
that drug use 
occurs, and open 
use of alcohol is 
permitted. This 
tolerance of drug 
and alcohol use is 
accompanied by the 
provision of a range 
of support, either 
direct or delivered 
jointly with other 
services, to enable 
those in HF services 
to reduce, or stop, 
their substance 
use. The end goal 
of harm reduction 
services with a 
recovery orientation 
is the same as that 
for abstinence-
based services 
– but rather than 
instruction to 
immediately cease 
all substance use, 
it seeks to create 
an environment 
where an individual 
can stop or reduce 
using substances 
when they choose 
to do so.
The available evidence on 
the effectiveness of HF 
services, from the main 
studies on HF, suggests 
that, overall, service 
utilisation is associated 
with stabilisation of 
drug and alcohol issues, 
rather than significant 
reductions or increases 
in drug and alcohol use. 
There is no evidence 
that drug and alcohol 
use increase following 
rehousing.
1) Take lessons from other 
services; and 2) Enhancing 
HF in respect of health 
and social integration 
may involve recognising 
that different ‘levels’ of 
success will be achieved 
when promoting and 
enabling better health and 
social integration. Clear 
recognition that achievable 
goals may vary between 
each person using a HF 
service is the first step to 
becoming more precise 
about what HF services 
can achieve. Then, goals 
in relation to health and 
social integration outcomes 
should be defined, set, 













A rapid realist 
synthesis
2019 Undertaken in 








limited by their 




do not identify 
the contexts 
and mechanisms 
that may serve 
as facilitators 














and 2018 which 






Any study type, 










studies, 14 other); 
16 syntheses 





other); 16 brief 


















People who use 
or had used 
drugs, and who 
were at risk of 
homelessness 





Two of the included 
studies found an 
integrated COSMHAD 
day programme to be 
effective for the adult 
homeless population, 
reducing hospitalisation 
rates and decreasing 
substance use.
Policy/system: 1) Create 
incentives in payment to 
providers for integrating 
care of individuals with 
COSMHAD; 2) When 
developing service payment 
agreements, include 
deliverables that recognise 
the long path to recovery; 
3) Analyse the system 
as it relates to access to 
psychological services 
and align providers with 
service needs; 4) Examine 
payment structure for 
peer mentors, coaches, 
and instructors; and 5) 
Explore how resources can 
be allocated to support a 
holistic approach to care 
(e.g. housing, supportive 
employment).
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Search strategy No. of total 
included 
studies






Substance(s) Population details Intervention/
treatment overview
Outcome(s) summary Recommendations for 












related to the use 





A ‘review of 
reviews’
2017 Undertaken in 
the UK but with 
an international 
focus.
To provide a 





























to 2010 were 
included where 
evidence was 













Reviews only. Various 
interventions or 
treatments, not 
all relevant for 
people who are 
homeless. The 









with HIV who 
inject drugs; 
and people 






Not specific to 
people who are 
homeless but did 





people who are 




people with HIV 
who inject drugs, 
and people with 






of the following 
interventions/
treatment for 
people who are 
homeless due to 
increased risk of 










drug use and for 





There was no benefit from 
a mentoring intervention 
delivered in combination 
with drug use treatment 
to adolescents who are 
homeless. Adherence to 
HAART among people 
who use drugs was 
comparable to among 
people who do not use 
drugs. People who used 
drugs and engaged in OST 
had increased adherence 
to HAART and better 
treatment outcomes 
than those receiving 
HAART alone. Evidence 
supported DAART 
alone and integrated 
in medication-assisted 
therapy to improve 
treatment and virological 
outcomes. Findings for 
contingency management 
are inconsistent but 
promising in favour of 
it. Findings for nurse-
delivered interventions 
are inconsistent but 
promising. Individuals who 
received harm reduction 
approaches were 
significantly more likely to 
reduce drug use, but no 
significant differences in 
needle sharing between 
individuals who received 
harm reduction and 
controls were seen.
Because this review was not 
specific to people who are 
homeless, there were no 
specific recommendations 
in this area. However, the 
results in the outcomes 
summary column (see left) 
show what could work for 
future treatment/services 
for this population.
Evidence review of drug treatment services for people who are homeless and use drugswww.hrb.ie 117116
Author (and 
organisation)




Search strategy No. of total 
included 
studies
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treatment overview
Outcome(s) summary Recommendations for 










its Use with the 
Homeless
2017 Undertaken in 
England, but had 
an international 
focus: 9 USA, 






about IPS and 
homelessness. 
How IPS is 
currently being 






and if IPS is a 
viable option 





of IPS with 
a homeless 
population – 








of IPS and its 
effects on those 
experiencing 
homelessness, 
with a minimum 


















Any type of 
study could be 
included, and 







IPS, where the 





People who are 
homeless (at least 
30% of each 
study’s sample), 
but did not look 
specifically at 
people who use 




those engaged in 
services.
IPS is termed 
‘intentional’ 





IPS can be either 
mentorship support 
or mutual support; 
thus, studies that 
are using IPS may be 
using peers as client 
mentors or as an 
adjunct to services 
provided, such as 
combining peers 
and professionals 
in the delivery of 
services. IPS models 
are quite diverse; 
organisations not 
only utilise peers in 
multiple ways, but 
peers may or may 
not be trained and/
or paid for their 
work.
All studies report some 
positive effects of IPS. 
Overall reduction in harm 
related to addiction 
observed. One-half of the 
studies report reduction 
in drug and alcohol use, 
and reducing relapse 
rates. Three studies 
report improvements 
on homelessness: 
decreases in number of 
homeless days, reduced 
relapse to homelessness, 
and reports of an 
overall improvement in 
environment. Positive 
outcomes relate to the 
improvement of the 
participants’ overall QoL; 
specifically, the reduction 
of drug/alcohol use, 
improved mental/physical 
health, and increased 
social support.
IPS can have a positive 
impact on outcomes for 
homeless people. Based on 
the evidence in this review, 
homeless organisations 
utilising peers should focus 
their outcomes on the areas 
where peers are shown 
to have impact, such as 
reduction of drug/alcohol 
abuse/use, increasing 
mental and physical 
health, and increasing 
social support. Practical 
applications of these results 
pertain to the training of 
peers, whereby training 
sessions focus on the 
common elements and the 
identified outcomes. For 
example, peers could learn 
how to use their shared 
experiences in a manner 
that models recovery from 
homelessness.
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included 
studies






Substance(s) Population details Intervention/
treatment overview
Outcome(s) summary Recommendations for 

























were all from the 
USA and Canada.
A policy approach 




America – the HF 
model provides 
rapid housing that 







RCTs for the 









from 1992 up 
to the date of 
the search (15 

























































as ICM or ACT) 
was not used 






























of whether they 
were identified 





Adults (16 years 
and older) who 
meet at least one 










housing. Did not 
specifically look 
at substance use 
but 2/4 studies 
reported on this.
Providing access 










as intended to 
be permanent, 
counting sustained 







with the process 
of securing and 
entering housing 
initiated at first 
contact with the 
homeless person 
and with the aim of 
beginning tenancy 
promptly.
HF resulted in large 
improvements in housing 
stability, with unclear 
short-term impact 
on health and well-
being outcomes. For 
mental health, QoL, and 
substance use, no clear 
differences were seen 
when compared with TAU. 
HF participants showed 
a clear reduction in non-
routine use of healthcare 
services over TAU. This 
may be an indicator of 
improvements in health. 
Two studies reported 
substance use outcomes 
with mixed results.
HF approaches appear 




in several direct 
measurements of short-
term health outcomes, the 
impact of HF is not clear. 
Further evidence could 
be valuable in assessing 
the long-term effects of 
improved housing stability 
on health. HF could be 
implemented with strong 
confidence in its success 
as a housing intervention, 
alongside some confidence 
in a lack of immediate 
adverse effects on health, 
but with caution in relying 
on this model for certainty 
in improved health 
outcomes.
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Outcome(s) summary Recommendations for 
































majority of the 
included studies 
are from the 
USA.
The Pathways to 
Housing model 
has influenced 
the creation of 
several hybrid 
programmes, 
based on the 
HF approach 
combined with a 
range of services 
and diversified 
housing. This 
approach is based 
on the same 
philosophy as the 
original model: 
that people 







In Canada, the 
Government 
plans to primarily 
subsidise 
programmes 




out in several 
databases 




to January 2012 
was the time 
frame within 
which results 
needed to have 
been published 
in order to be 
included, and 









and 14 of 
them were 
excluded due 




























































refers to all the 
programmes 






















on the HF approach 
and any type of HF-
based programme 
with add-ons.
All the studies that 
have compared the HF 
approach with access 
to usual services show 
that participants in 
programmes based on 
the HF approach spend 
more time in housing and 
less time on the street. 
The results of the effects 
on QoL and satisfaction, 
crime, incarceration, 
participation in 
community life, and 
victimisation are mixed. 
Other results show that 
the HF approach does 
not have a more positive 
effect on mental health, 
physical health, substance 
use, or social support 
than access to usual 
services.
In the province of Quebec, 
HF types of programmes, 
typified by varying levels of 
housing and intervention 
intensity, should be 
promoted. However, they 
must take into account the 
ever-present dichotomy 
between the rural and 
urban realities of Quebec.
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Outcome(s) summary Recommendations for 
















on housing and 
mental health 
outcomes.
2015 Undertaken in 




of the best 
available research 







illness and the 





status and mental 
health.
Limited to 
studies in which 
permanent 
housing was 
offered as an 
intervention 
and research 








































who were not 
mentally ill or 
individuals with 
mental illness 











for housing homeless 
individuals with 
mental illness exists 
to guide research 
or policy. Housing 
studies involving 
this population 
are plagued by 












Did not look 
at substance 
use specifically 









in a variety of 
ways. Most of the 
studies did not 








in a variety of ways. 
Seven studies used 
ACT teams and 
others used services 







Majority of participants 
placed in experimental 
housing programmes 
with case management 
support remained in 
housing for at least one 
year or experienced 
more days housed than 
homeless relative to 
a comparison group. 
7 of the 14 studies 
reported mixed 
clinical and substance 
use outcomes. One 
study reported that 
the experimental 
housing condition 
was associated with a 
reduction in substance 
use. Another study saw 
substance use decline 
in both conditions. 
Four studies found 
that the preferred 
housing condition did 
not yield any advantage 
in clinical outcomes 
over the comparison 
or control condition, 
either because no 
improvements were 
found or because 
both experimental and 
comparison groups 
showed similar gains.
There is a need for 
further experimental 
research to inform 
funding and policy 
decisions. The body of 
research is unable to 
answer fundamental 
questions about 
what type of housing 
programme works best 
for homeless individuals 
with mental illness. 
This review of the best 
studies on permanent 
supportive housing 
identified a small base 
of research with limited 
usefulness for decision-
makers seeking empirical 
evidence to justify policy 
choices. The research 
cannot yet pinpoint 
which factors drive 
positive housing and 
clinical outcomes.
Brunette 




















in USA, with 
unclear focus. 
Studies from the 






























people with dual 
disorders, but 
their effectiveness 
was uncertain at 
the time. Authors 
categorised the 
interventions 
as short term 
(average stay <6 
months) or long 
term (>6 months), 
as longer length of 
participation may 















9 of 10 studies suggest 
advantages for 
integrated residential 
programmes that were 
modified to meet the 
needs of clients with 
severe mental illness, 
although each of these 
studies has major 
methodological issues.
Ultimately, a continuum 
of housing supports 
is necessary to serve 
people with dual 
disorders at different 
stages of treatment.
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Outcome(s) summary Recommendations for 
policy and practice 
development
ACADEMIC LITERATURE



































rates of problem 
substance use but 
difficulty engaging 
with treatment 















people who are 
homeless, but 
these individual 
studies need to 
be synthesised to 
generate further 
practice-relevant 












































and 2019, plus 
grey literature. 








(b) was published 
in English; and 
(c) included 
adults aged 18 or 
















Adults aged 18 or 
over who were 
homeless/at risk 
of homelessness 




use (currently or 
in the 10 years 
prior to the study 
being conducted). 
Studies focusing 
on youth were 
excluded.
The 21 studies 
were conducted 
between 2002 
and 2018 in the 
USA (n=11), Canada 




recruited from a 
range of services 
rather than 
directly from the 
streets. 10 studies 
provided insight into 
participant views of 
services generally, 
1 study explored 
a hypothetical 













Participants in all 
types of interventions 
preferred harm reduction 
services and considered 
treatment effective when 




time; choices; and 
opportunities to (re)learn 
how to live. Longer-
duration interventions 
that offered stability to 
service users were valued, 
especially by women. 
Critical components 
of effective substance 
use treatment include 
a service context of 
good relationships, with 
person-centred care and 
an understanding of the 
complexity of people’s 
lives.
Participants considered an 
effective intervention to be 
one which provided long-
term treatment and ongoing 
support to help them to 
achieve stability. There is a 
need for development and 
evaluation of longer-term 
treatment and aftercare 
models, to avoid relapse, 
enhance stability, and 
enhance the likelihood of a 
range of positive outcomes, 
within both harm reduction 
and abstinence-based 
interventions. This desire 
from participants is in 
conflict with the reality of 
services globally, where 
austerity and systematic 
underfunding and cuts 
to services put pressure 
on services to discharge 
people as quickly as 
possible.
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treatment overview
Outcome(s) summary Recommendations for 

















adults and its 
relationship to 
wellbeing
2017 Undertaken in 
the UK, focus is 
international.







factors can have 
an important 
influence 




review on housing 
and well-being 




























































































or carers, and 
providers of 
housing services. 
Had to include 
an intervention 










those who were 
homeless or 
had a history of 
homelessness, 
people with a 
history of mental 
illness, people 







HF (47)‚ other 
interventions for 
homeless people 











Strong evidence that 
HF can improve housing 
stability and measures 
of physical health in the 
short term. Evidence 
was classed as moderate 
for positive effects on 
personal well-being, 
mental health, and 
locality-related well-being 
(i.e. well-being related 
directly to one’s living 
situation and conditions) 
and for absence of effect 
on personal finance and 
community well-being. 
In other interventions 
for people with mental/
physical health problems, 
a key finding was that they 
provide an opportunity 
for recovery but not 
everyone benefits. 




from alcohol or illegal 
drugs. Supportive housing 
found moderate strength 
of evidence for a positive 
effect on housing stability. 
However, strength of 
evidence for well-being 
outcomes was low or very 
low.
Findings may be difficult to 
translate into ‘actionable 
messages’ for policy and 
practice. Providing housing 
support for vulnerable 
people is clearly necessary 
but may not always be 
sufficient to improve their 
well-being and that of the 
community as a whole. In 
considering how to apply 
the evidence, decision-
makers also need to take 
into account the wider 
context, including pressure 
on local authority budgets 
and changes in the political 
environment.
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treatment overview
Outcome(s) summary Recommendations for 
policy and practice 
development
ACADEMIC LITERATURE
de Vet et al. 
(Department 
























2013 Undertaken by 
Dutch/Belgian 
team, focus is 
international: 
20 studies from 
















and June 2011 
in electronic 
databases. The 
title or abstract 
had to indicate 




text article, at 
least one of 
the included 
interventions 
had to be 
identified as 
adhering to, or 
being based on, 
one of the four 


































Participants in eligible 
study samples were 
aged 18 years or over. 
The recruitment 
strategy of the 
study had to target 
a predominantly 
homeless population, 
as evidenced by the 
description of the 
target population, 
recruitment 




SCM, ICM, ACT, and 
CTI for homeless 
adults.
Across the four 
different models, case 
management generally 
seemed to have a positive 
impact on housing 
stability and patterns 
of service use. Findings 
about substance use 
outcomes were mixed, 
and effects on variables 
measuring health, societal 
participation, and QoL 
were largely non-
significant.
To properly inform policy-
makers in the European 
Union, experimental trials 
should be conducted 
among different homeless 
groups in a variety of 
service settings and 
countries. These studies 
should be carefully 
designed. They should 
aim for more uniformity in 
outcomes examined and 
for more standardisation of 
measurement instruments. 
Practitioners could employ 
case management to assist 
homeless persons with 
improving their housing 
stability and changing their 
service use patterns.
Formosa et al. 













2019 Undertaken in 
Canada; unsure 
about focus.

































patients at the 
level of the ED.
13 studies. Included studies 
had a control 







access to the 








Included studies of 
homeless patients (or 
majority homeless 
patients) that 
recruited patients at 








desks, and ED 
compassionate 
care.
8 studies (2 HF) sought to 
improve access to housing 
and 6 demonstrated 
significant reductions 
in homelessness and 
increased access to 
stable housing. 6 studies 
focused on homeless 
people using substances. 
1 found extended-release 
naltrexone feasible in a 
homeless demographic. 
3 case management 
interventions reported 
reductions in alcohol 
and substance use and 
enrolment in substance 
use treatment. 1 study 
found no change in 
opioid overdose rates 
after opioid overdose 
education harm reduction 
initiative.
ED is in a unique position to 
try intervening in breaking 
the cycle of homelessness. 
While ED programmes that 
directly connect people 
with housing are beneficial, 
studies of ED-initiated case 
management can have 
similar results.
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to improve the 
health of the 
homeless: a 
systematic review
2005 Undertaken in 



















































analyses of RCT 
data where the 
intervention was 
not the same as 
that allocated in 
the original trial.
Interventions 
































as part of the 
population had to 
include at least 
half who were 
homeless and 
report the results 
separately.
Studies of any 
intervention 
provided by 
primary care, or 
to which homeless 
patients could 





(usual care). Those 
included in the 


























for homeless adults 
with mental illness or 
substance use generally 
result in better health 
outcomes than usual 
care. Cash incentives 
were effective in 
increasing adherence to 
tuberculosis screening 
and improved completion 
rates; education 
initiatives improved 
HIV risk behaviours in 
runaway youth; outreach 
services reduced 
primary care utilisation 
in homeless families 
and children; education 
programmes reduced 
injection drug use among 
homeless women; and 
compassionate care 
reduced ED visits.
Practice: The authors stated 
that clinicians should focus 
on directing homeless 
people to tailored, 
coordinated treatment and 
support programmes.
Research: The authors 
stated that future studies 
should include usual 
care control groups and 
address the diversity of 
the homeless population, 
with focus on the needs 
of runaway youth and 
homeless families and 
children.
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2009 Undertaken in 


































in English in 
peer-reviewed 
journals.
Not reported. (1) The target 
population 
(homeless, with 
addiction or mental 
illness); (2) Use of 
quantitative data; 
(3) A comparative 




a linear or HF 
approach; and (4) 
Inclusion of housing 
outcomes. Several 
non-comparative 
studies (e.g. case 
series) were 
included if they had 




More than 350 
communities in 







































the long-term goal 
of returning to 









depends on the 




from drugs and 
alcohol.
HF reports document 
excellent housing 
retention, despite the 
limited amount of data 
pertaining to homeless 
clients with active and 
severe addiction. Several 
linear programmes cite 
reductions in addiction 
severity but have 
shortcomings in long-
term housing success and 
retention.
This article suggests that 
the current research data 
are not sufficient to identify 
an optimal housing and 
rehabilitation approach for 
people who are homeless 
and use substances. The 
research regarding HF and 
linear approaches can be 
strengthened in several 
ways, and policy-makers 
should be cautious about 
generalising the results of 
available HF studies to those 
with active substance use 
when they enter housing 
programmes.
O’Campo 

















































2009 Undertaken in 







based partners to 
conduct a realist 
review focusing 
on both whether 
programmes are 
successful and 
why and how they 
lead to improved 
outcomes. 
















present a list 









authors of the 
included studies 
to learn more 
















on the 10 
programmes.
All English literature 
since 1980 with 
keywords related 
to interventions 
and mental health 


















































and SUDs that 








and a holistic 
approach through 
which many of the 








approaches to the 
same strategies.
Authors identified six 
important and promising 
programme strategies that 
reduce mental health and, 
to a far lesser degree, 
substance use problems: 




client and provider, ACT 
approaches, providing 
supportive housing, 




Continuous involvement of 
community-based agencies 
in various stages of the 
research process. While 
experience and expertise 
from the community 
partners was key in the 
integration of knowledge, 
the evidence gathering 
process, as well as the 
extraction and synthesis 
phases, the authors were 
particularly motivated 
to retain involvement of 
these key stakeholders to 
maximise the chances that 
the evidence will be used 
to change or inform current 
practice or policy.
Evidence review of drug treatment services for people who are homeless and use drugswww.hrb.ie 135134
Author (and 
organisation)




Search strategy No. of total 
included 
studies





Substance(s) Population details Intervention/
treatment overview









































the UK, and 
Canada; focus 
is international. 
Most of the 
studies originate 
from the USA 
and one from 
the UK.
The ACT model 
was originally 
developed for 
patients with a 
severe mental 
illness but has 
been adapted 
for patients with 





This paper aims 
to assess the 
effectiveness of 
ACT for patients 






















2017 found on 
the electronic 
databases.
The key elements of 
the ACT model are 
assertive engagement, 
delivery of services 
in the community, 
high intensity of 
services, holistic and 
integrated services by 
multidisciplinary teams, 
and continuity of care. 
In order to provide a 
high intensity of care, 
the caseloads are small 
and in the original 






in the studies 
had a diagnosis 
of SUD. Two 
datasets included 
homeless patients 
and two datasets 
included patients 
with high service 
use.
The services in 
the included 
studies all used the 
principles of ACT 
in their approach, 
with services 
provided in the 
community, assertive 
engagement, high 
intensity of services, 
small caseloads, 24-
hour responsibility, 
a team approach, 
and multidisciplinary 
working.
The results of the 
very few existing RCTs 
are mixed. Treatment 
engagement was higher 
for ACT in four datasets. 
One dataset reported 
higher service contact 
rates for the ACT group 
than for controls. In 
two datasets a positive 
effect on hospitalisation 
rates was found. Higher 
fidelity to the ACT model 
appears to improve 
outcomes. Substance 
use reduced only in 
half of the datasets, of 
which only one showed 
a significant reduction in 
the ACT group.
The research base is 
variable concerning 
the usefulness of 
ACT in the field of 
addiction. Higher 
fidelity to the ACT 
model appears to 
improve results 
and studies often 






‘ingredients’ of ACT. 
This would help to 
conceptualise a 
specific ACT model 
that may be more 
effective. Further 
research is needed 
to examine which 





in order to 
innovate treatment 
approaches and 
reach out to 
patients.
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2012 Undertaken in 










a framework and 
strategies for 





lists of located 
articles.












that goes one 
step beyond a 
discharge plan, 
where during the 
first months after 
discharge, when a 
client’s relationship 
with people in 
the community 
may be fragile, CTI 
strengthens the 
client’s adjustment 
to the community 
by pairing the client 
with a social worker 




the client to 
appointments, 
and helps the 
client develop 
relationships with 
people at the 
appointments and 
provides advice in 










the treatment goals 
and methods and 
engages the client 
to explore his or her 
own understanding 





emerged from a literature 
review: (1) ensuring an 
effective transition for 
individuals with COSMHAD 
from an institution; (2) 
increasing the resources 
of homeless individuals 
with COSMHAD by 
helping them apply for 
government entitlements 
or supported 
employment; (3) linking 
homeless individuals 
to supportive housing, 
including HF options 
as opposed to only 
treatment first options, 
and being flexible in 
meeting their housing 
needs; and (4) engaging 
homeless individuals in 
COSMHAD treatment, 
incorporating modified 




This article suggests four 
components: (1) ensuring 
effective transition of 
homeless individuals from 
institutions into community 
living; (2) helping them 
apply for government 
entitlements and obtain 
supported employment; (3) 
linking them with supported 
and supportive housing; and 
(4) applying and combining 
modified ACT, clinical 
case management, MI/
Motivational Enhancement 
Therapy, CBT, contingency 
management, and 
specialised 12-step groups 
to maximise treatment 
effects.
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use of homeless 
persons]
2018 Undertaken in 







is one of the 
most prevalent 
health problems 
in people who 
are homeless. 







of substance use 



























and French in 




















Case management is 
an option with effective 
results either as a 
single intervention or 
in combination with 
others. Programmes 
that combine case 
management and 
interventions carried 
out in the context of 
interdisciplinary teams 
(nursing, medicine, 
psychology, and public 
health) have better 
results than standard 
interventions.
Nursing must be involved 
in programmes that 
develop feasible and 
effective interventions 
that reduce the health 
problems in people who 
are homeless. Apart from 
being effective alone, it 
could be accompanied 
with good results by 
other interventions 
such as contingency 
management with positive 
reinforcement or incentives, 
artistic therapy, health 
prevention and promotion 
programmes, and 
multidisciplinary teams.








































therapy on the 
incidence of 
hepatitis C virus 
in injecting drug 
users: pooling of 
UK evidence
2011 Collaborative 
study by various 
researchers 
across the UK, 





therapy and NSPs 























































therapy) and a 
measure of newly 
acquired HCV 
infection among 























not look at 
homeless people 
specifically, 
but each study 
sample contained 
between 32% 
and 62% of 
people who were 




PWID are opiate 
substitution therapy 
to reduce drug 
dependence and 
injecting frequency, 
and the provision 
of clean injecting 
equipment through 
NSPs to reduce 
unsafe injecting 
(i.e. sharing used 
syringes).
Both receiving opiate 
substitution therapy 
and high NSP coverage 
were associated with a 
reduction in new HCV 
infections. Full harm 
reduction (on opiate 
substitution therapy 
plus high NSP coverage) 
reduced the odds of 
new HCV infection by 
nearly 80% (adjusted 
odds ratio (AOR)=0.21, 
95% confidence interval 
(CI): 0.08–0.52). Full harm 
reduction was associated 
with a reduction in self-
reported needle sharing 
by 48% (AOR=0.52, 95% 
CI: 0.32–0.83) and mean 
injecting frequency by 
20.8 injections per month.
NSP, especially if combined 
with opiate substitution 
therapy, was effective, and 
supports recommendations 
within the UK, Europe, 
and globally on the need 
to expand NSP and opiate 
substitution therapy to 
prevent HCV infection. The 
question remains on what 
levels of opiate substitution 
therapy and NSP coverage 
(and behaviour change) are 
required to drive down HCV 
prevalence (and whether 
these are sustainable).
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pertaining to the 
healthcare of 
homeless people 















The review was 









1966 to 2003 
included.























Looked at people 
who are homeless 
but, in their 
search, included 
key terms relating 
to substance use, 









and hepatitis A and 
B immunisation, 
safer injecting 
advice, and access 
to needle exchange 
programmes. 
There is emerging 
evidence for the 
effectiveness of 
supervised injecting 
rooms for homeless 
injecting drug users 
and for the peer 
distribution of take-
home naloxone in 
reducing drug-
related deaths. 




those with mental ill 
health, supportive 
programmes to 
aid those with 






health can lead to 
lasting health gain.
Effective interventions for 
drug dependence include 
adequate oral opiate 
maintenance therapy, 
tetanus and hepatitis 
A and B immunisation, 
safer injecting advice, 
and access to needle 
exchange programmes. 
Emerging evidence for 
the effectiveness of 
supervised injecting 
rooms and for the 
peer distribution of 
take-home naloxone in 
reducing drug-related 
deaths. Some evidence 
that assertive outreach 
programmes for those 
with mental ill health, 
supportive programmes 
to help address alcohol 
dependence, and informal 
programmes to promote 
sexual health can lead to 
lasting health gain.
As multiple morbidity is 
common among homeless 
people, accessible 
and available primary 
healthcare is a prerequisite 
for effective health 
interventions. This requires 
addressing barriers to 
provision and multi-agency 
working so that homeless 
people can access the full 
range of health and social 
care services. There are 
examples of best practice in 
the treatment and retention 
of homeless people in 
health and social care, and 
such models can inform 
future provision.
Evidence review of drug treatment services for people who are homeless and use drugswww.hrb.ie 143142
Author (and 
organisation)




Search strategy No. of total 
included 
studies





Substance(s) Population details Intervention/
treatment overview
Outcome(s) summary Recommendations for 
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2006 Undertaken in 






of this research 
project was to 
examine the 
effectiveness 
















five years and 
reference 




























were eligible for 
inclusion.
A significant 








































































and 1-hour group 
session (covering 
AIDS education, HIV 
testing, condom 
use, use of bleach 
to sterilise injecting 
equipment, and a 





and 2-hour session 








discussion of coping 
skills, and enhancing 
self-esteem.
There is concordance 
between the studies that 
sexual health promotion 
interventions resulted in 
increased knowledge of 
both sexual risk and drug 
issues. The interventions 
also initially led to a 
reduction in sexual 
risk and a reduction in 
drug use. There was no 
concordance between 
the studies regarding 
whether the effect of 
the intervention was 
sustained over a 2-year 
period. The relationship 
between the intervention 
and psychosocial 
outcomes appeared 
to be more complex. 
Broadly speaking, the 
interventions improved 
psychosocial functioning.
Brief interventions appear 
to confer significant 
benefit. However, there 
is a need for further 
implementation and 
evaluation of health 
promotion activities in 
the UK context which 
target the individual, the 
social setting, and societal 
structure. There is a need 
to formally plan, initiate, 
and evaluate interventions 
to promote sexual health 
among UK homeless drug-
using populations.
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